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Abstract
Bardet-Biedl syndrome (BBS) ischaraclerized by retinal dYSlrophy, dysmorphic
extremities, renalslructural abnonnalities, obesilY, and hypogenitalism in males. This
:lulosomal recessive disorder is genetically heterogenous with four identified loci, BBSI-4
(11q, 16q. 3p and ISq respectively). BBS is a relalively I1lre disorder, bul it is
approximately ten limes more prevalent in NewfOWldland than in northern European
populalions.
To investigate the high incidence of BBS in Ihe Newfoundland population.
members of 17 BBS families were analyzed by haplotype and linkage analyses. rnilially,
linkage of five families to 8BSI. one each to BBS1 and BRS] and exclusion of six
families from the four kno"'T1 BBS loci was observed.
A large consanguineous Newfoundland BBS family. excluded from the four
known BBS loci......as used to idenlify a fifth BBS gene locus (BRSI) on 2q31 in a
genome-wide scan. However, this gene did not segregate in any other of the five
unlinked families. Therefore, another genome scan was implemented on a
consanguineous family excluded from the five BBS loci. Evidenc:e ofa sixth BBS gene
(BBS6) on 2Opl2 was established and the critical interval narrowed to 2 cM using five
other unlinked families. located within this region is a putative chaperonin gene (MKKS)
involved in McKusick-Kaufman syndrome.:I disorder wilh an overlapping phenotype
with BBS. When MKKS was screened for mutations in six Newfoundland BBS families,
one missense and two frameshift mutations were identified. Thus. ",(KKS was the first
gene identified to eause BBS. Reman:ably, one familyeould be eltduded from all six
BBS loci. indicating the aistenee ofa sc\'enth BBS gene (BBSn.
By mutational and/or haplotype and linkage analyses. it was possible to assign 14
of the 17 Newfoundland BBS families to known BBS loci. Silt families had mutations in
MKKSlBBS6. five families wen:: associated with the BBS/locus. and one family to eaeh
of the BBSl. BBS] and BBS5Ioci. Additionally. one family was eltduded from the six
known BBS loci. The discovery ofMKKSlBBS6 should aid in the aseenainment ofother
BBS genes and contribute to the basic understanding of the manifeslations ofBBS.
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Chapter I Introduction
1.1 A Brief I.troduetioa to tke Tilesis
The island ofNcwfoundland. where the subjects studied in this thesis originate.
has long been regarded as isolated from the rest ofCanada. Newfoundland has a
population ofapproximately half a million persons, a quarter of which are located in the
capital city ofSt. John's. The remaining majority of the populace is spread over an area
of III 390 km1. Such a sparse population density has contributed to the many small.
isolated communities which sprung up on the shores of the island. These communities
were traditionally founded on the coastal regions because fishing was the primary
industry of the Newfoundland people. An environment such as this may be partially
responsible for the increased prevalence ofa particular aulosomal recessive condition in
Newfoundland - Bardet-Bicdl $)-ndrome (BBS).
Bardet-Biedl syndrome. a relalively rare condition worldwide, is a systemic
disorder. The primary characleristics include retinal dystrophy, renal abnonnalities. limb
malformations. obesity and hypogenitalism in males. At the origin of this study. only the
approximate chromosomal locations (spanning regions 2;9 cM) of four BBS genes (BBSI.
4) were known. Newfoundland was considp.red a suitable community 10 detenninc more
information aboullhe genetics of this rare disease because of: (I) Ihe relatively higher
incidence ofBBS in Newfoundland (2) the well characleriz~ nature of the disease in 17
BBS families on the island (3) the highly cooperative nature oflhe families involv~ and
(4) the unique population struclure of the pro\"ince. It is the purpose oflhis thesis 10
genelicaJly characlerize the 17 BBS families and atcempt 10 identify one or more of the
genes causing BDS in these kindreds.
1.1.1 The Settling of Newroundland
To understand the genetic disposition of the inhabitants of the island of
Newfoundland. elucidalion of the origins and migratory patterns of Ihe founders of our
contemporary population is necessary. The peopling of Newfoundland was unique in
North America in the maintenance of its isolation and the restriction of founding
communilies to the coastline. Settlements have been comparatively isolated unlil modem
times. As well. most immigrants originat~ from one oflwO highly localized areas: the
southwest of England and the southeasl oflreland.
AI first. in the late 16- and early I"" centuries, there was a migratory fishery
conducted by European nations who discouraged pennanent seUlemenl. This continued
until the late ISill century. Seasonallishermen stayed during the summer to work on the
inshore fishing ships and returned home in autumn. Later, a few remained over the
winter for one or two years, some being accompanied by women and children. This
began the transition to pennanent settlements. However, during the I~ and IS·
centuries. less than 5% of temporary British migrants became permanent senlers
(Mannion. 1986). This slow rate ofcolonization would be a familiar theme over the
follo\lo'ing centuries.
The first permanent British settlements established in the early 17th century were
ones erected by the will of the merchants, to han'est the fruits oflhe land and sea - furs
and seals. Colonies in Conception Bay and the Southern Shore of the Avalon Peninsula
were created. However. by the end of the 17111 century. there were only approximately
3000 colonists in 30 communities spanning the area between Bonavista Bay, in the nonh,
and Trcpassey. in the south. In the second quaner of the IS" cenlury, lhe scllicment rale
of the English intensified and small colonies were founded increasingly westward in the
south, and nonhward and westward in the north. due to the increase in resource
diversification during the non-fishing months. Between 1725 and 1775, a relativdy large
growth spurt occurred because of increasing demand for cod in Europe. There was an
increase: in women and children amvingon the shores of Newfoundland at this time. but
there still remained a great number ofunattaehed adult males in the population. indicating
thai the seasonal and temporary sectors remained aclive (Mannion, 1986).
Migration and pennanent settlers from southwest England and southeast Ireland
increased dramatically during the early 19'" century and continued to do so until the mid
I830s. In these three decades, primarily duc to influx of migrants, the population of
Newfoundland almost quadrupled. from 19000 to 75 000 people. Of the 45 000 persons
.....ho came otTthe British ships al this time. approximately 75% .....ere Irish. 23% English
and 2% from the Channel Island of Jersey. However. it is impossible to mow how many
orthese remained pennanmt residents ofNewfoWldland. lntttestingly. there were (1,0,'0
major migrations of Irish during this time. one between 1811 and 1816 and the other
between 1825 and 1833. The English. on the other hand. maintained a relatively constant
rate of immigration and. since they had been the earliest inhabitants. there was now an
even ratio of English to lrish on the island. A ratio of53:47 percent. favoring the
English. not only described the derivations of the inhabitants but also their religious
affiliation. as almost invariably English was synonymous with Protestantism. and Irish
..... ith Catholicism. Although the migration of peoples increased during this era, what
contributed most profoundly to the lasting population was the marked increase in women
and children. Now there was an availability of female spouses for the many young single
men (Mannion. 1986).
Unlike most other New World colonizations. the majority of~t1lers to
Newfoundland can be pinpointed to merely a few localized origins in England and Ireland
o\'er the history ofthe migration. English emigrants came from the contiguous counties
of Devon and Dorset and the neighboring areas ofSomerset and Hampshire in lhe
southwest of England. These were the source areas that contained the pons involved in
the Newfoundland migratory cod fishery. In the southeast of Ireland the situation was
similar. The majority oflrish involved in the cod fishery originated within a 30 mile
radius of the city of Waterford, including regions of Wexford, Kilkenny, Tipperary. Cork
and County Waterford. Up until the mid to late 171tJ century there was intermingling of
the two nationalities because almost all persons were transponed by English ships.
Originally, the Irish settled in the same areas as the English, between Trepassey and
Bonavista Bay. However, over time the Irish tended to predominate on the Avalon
peninsula and the English elsewhere. This pattern can still be recognized today
(Mannion, 1986).
Once the major migrations had concluded after the 1840s, natural increase became
the dominant mechanism of population growth. By the 201tJ century approximately
221 000 people inhabited Newfoundland and Labrador, and the population doubled again
by the early I960s, slowly increasing until it reached a maximum of 58 I 800 in 1984
(Census of Canada, Census of Newfoundland). The steady increase in population
resulted in the establishment of new settlements. Community expansion usually occurred
in one of three ways: by partitioning ancestral land among heirs; by movement to nearby
uninhabited lands inside the seulement core; and by migration funher west on the nonh
and south borders of the coiony. This eventually led to settlements further along the west
and north coasts of the island. The former two mechanisms were, by far, the most
common and kept related families close together. This was a strong theme in the
peopling of Newfoundland (Mannion, 1986).
During the 191tJ century, the cod fishery remained the primary source of income.
However, in the 1880s, with an increasing populace in the outports relying on the same
resources, the average intake of fish by fisherman had declined to only one quanerofthat
harvested in the early part of the century. Due 10 lack of increase in fish prices and Ihe
added expense of imported goods, the economy began to decline and communications
and transportation within the island was slowed. Also, in the last two decades of the 19'"
ccntury, growth oflhe population decreased substantially. This was attributcd to the
emigration of many persons to the Uniled States. These were primarily Irish
Newfoundlanders, who heard from relatives lhat there was work to be obtained for
artisans and laborers in the New England stales. Due to the stagnancy of the economy,
the outport communities became increasingly isolated from the outside world and from
each other(Mannion, 1986).
Scenarios were prescnt throughout Newfoundland's colonization and subsequent
continued habitation that were unique in the New World, creating a population that was
isolated, homogenous and partitioned into small, separale communities. Firstly,
Newfoundland is separaled from mainland centers by hostile waters, historically making
tra\'elto and from the island difficult Secondly, the majority of immigrants originated.
over almost the entire period ofsettlement, from only a few distinct locales in England
and Ireland. The settlement of the island lranspired at a slow pace o....er centuries as
seasonal fishennan became temporary inhabitants and eventually pennanent. However.
during this time there were two periods of punctuated immigration - during lhe third
quarter oflhe 18'" century and early 19'" cenlury. From these migrations came most of the
present population, As well, communities were set up primarily on the coast and
remained relatively small. isolated entities. In 1982, approximately SOO!o ofthe
population lived in communities of fewer than 2 500 inhabitants and 41 % in communities
fewer than 1000 people (Bear el al., 1987), Such a social climate and geographical
distribution of peoples may have lead to a static gene pool. Families were isolated in
small communities, constructed by environmental and socio-economic conditions that
encouraged kinships to remain adjacent to one another. Perhaps for these reasons, one
hereditary recessive disease, Bardet-Biedl syndrome, is approximately ten fold more
prevalent here than in the original Nonhem European populations (Beales et ai" 1997).
1.2 Pheno~'pe of Bardel-Riedl S,'lIdrome
Initially, the cardinal manifestations of Bardet-Biedl syndrome were considered to
be retinal dystrophy, polydactyly, obesity, mental retardation and hypogonadism
(Cockayne etal., 1935; Bell etal., 1958; Klein and Amman. 1%9), Recently, an
additional cardinal feature has been added - renal abnormalities (Churchill et al., 1981;
Cramer el aJ., 1988; Bmford et at., 1997; Beales el at., 1999). Also, Green el al. (1989)
suggested that mental retardation should not be included in the cardinal manifestations,
and that hypogonadism and polydactyly should be modified to hypogonadism in males
and dysmorphic extremities, respectively. The discrepancies in the essential features of
BBS may be due to the different ethnic origins of the patients included in the studies.
Also, the completeness of the clinical evaluations on the patients and their families,
particularly regarding renal imaging, has been a factor. Other problems include the lack
of follow up of affected children who have not yet developed particular features; and, in
the case of testing for mental retardation, the absence of an appropriate exam for the
visually impaired. Howcver, for consideration orBBS in this thesis, an individual must
have had at least four ofthe six cardinal manifestations, which include: retinal dystrophy.
dystrophic extremities, obesity, learning disabilities, hypogonadism and renal dysfunction
(Green el a/., 1989; Beales et a/., 1999). Beales el al. (1999) recently proposed a new
diagnostic scheme which stated BBS patients must have four of the six cardinal features.
or three cardinal features and two secondary features. The laller includes speech disorder
or delay; strabismus, cataracts or astigmatism; brachydactyly or syndactyly;
developmental delay, polyuria or polydipsia; ataxia, poor coordination or imbalance; mild
spasticity; diabetes mellitus; dental abnormalities; hepatic fibrosis; and congenital heart
disease.
1.2.1 Relinal Dystrophy aad Other Ocular Maaireslatioas
Retinal dystrophy in Bardet-Biedl syndrome has been well documented due to its
prevalence, inherent complexity and ease ofevaluation. In three large reviews of BBS,
the presence of retinal dystrophy was reported in at least 91% of the patients. making it
the most prevalent manifestation, and one that will most likely lead to a successful
diagnosis of this disorder (Bell, 1958; Klein and Ammann, 1969; Beales et af., 1999).
However, there is a large degree of variability in the age of onset of blindness and in the
spectrum of the retinal disease. Also, there is a lack of consensus on the mechanism of
the retinal dystrophy.
Many studies have shown the heterogeneous nature ofretinal abnormalities in
BSS patients (Klein and Amman 1969; Bergsma and Brown, 1975; Green et af., 1989;
Leys et af., 1988; Jacobson et af., 1990). Regardless of the variety of retinal dystrophy,
electroretinogram (ERG) results have been shown to be abnormal before pigmentary
changes arc apparent; thus it is a useful aid in early diagnosis (Francois et af., 1954;
Prosperi et af., 1977; Campo ct al.. 1982; Fralick et af., 1990; Lavy et al., 1995).
In some studies, retinal dystrophy consisting of rod·cone degeneration was a
predominant finding in patients who had had an ERG performed (Klein and Amman.
1969; Campo et al., 1982; Jacobson el al.• 1990; Lavy et al., 1995). These investigations
suggested that the retinopathy is a widespread receptor disorder affecting the peripheral
rods initially and later affecting the cones in the macula and periphery. This progression
has been termed typical retinal dystrophy. Iannaccone et af. (19%) went as far as to
hypothesize that the rods are congenitally non-functioning and the cones degenerate
shonly after binh.
However, there is some evidence that cone dysfunction occurs prior to rod
dysfunction in some BSS patients (Schachat and Maumenee. 1982; Rizzo et aI., 1986;
Yagasaki and Jacobson, 1989; Jacobson el af., 1990). It should be mentioned that no case
or BBS in which an abnormal ERG was observed has been rollowed by a nonnal ERG.
Typical retinilis pigmentosa wi!h !he presmce or bone spicules is round only in
approximately 15% to 20'1. oreases. wi!h fundus changes in the majority being 'atypical'
(Klein and Ammann. 1969: Ehrenreld el 01., 1970; Runge et al., 1986). Wrinkling.
hypopigmentalion, bull's~ lesions and geographic atrophy orthe macula have also
been noticed in patients (Campo et 01., 1982: Jacobson et al., 1990; Hrynchalc, 2000).
The heterogeneity observed in these studies may reneet a speclrum of disease wilhin the
syndrome or the description or patients at differenl points or development oflhe disease.
Despitc varied presenlations of retinal dystrophy, scvere visual loss always occurs.
Studies have shown that visual acuity is modcratcly rtduced at the beginning oftcenage
years, with rapid deterioration by the Ihird decade (Klein and Ammann, 1969; Runge et
aI., 1986: Leys er al., 1988; Riise e/ 01., 1997). Visual evoked responses (VER) were
often normal in childhood but deler10n1ted with age (Ehrenreld el 01., 1970; Campo ef
01.. 1982; Jacobson el 01., 1990: Lavy el 01., 1995; Beales er aI., 1999). Compared with
isolated typical retinitis pigmentosa.. BBS patients have a more rapid progression or visual
1055, with a mean orscven years rrom diagnosis to blindness (Be,des er 01., 1999).
Unfortunateiy, relinal dystrophy is not Ihe only ocular abnormality occurring in
BSS. Beales el 01. (1999) noted astigmatism, strabismus, cataracls, color blindness,
macular oedema and degeneration and optic atrophy. Ehrenreld el af. (1970) observed
cataracts in one of their patients as did Schachat and Maumenee (1982). Myopia, ptosis
and microphthalmia have also been reported (Rizzo et al., 1986). Nystagmus was
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documented in twins with BBS (GoUlob and Helbling, 1999), and in a Scandinavian
study cataracts and myopia were lttquently observed (Riise e( a/.. 1997).
Ckular histopathology in BBS has not~ investigated extensively. In the few
studies done. patients were over 18 years of age and had end stage retinal degeneration
(Klein and Ammann. 1969; Bisland., 1951; Lahav et af.• 1977). or the patients were so
young they may not have had time to develop pigmemary retinopathy (Mcloughlin and
Shanklin, 1967). However, the eyes ofa four year old boy considered [0 have Bardet-
Biedl syndrome. who died shonly after a renal transplant. showed photoreceptorcell
degeneration without significant ehanges in the retinal pigment epithelium (RPE) (Runge
et al.• 1986). The authors noted se\'ere lesions in the macula with both rod and cone
degeneration, although no underlying mechanism for these features was determined.
There was a build-up ofIipofuscin and other granular inclusions in the RPE cells thaI
were hypothesized to have acewnulated because of a problem in lysing and voiding of an
ingested phagocytic load. ~ authors suggesled the problems in the RPE could be
secondary to biochemical anomalies within the outer segments (e.g. an inability of the
photorectptor cell membranes 10 evoke a proper phagocytic response). The conclusion
that the photoreceptors were the primary problem was strengthened with the observance
that the RPE was nonnalthroughout the tissue. but the overlying photoreceptors were
either normal. absent or damaged. Some problems with this study were the small sample
size and the fact that the deceased may not have had BBS. Some of the manifestations
described in Ihe boy, like the mild mental retardation and the mild ataxia, may have been
"
the result ofhis chronic renal failure. There was also an extensive family hisloryofrenal
disease. In addilion. obesity and hypogonadism were nol ~ed, although often !hc:se
clwacteristics do nol present at such a young age.
More recently, work on membrane fatty acids has shown an enrichment of
polyunsaturated fatty acids in !he cell membranes of BSS patients thai may indicate
increased lipoperoxidation uhimately resulting in the development of relinal degeneration
(Corrocher et ai.. 1989). Abnonnal retinal vascularity has also been observed which
could be a nonspecific response to the metabolic imbalance following degeneration of
photoreceptors or RPE (Campo et al.• 1982; Sek et al., 1995).
In the Newfoundland BSS population. all patients presented wilh severe retinal
dystrophy (Green et al.. 1989). All tested patients had markedly constricted visual fields.
severe abnomtalities ofcolor vision, raised dark-adaptation thresholds and extinguished
or minimal rod-eone responses on ERG (Green et ai.. 1989). Of28 patients examined.
two (go;.) had a typical retinitis pigment0S3 with dense bone spicule pigmentation. pale
optic disks and attenuated vessels. Eighteen patients (69%) had an atypical retinal
dystrophy with sparse pigmentation. central and peripheral atrophy, attenuated vessels
and mild to severe optic disk pallor. Six patients (23%) had severe macular dystrophy
with only sparse pigment clumping in the mid-periphery. However, four of these six
patients had night blindness at the time ofstudy, indicating rod involvement. In two other
patients. the retinas were not visible because of dense cataracts. In the len families with
more than one affected individual. the retinal dystrophy was similar in all affected family
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members.
In 1993, eight additional patients were ascertained and examined (O'Dea el 01.•
1996). At this time, 86% of the 36 patients examined were legally blind, compared with
none of the 45 siblings evaluated. The age range ofrccorded legal blindness was 5 to 29
years. Twcnty-five percent were legally blind by the age of 13, 50% by 18 and 100% by
age 30. The five patients not legally blind at last examination were all under the age of
12 years.
Other ocular abnormalities which are often associated with retinal dystrophies
were also observed, including myopia, astigmatism, nystagmus, glaucoma, posterior sub-
eapsularcataracts and mature cataracts or aphakia (O'Dea et al., 1996).
1.1.2 Limb Ab.crmalities
Postaxial polydactyly (PAP) is often the first indication of Bardct-Biedl syndrome,
being observable at birth. However, PAP is not a universal finding. Reports of the
proportion ofpatiems with this manifestation have varied from 45% (Riise el al., 1997) to
about 70% (Bell, 1958; Klein and Ammann, 1969; Beales et aI., (999). Polydactyly may
occur in only one limb or as many as all four (Klein and Amman, 1969). However, the
lower limbs seem to be more often affected than the upper: Klein and Ammann (1969)
found isolated hexadaclyly affecting the feet twice as often as affecting the hands, and
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Beales el af. (1999) observed polydactylous toes three times as often as polydactylous
lingers.
Only one study has investigated the skeletal anomalies in a large group ofBBS
patients through radiography (Rudling et al., 1996). In this report, 43 Scandinavian BBS
patients were examined. Thirty-three of these patients (77%) had PAP of the hands. feet,
or both. Short linger and toe bones were frequently secn and a high percentage of
patients had flat rather than rounded distal joint surfaces of metacarpals and metatarsals.
There was no difference in right and lell limb findings and no typical polydactyly
'pattems' were found within families. Interestingly, Beales et af. (1999) also observed a
lack of any familial pattern, emphasized by a set of monozygous twins in which one had
polydactylyofthree limbs and the other had no polydactyly.
Green etaf. (1989) reported PAP in 18 of31 (58%) BBS patients in
Newfoundland. Seven of 18 (39%) patients had polydactyly of both the hands and feet,
nine had polydactylyofthe feet only, and two of the hands only. Thirteen of26 (50%)
patients tested exhibited brachydactyly using anthropomorphic measurements, but 14 of
15 (93%) had brachydactyly with the use of metacarpophalangeal proliles. Most patients
(90%) had syndactyly, polydactyly, or both. Both Beales el af. (1999) and Green et af.
(1989) reported that in families with more than one affected member, there were patients
with and without polydactyly.
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1.2.3 Obesity
Obesity, from mild to severe degree, is the second most common manifestation in
Bardet-BiaU syndrome patients. after retinal dystrophy. It is uncommon in children
younger than three years old, usually beginning in childhood and increasing in SC\'Crity
with age (Dckaban el aJ.• 1972; Bauman and Hogan. 1973). HowevC'!". patients can
reduce their weight with diet and exercise regimes. In adults, the obesity is usually
restricted to the trunk and proximal limbs and Icss frequently to the face (Hrynehak.
2000), but it has been deseribed as diffuse and non.specific in distribution during early
life (O'Dea el a/.. 1996).
Methods of measurement of obesity have changed since the first large scalc
studies ofBBS took place. Klein and Amman (1969) based their obesity estimates on
weight alone, comparing these with the nonnal population distribution. and calling
weights ovC'!" the S<rl' pen::cntile as obese. Using this evaluation ofobesity, 96% of their
patient population was obese. Similarly, Bell (1958) observed obesity in 91% ofher
patients. In more rc<:ent studies, the body mass index (BM!) "fan individual
(.....cightlheight1) has been calculated. In a study of 25 Scandinavian BBS patients, 22 of
25 (88%) individuals were regarded as obese, with obesity defined as a BM! grcaterthan
28 kglml (Riise et al., 1997). Beales el al. (1999) reported that 72% of their cohort of
109 patients were obese. a lower proportion than previously observed. They suggested
this was a result of their more stringent criteria (a BMI > 29 kglmlwas considered obese).
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The criteria for obesity in the Newfoundland cohort of Bardet-Biedl patients was
weight for height greater than the 90'" percentile in relation to average adult Canadian
men and women (Green et aJ., 1989). With this standard, 22 of 25 (88%) patients were
obese. Three were considered to be of nonnal weight, two of whom were previously
obese. Five patients lost substantial amounts of weight on calorie-restriction diets.
Twelve patients (48%) were considered grossly obese, with weight well above the 951tl
percentile. Female Bardet-Biedl patients were more obese than their affected brothers
(O'Deaetal., 1996).
1,2,4 Renal Abnormalities
Renal abnonnalities were a frequent finding in early BBS studies (Mclaughlin
and Shanklin, 1967; Alton and McDonald, 1973; Falkner et aI., 1977; Linne el aJ., 1986),
and recently have been considered a sixth cardinal feature ofBBS (Churchill el af., 1981;
Cramer el aJ. 1988; Hamell et aI., 1988; Green el aJ., 1989; Anadoliiska and Roussinov,
1993; Beales el aJ., 1999). Early diagnosis of renal disease was initially made by
computed tomography, but now, with the use of high resolution ultrasonography, there
has been a marked increase in reports of prenatal and perinatal renal findings (Ritchie el
aI., 1988; Garber and Bru)TI, 1991). Structural or functional renal anomalies have been
reported in 100% ofBBS patients in one series (Harnett et aJ., 1988). Renal involvement
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is progressive and dictates the clinical outcome in approximately 50% of reponed cases
(Dippel! and Varlam, 1998).
In early BBS studies, the renal involvement was detected because of symptomatic
disease in late childhood or adolescence (Dippel I and Varlam, 1998). Polydipsia,
polyuria, reduced concentrating ability and aminoaciduria as symptoms of tubular
dysfunction are often the first renal clinical signs in patients with BBS (Tieder et aI.,
1982; Fralick et Ilf., 1990). Other indications of renal involvement such as hypertension
and urinary tract infections are less common symptoms (Anadoliiska and Roussinov,
1993). Unfonunately, renal involvement was usually identified when chronic renal
failure or end stage renal disease (ESRD) developed (Alton and McDonald, 1973; Hurley
et al., 1975; Linne et al., 1986).
Many histological changes of the kidney have been noted in BBS including
mesangial proliferation and sclerosis, cystic dilatation of the tubules. conical and
medu]larycysts, chronic cell infilttation and peri-glomerular and interstitial fibrosis
(Hurley el al., 1975; Price et af., 1981). Pathological studies of kidneys from patients
with BBS suggest that renal disease originates mainly from the medullary cyst
involvement (Dippel I and Varlam, 1998). The tubulo-interstilial changes and the cyst
fonnations may be related to underdevelopment and defective connection of the tubular
systems in the fetal kidney (Anadoliiska and Roussinov, 1993).
The spectrum ofrenal disease has been comprehensively documented in the
Newfoundland BBS population (Hamett el al., 1988; O'Dea el al., 1996), without the
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referral bias which has beset other studies (Hurley et aI., 1975), because almosl all
patients have been ascertained through ophthalmologic r«ords. Almost all
Newfoundland BBS patients had either structural and/or functional renal abnormalities.
Initially, 23 patients with BBS, ranging in age !Tom three to 52 years, underwent renal
imaging with ultrasound and urography (Cramer et al., 1988). Twenty-two of 23 (96%)
patients had calyceal clubbing or blunting, and calyceal cysts/diverticula were evident in
17 patients (74%). Veslcoureteral reflux was only observed in one patient. and thus was
not the cause of the calyceal changes in most patients, as had been suggested previously
(Hurley et (It.. 1975). Rather, these abnormalities are probably dysplastic in nature.
Twenty-one patients (91%) had fetal lobulation of the kidney and diffuse cortical loss was
evident in six patients (26%), of which three (13%) had impaired renal function. Fetal
lobulation has been observed in other BBS studies (McLaughlen and Shanklin. 1967;
Alton and McDonald, 1973; Beales el at.. 1999), and is normally seen in the fetus and
neonate but usually dissipates during maturation. From these findings Crameret al.
(1988) proposed that the combination ofcalyceal clubbing and diverticula, and fetal
lobulation may well be diagnostic ofBBS.
Among the Newfoundland patients. 17 (74%) had concentrating defects and seven
(30%) had acidification def«ts, but there was no relationship to the severity of the
calyceal orcyslic changes on the intravenous urograms (IVU). This lack ofcorrelation
between the structural and functional abnormalities suggests that microscopic changes
may be responsible for the altered function rather than obvious structural ones (Cramer el
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aI., 1988). They concluded that lVU is the best method for defining Ihe calyceal and
cystic changes, but sonography will reveal cortical changes.
O'Dea ef 01. (1996) reevaluated the importance of renal impainnem in the natUl"3I
history of BBS in Newfoundland. A lotal of38 patients, ranging in age from I to 63
years, and 58 unaffected siblings were studied in 21 families. Renal impainnent was
observed in 9 of 36 (15%) BBS cases. with the earliest age ofonset being two years. By
nge 48,25% ofBBS cases had chronic renal insufficiency whereas only one unaffected
sibling had mild renal impainnent. This lower frequency ofESRD in BBS patients
contrasts with previous repor1s (Alton and McDonald, 1973; Hurley et al., 1975; Linne el
01., 1986), but these previous studies may be biased. The patients studied in previous
investigations were referred because of a specific renal problem. and thus may represent
the subset of BBS patients who have more severe renal disease.
Twenty-five of38 (66%) Newfoundland BBS patients were hypertensive,
compared with only 5 of 45 (II %) oflhe unaffected siblings. Longevity was significantly
reduced, as 25% of affected individuals died by the age of44, compared with only 2% of
unaffected siblings. Of the eight patients who died by last follow-up, six (75%) had
developed renal failure at lime ofdeath, while only one unaffected sib had died, and that
was ofa myocardial infarction. Renal transplantation was successful in one individual
from this series. A few other incidences of renal replacement therapy have also been
reported (Linne el 01., 1986; Williams ef al., 1988; Norden et af., 1991; Crocker et af.,
1994; Beales et aI., 1999).
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In the Newfoundland BBS cohort, which was ascertained through
ophthalmological records. 100% of patients had renal abnormalities. From these
observations, the combination of calyceal clubbing and diverticula. and fetal lobulation
were considered to be diagnostic of BBS. Thus, renal manifestations were considered a
sixth cardinal feature.
U.S H}'pogonadism in Males
The presence of small testes and very small penis has been documented in most
males with Bardet-Biedl syndrome. The incidence of hypogenitalism ranges from 74%
(Bell, 1958) to 96% (Beales el ai., 1999) in the large BBS review studies. Almost all the
literature on hypogenitalism is based on a qualitative definition of the trait. Very few
endocrine studies have been undertaken. thus the origin of male hypogonadism is not
determined (Toledo et ai.• 1977; Green el af., 1989). In one investigation. hypothalamic-
pituitary-gonadal function was evaluated in three male siblings with BBS. and testicular
biopsies were performed (Toledo el ai., 1977). The authors suggested an evolving
gonadal disorder that progresses throughout adult life. Mozaffarian el af. (1979) reported
a patient with germinal aplasia in one testis, incomplete spermatogenesis in the other. and
a failure of the genitalia to respond to 11 months of testosterone treatment.
Seven ofeight (88%) Newfoundland male patients had small testes and very small
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penises (Green el al., 1989). Three (38%) patients had high basal follicle stimulating
hormone (FSH) levels and, in all eight, FSH responded to pituitary stimulation. Two
(25%) had low testosterone levels. Three had supranormal responses 10 gonadotropin
releasing hormone, but in the remaining five, response was normal. One patient (13%)
had high basal lutcinizing hormone levels. Male fertility has bcen reported in just one
instance· in an Iranian patient having seven offspring (Ghadami et aI., 2000).
1.2.6 Other Observed ManifestalioBs in Bardet·Biedl Syndrome
Many abnormalities other than the cardinal manifestations considered above have
been associated with Bardel-Biedl syndrome. In the past, hypogonadism in both sexes
and mental retardation were considered primary characteristics of BBS. The clinical
features dcscribed below are important when considering BBS as a diagnosis.
1.2.6.1 Cogdive Defidt
Initially, mental retardation was regarded as a cardinal manifestation of Bardet-
Biedl syndrome (Biedl, 1922; Cockayne et af., 1935; Bell, 1958; Klein and Amman,
1%9). However, during this period, intelligence tests, if any were employed, did not take
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into account sevettly impaired vision. Also. most often. BBS cases were not diagnosed
until visual loss had become debiljtating and it ...."a$ too late to address the situation
educationaJly or socially. Under these circumstances. most, ifnot all. individuals would
'appear' mentally retarded. The social implications of being ~mental1yretarded" at these
times would. ofcourse. be an additional barrier in obtaining educational aid Today, with
earlier diagnosis and an appropriate environmenl, many people with BBS are capable of
much more independent lives r«ulting from increased education (G~ et ai.• 1989:
Riise et ai.• 1997: Beales et ai.• 1997). Riise el ai. (1997) reported that the majority of
their 25 Scandinavian patients functioned within the nonnal range of intelligence with no
obvious differences from their unaffected sibs. Be31es el 01. (1997) results were less
favorable. but still reassuring. with 8 of28 (28"1.) children capable of remaining in
mainstream education. although with classroom aids. Another 28% went to s~ial
schools based on educational needs apart &om vision loss.
In the Newfoundland aas c:ohort. only a minority of patients (41 %) were
diagnosed mentally retarded when appropriate verbal and perfonnance IQ tests for the
visually impaired were used (e.g. the Haptic lntelligtnee Sc:ale). Perfonnance IQ tests
results were llSually better than verbal scores., espetially in patients with a good fonnal
education. Six patients achieved grade 9. one a university degree. and another takes
computer courses (Parfrey el af.. 1997). Although learning deficiency varies among
individuals with BBS. and indeed within families. some leaming difficulties are present
in many cases.
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1.2.6.2 Hypogonadism i. Females
As discussed above, hypogenitalism was originally determined 10 be a primary
trait ofBardet-Biedl syndrome (Biedl. 1922; Cockayne el al.• 1935; Bell, 1958; Klein and
Amman, 1969). It has now been relegaled to the category of 'other features'. The
incidence of hypogonadism in females. which is more difficult to detect, is not as high as
in males. Unlike in males. there have been several cases ofreproductive success in
femaies (Bell, 1958; Green el al.• 1989; Riise et al., 1997; Beales et al.. 1997). Studies
on females with BBS have failed to identitY a consistent primary or secondary endocrine
dysfunction (Lcroith et al.• 1980; Campo and Aaberg. 1982; Lee et al.• 1986). However.
Green et al. (1989) observed that 12 patients of reproductive age had irregular menstrual
periods. one patient (8%) had hypogonadolropic hypogonadism. and two (16%) were
hypoestrogenemic. but with high or normal gonadotropin levels. Several women had
abnormally high luteinizing hormone levels and high normal prolactin levels, which are
characteristic of polycystic ovary s~drome. However. their ovaries were normal on
ultrasound. although. in some cases. visualization was limited by obesity.
There have also been reports of structural urogenital abnormalities in female BBS
patients (McLoughlin and Shanklin. 1967; Klein and Ammann, 1969; Nadjimi el al..
1969; Campo and Aaberg, 1982; Srinivas et al.• 1983). Sioler el al. (1995) reviewed the
literature for structural anomalies and reponed two cases of vaginal atresia in women
with BSS. Additionally, Mehrotra et al. (1997) and Oguzkurt et al. (1999) reported three
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more cases of vaginal atresia. Stoler et af. (1995) found II instances of female structural
genital abnormalities including those identified in the Newfoundland population (which,
in two cases, they counted twice) (Cramer et al., 1988; Green et aI., 1989). The majority
ofthcse patients had hemato- or hydrometrocolpos. More subtle findings, such as
abnonnally placed urethra or asymptomatic vaginal atresia, are likely under reported
hecause often a complete pelvic examination is not performed. These structural genital
abnonnaJities are an important part of the phenotype orBBS in females.
1.2.6.3 Diabetes Mdlitus
In Newfoundland, diabetes mellitus was reported in 12 or38 (32%) BBS patients.
compared with none of the 45 unaffected sibs (O'Dea et al., 1996). Twenty-five percent
ofpatients were diabetic by age 35 and 50% by age 55. All patients had large increases in
serum insulin levels after a glucose load, suggesting insulin resistance. Thus, diabctcs in
this cohort was probably type II (Parfi'ey et al.• 1997). This was a much highcr rate than
was found by Klein and Ammann (14%; 1%9).
Seven patients (6%) had non-insulin dependent diabetes mellitus (NIDDM) in a
study in the United Kingdom (Beales et al.• 1999), and three patients (12%) of
Scandinavian origin were also reported to have diabetes mellitus (R.iise et aI., 1997). The
fonner study stated that NIDDM in BBS was a consequence of severe insulin resistance.
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Obesity is likely involved in the palhogenesis. by creating a reduclion orcellular insulin
tteeplors. which leads to a decre.sed insulin sensitivity and an increase in insulin levels
(Parfrey et aJ.. 1997). In at least one stud)', diabetes has been observed as a dittet cause
ordeath (E.scallon et al.• 1989).
1.2.6.4 Cardiac M•• irfStalioas
McLoughlin et af. (1964) reviewed the literature or330 published cases orBBS
and noted nine cases or congenital heart derects. Heart malronnations have occurred
mostly in males (Moench. 1954; Blume! and Kniker. 1959; Spigolon el al., 1959).
Acquired heart disease has been nOled r~uenlly in association with hypertension and
renal disease in patients with BBS. Twenty-two BBS patients or Bedouin descent were
subjected to echocardiography(EKG) in a tteenl study(Elbedour et ai.. 1994). Seven
patients (32%) showed an EKG abnonnalilY. and three orthesc (43%) were determined to
have a definite congenital anomaly. Beales et aJ. (1999) also reponed congenital hean
derects in eight patienls (7%).
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1.2.6.5 Additio..1Prae.t.tio.s
Dental anomalies. first documented in 1960 (Magnusson), were frequenlly found
in Bardet-Biedlsyndrome palients when an appropriale on.l assessmenl was perfonned
(Borgslrom er al.• 1996; Beales et al.• 1999). The mosl significant findings were
hypodontia. smalll~th. enamel hypoplasia. short roots and a thickened mandible. as well
as a high arch palate. Twenty-seven pert:ent (29 of 109) of patients in the Beales et 01.
(1999) study had dental problems. Kobrin el of. (1990) reported the first case of
oligodontia (Ihe lack ofa large number orteeth) in a BBS patient.
Hepatic fibrosis has been reported previously (Ross et al., 1956; Meeker and
Nighbert_ 1971; Pagon et 01., 1982; Nakamura et al., 1990) but has not been properly
assessed in most BBS studies. Thus. the true frequency of hepatic fibrosis is unknown.
Early onset asthma was reponed in 28 of 109 (25".) patients in the Beales et 01.
(1999) study, all of whom were from kindreds linked [0 the DDS/locus. This prevalence
is three times as high as the United Kingdom general population pmoalence (7%).
Other traits which have betn observed in patients with Bardet-Biedl syndrome
include: Hirschsprungdisease (Maeda er 01., 1984; Radelli et al., 1988; Islek er 01., 1996;
Parfrcyet 01., 1997; Beales et 01., 1999; Lorda-Sanchez et al., 2(00), anal atresia (Biedl,
1922; Kalangu and Wolf, 1994), spffi:h deficit (Beales el 01., 1999), behavioral
difficulties (Klein and Ammann, 1969; Green el af., 1989; Beales ef al., 1999), poor
motor coordination and mulliple widespread pigmented naevi (Beales el al., 1999).
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1.3 Dis~mlen Onrtappiaa i. Pbuotypc "Ua. Bardet-Biedl SYllldrome
Due to me number and variability of manifestalions in Bardel·Biedl syndrome,
mere are numerous s)ndromes which overlap wim BBS in some manner. Howe,<er, me
disorders most oRen identified in the differential diagnosis of BBS are Lawrence-Moon.
McKusick-Kaufinan. Alstrom and Biemond II syndromes (Table 1.1).
1.3.1 Laurence-Moon-Bardel-Biedl Syadrome _An Hislorltal Perspeclin
The nosology of syndromes combining the manifestations ofocular defects,
hypogonadism, obesity, mental retardation and eXlremity malfonnations has been fraught
with difficulties. The phcnlype now called Bardet·Biedl syndrome \l:as not originally
termed mis, nor is its name presently use:d in a consislent way in medicallileralure.
Initially, Laurence and Moon. in 1866, described four members ofone family with short
stature. hypogonadism. mental retardation and spinocerebellar ataxia. Also, all four had
nystagmus; two had bone corpuscle pigmentation orthe fundus. and IWO had choroidal
atrophy. At this point, the described syndrome was called Laurence-Moon. later,
members orthe same family were reviewed by Hutchinson (1900) and were noted to have
developed spastic paraplegia, which was added as a feature of this disorder. Then in
1920. Georges Banlet described a little girl with infantile obesity, polydactyly of the right
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Table 1.1 S}'.dromes wilb di.kat ra..ifeslaliolls wbid. ovtrtap witlil 8BS
(+. prat.t; -.•bsul).
Features 8.nlel- L••rnll:e- McKasKk- Alslrom 8ielllOlld
8iedl ..... K..fma• n
Pigmealary
relinopalb}'
Reaal +1-
abnormalilies
Obesity
Hypogenilalism
Limb
abaormalilles
COl.itivt dertdl
Deafeess
Spastic
panplecia
lrismloboma
Hydl'OlDrU"1KOlpos +1-
Co.geailal beart +1- +1-
disease
Mode of autosomal autosomal autosomal autosomal auto. fee.
iallerilance recessive recessive recessive recessive auto.dom.
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foot. and retinitis pigmentosa. Soon after. Artur Biedl (1922) added hypogenilalism.
menial retardation. anal alreSia and skull defonnilies to the description of Bardet., as well
as his name. to form Bardet-Biedl s)TKlrome. Unfortunaldy. this was not the end of this
nomenclature lale. In 1925. Solis.cohen and Weiss observed four cases in a single
family with what would currently be tenned Bardet-Biedl syndrome. However. they
defined it as Laurence-Biedl s)T1drome - combining the two syndromes. From there.
other fonns w~ fashioned including Laurence·Moen-Biedl and Laumlce-Moon-Bardet-
Biedl (LMBB), depending on Ihe scientist and what was in vogue.
Schachat and Muamenee (1982) performed a literature review of the Laurence-
Moen syndrome as described by Laurence. Moon. and Hutchinson and discovem:l21
cases which fit that criteria. However. as slated above, Baniet-Biedl and Laurence-Moon
were lumped together in the 19205, and called Laurmce·Moon-Bardct-Biedl s)TKlrome.
It was later acknowledged. by many, that L\iBB syndrome actually comprised two
separate syndromes, BBS and Laurence-Moon syndrome. The latter is characterized by
ocular abnormalities. mental retardation. hypogenitalism and spastic paraparesis (Lancel,
1988). It differs from BaS by the absence ofobesity, malformations ofthc extremities
and renal abnormalities, and by the presence of neurological complications. The
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recognition ofa distinction between the twO syndromes is not universal however.
Physicians and scientists in NOM America generally distinguish befv,'een the lWO
syndromes. bUI in the United Kingdom. there is a lendency to refer 10 BBS as LMBB.
Like B8S. Laurence·Moon syndrome exhibits an autosomal recessive inheritance pattern.
No genetic locus has yet been idenlified for Laurence-Moon syndrome. perllaps due 10 the
dearth of identified families.
1.3.1: I\IcKusick-Kaufmaa Syndrome
McKusick·Kaufman syndrome (MKS) was firsl described in two Amish families
in 1964 by McKusick t!( al.. and Ihe diagnosis confirmed in other families by Dungy e( al.
(1971) and Kaufman t!t al. (1972).
The cardinal manifestations of MKS are hydromelrocolpos (HMC), present in So.
95% of females, and polydactyly present in about 95% of males and females.
Addiltonally, congenilal henn disease: (CHD) occurs in approximately 10-10 ofall patients,
and hypospadias has been documented in males. For females without a family history.
HMC with distal vaginal agenesis or a transverse vaginal membrane and PAP are
considered sufficient clinical evidence of MKS. Over 90 cases have been recorded to
date (David et al.• 1999; Slavotinck and Biesecker. 2000).
HMC occurs because ofa failure to canalize the junction between the inferior
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uterus and the vagina. Usually identified at birth. the accumulalion ofsecretions cause
distension of the abdomen and can be associated with respiratory compromise. edema or
hydronephrosis (Slone et 01.• 1998). These complications can be life-threatening.
Until recently. the phenotypic overlap between MKS and 885 had been
overlooked in the literature. Polydactyly is the manifestation most frequenlly occwring in
both syndromes. However. vaginal atresia which is frequently present in MKS. but rare
otherwise. has been reponed in at least 16 female 885 patients. Olher instances oflower
urinary- tract anomalies have also been described in BBS (Vcrlocs et af.. 1997; David et
01., 1999; Siavolinek: and Biesttker, 2000). CHD has also been associated with BBS,
although infrequently. In reviews by McLoughlin el 01. (1964 and 1967). 90f330
patients had CHD and a repon by Chitayat et af. (1987) associated CHD with BaS 9"'/. of
the lime. More recently, Elbedour et 01. (1994) examined a series of Bedouin patients
having cardiac manifestations including cardiomyopalhy. pulmonary stenosis and
bicuspid aortic valve in II of22 (SOOt.) BSS patients.
Nine female patients with genital and digital anomalies. and consequently
diagnosed with MKS in infancy, were studied in follow-up by David et of. (1999).
Because oflhe development of retinal dystrophy, obesity. mental deficiency and/or renal
abnormalilies. a new diagnosis ofBBS was assigned. The authors suggested that MKS is
an over-diagnosed condilion, thai children with polydactyly and HMC do not necessarily
have MKS. They also suggested that these children should be followed closely to
determine whether other BSS manifestations occur later, especially retinal dystrophy.
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Thus, studies ofMKS without long tcnn follow-up should be interpreted cautiously.
In a literature review of49 MKS patients of non·Amish descent, 15 MKS patients
of Amish descent and 19 patients with BBS who were mis-diagnosed as having MKS in
the neonalal period. Slavotinek and Biesecker (2000) concluded thaI there were no
features allowing reliable differentiation of the two syndromes in the neonatal period.
However, it was noted that uterine. ovarian and fallopian tube anomalies (other than
HMC) are more common in BBS patients, and these may be useful in discriminating
between the two syndromes in the newborn.
In order to map the gene for MKS, Slone et 01. (1998) employed two large
consanguineous Old Order Amish pedigrees. originally idcntified by McKusick (1978).
They perfonned a genome screen using microsatcllite genetic markers. searching for
homozygosity by descent (HBD) in affectcd individuals. Through this method they
identified an MKS gene locus on chromosome 2Op12. By observance of recombinations
in the large Amish families, a region ofone centimorgan (cM) was identified as
containing the putalive MKKS gene. An extension of the physical map already assembled
by others looking for the Alagille syndrome gene, now known to be JAGI, was created
and the critical interval for MKKSwas narrowed to less than 500 kilobases (kb).
As a follow up. Stone et 01. (2000) sample-sequenced the MKKS critical region
looking for unique genomic sequences. A six exon transcript with a predicted open
reading frame (ORF) of570 amino acids and two alternative 5' tcnninal exons was
discovered. This transcript was expressed in a wide range ofadult and fetal tissues,
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including skeletal muscle, hean, testis, brain and kidney. The authors looked for
alterations in two MKS families; one was the large Amish family in the previous study
and the second a non-Amish sporadic MKS patient. Alterations were found in both.
AITected individuals in the Amish family were homozygous for the complex allele
H84YtA242S in exon 3. The sporadic patient was a compound heterozygote for a
substitution (Y37C) in exon 3 and a two base pair deletion (deIGG) in elton 5. A mouse
homolog was cloned. sequenced. and a tissue expression pattern similar to the human one
was observed.
Interestingly, three individuals (two females and one male) from the large Amish
kindred homozygous for the H84YtA242S mutation had no apparent manifestations of
the disorder. Thus, the authors suggested, MKS could be considered incompletely
penetrant, a phenomenon never previously clearly demonstrated for a human autosomal
recessive syndrome.
The putative human protcin product ofMKKSwas compared with protein
database infonnation and showed greatest similarity to the archebacterial chaperonins and
the t-complex-related proteins (TCRP). Comparison of the presumed folding pattern of
the MKKS protein with the database suggested it was most closely related to the
thennosome of Thermoplasma acidoplu'lum, a member of the group II chaperonin family
(Stone el al., 2000).
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1.J.J AIs1rom Syadro,.
Obesity. rainal dystrophy, diabetes mellilus and pro~ive scnsorineur.tl
deafness were: !he characteristics which Aistrom ~t 01. (1959) first described in lhm:
individuals. He and co-workers slated thai Alstrom syndrome (AlMS) differs from
Bardet-Biedl syndrome in its lack of polydactyly, menial deficiency and gcnilal
anomalies. However, in 1969. Klein and Amman added acanthosis nigricarls and male
hypogenilalism 10 the list of manifestations of ALMS. Other features which have been
associated wilh ALMS include cardiomyopathy, renal and hepatic degeneration.
hypothyroidism. insulin resistance, growth honnone deficiency. progressive baldness,
hyperuricemia. hypercholesterolemia, h)'pCrtriglyceridemia, gynecomastia and reduced
fel1ilily (Russel-Eggilt ~/ 01.. 1998).
The ocular phenotype of Alslrom syndrome differs from BBS in its severity;
nystagmus occurs by one year ofage, pholophobia is common and the ERG is
exlinguished or shows cone-rod dystrophy in infancy. Usually in ALMS, a patient's
vision is severely impaired by !he end ofthc first decade; bone spicule pigmcnlation is
not common nor is the bull's eye maculopathy (Millay et 01.. 1986: Russel-Eggilt et aI.,
1998). ALMS is also differemiated from BBS by ils progressive deafness. usually
beginning in childhood, and the frequem presence of acanthosis nigricans.
Although there have been only approximately 70 cases of ALMS reported, there
have been sludies concerning its molecular genetics conducted. An autosomal recessive
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mode of inheritance had been presumed, as consanguinity was documented in a number
ofcases (Alstrom et al., 1959; Klein and Amman, 1969; Charles et aI., 1990; Marshall et
al., 1997). Collin and associates (1997) e:<amined a large consanguineous French
Acadian kindred witn ALMS to determine the chromosomal location of the ALMSl gene.
Firstly, they tested candidate gene regions for linkage. Since tne mouse mutant tubb)'
shared phenotypical similarities with ALMS including obesity, insulin resistance and
retinal and cochlear degeneration, they hypothesized tflb a good candidate. tllb is located
on mouse chromosome 7, syntenic with human chromosome Ilp15. However, no
linkage was identified. Then the authors tested linkage to syntenic regions of other
mouse obesity genes, includingfat, ab, A" and db and growtn·associated candidate genes
like growth hormone (GH). GH receptor and GH releasing factor. Once again no linkage
was found between the disease and these loci. A genome-wide scan was then
implemented and a putative locus covering a 14.9 cM region on chromosome 2plJ was
identified. Subsequent confirmation of this locus and its refinement to a 6.1 cM region
was made (Macari et al., 1998; Collin et aI., 1999). Candidate genes identified in this
region include transforming growth factor alpha (TGFA), a cell membrane cytoskeleton
gene (ADD2), the BI subunit of ATP6(ATP6BI), dynactin I (DeTNl) and tachykinin I
receptor (TAC1R), all of which have been excluded by mutational analysis (Collin el 01.,
1997 and 1999) or because they are associated with phenotypes which do not wholly
overlap with ALMS (Bianchi etal., 1994; De Felipe el 01., 1998; Karel etal., 1999).
More recently, a gene from the sodium bicarbonate cotransponer (NBC) family, NBC4,
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has been cloned and isolated to 2pl3 (Pushkin et al., 2000). It has been suggested as an
ALMS candidate because of its chromosomal location and expression patlem
1.3.4 Biemo_d II Syndrome
Biemond. in 1934. described two siblings with a BBS-like syndrome. consisting
of short stature. iris coloboma. mental retardation. preaxial polydactyly and
hypogenitalism. He called this group of manifestations Biemond If syndrome (B52).
Hydrocephalus and hypospadias were included later in the syndrome description.
Because of the clinical variation between the original rcport by Biemond and subsequent
papers, Verloes et al. (1997) reviewed the literature on BS2 and categorized the few
existing eases of BS2. The six categories included: (I) BBS with fortuitous iris coloboma
or aniridia; (2) BS2 in its most strict fonn· the initial report; (3) a "new" dominantly
inherited fonn ofcolobomatous microphthalmia occasionally associated with obesity,
hypogonadism and mental retardation; (4) cytogenetically proven Rubinstein-Taybi
syndrome; (5) an unclassifiable, early lethal genetic syndrome; (6) a "new" coloboma-
zygodactyly-clelling syndrome.
For most families. the mode of inheritance appears to be autosomal recessive;
howevcr. there have been reports of autosomal dominant inheritance in twO families
(Grebe, 1953; Blumel and Kniker. 1957). Also, Verloes el al. (1997) diagnosed three
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patients that could be grouped into the dominantly inheriled eoloboma-obesilY-
hypogenitalism-mentaJ rcwdation syndrome (category] above). Due to the paucity of
cases and the ambiguilyofthe phenotype. it is unccn.ain ifBS2 actually exists. or is an
allelic fonn ofother relaled syndromes. such as BBS.
1.4 Prevakece of Bardel·8iedl Syndrome
The prevalence ofBardet-Biedlsyndrome varies greally among the populations
studied thus far. Klein and Ammann (1969) estimated a prevalence of I in 160000 in
Switzerland: in No......·ay it is I in 128 000 (Loflerod et al.• 1990) and in Denmark. 1 in
59 000 (Haim. 1992). The frequency in the United Kingdom was later ..'Slimated al I in
125000 (Beales el al.• 1997). Howe\'er. some smaller populations have a much higher
prevalence. The Bedouin of Kuwait have a prevalence of approximately I in I] 500. the
highest known rate in the world (Far.lg and Teebi, 1989). Newfoundland also has a
similarly high prevalence of 1 in 17 500 (Grttn el ai" 1989). These higher figures may
be explained by higher coefficients of inbreeding in smaller populalions. For example. in
a United Kingdom study, 8'/0 of affecled patients had consanguineous parenls (Beales el
al., 1999): while in Israel, Switzerland and Newfoundland. which are more homogenous
populations, a higher proportion of patients had consanguineous parents (50%. 48% and
]5%. respectively)(Amman, 1970; Ehrenfeld el al.• 1970; Green el af., 1989). Bell
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(1958) estimated that 39% of patients in a study of273 BBS patients from around the
globe had consanguineous parents.
The sex ratio for an autosomal recessive disorder is expected to be a I: I ratio. For
BBS. there seems to be a slight male preponderance. Among 462 patients examined in
four major studies. a 1.3:1 ratio was observed, favoring males (Bell. 1959; Klein and
Ammann. 1969; Green et al.. 1989; Beales et al., 1999). A breakdown of these studies
showed that the Newfoundland BBS population, consisting of38 individuals. exhibited a
perfect I: I ratio of males to females (O'Dea el al.• 1996). A smallcr study of BBS
patients in Scandinavia. consisting of 25 patients. exhibited a higher male predominance.
with 16 affected males and nine females (Riise el al., 1997).
Due to the identification of four BBS loci, the distribution ofBBS could be
described by loci. In three studies examining North AmericanlEuropean populations
(Beales et aJ., 1997; Bruford el al.• 1997; Katsanis el aJ.. 1999), BBSI families accounted
for between 36% and 56%, BBS2 between 24% and 27%. and BBS4 between 32% and
35% of BDS pedigrees. Only one family had been mapped to the BBS3 locus at the star!
of this thesis (Sheffield et al.• 1994).
1.5 Genelic Heterogeneity of Bardet·Biedl Loti
Originally, only a single BBS locus was predicted because of the rarity of the
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syndrome and complexilY oflhe phenotype. However, this turned OUI to be an erroneous
assumption, as four BBS loci had been mapped by 1995.
1.5,1 Bardet-Riedl Syadrome 1
Using 28 North American kindreds of Nonhern European descent, as well as three
Hispanic families, a locus for Bardel~Biedl syndrome was identified on chromosome
Ilq13 (Leppert el al., 1994). Genetic markers spanning Ihe genome were used to locate a
possible disease locus in 219 individuals, including 67 affected persons. Statistical
significance for linkage between the disease in these families and markers at two loci on
chromosome 11 q was demonstrated. One marker, PYGM, is the gene for human muscle
glycogen phosphorylase and the other, D115913, is anonymous. The additive lod score
forall)1 families was 4.31 (8"'0.15) at PYGMand 4.02 (8=0.13)at D/15913. Multi-
point linkage analysis using PYGM and the closest nearby marker,INT2, increased the
totallod score to 4.59 (6=0.20). Seventeen of the )1 families exhibiled posilive lod
scores at PYGM and 17 showed negative lod seores, indicating locus heterogeneity.
Taking the 17 families giving a positive lod score at PYGM,the authors localized
the gene to a 12.8 cM region by analyzing additional markers around PYGM and
D/ /59/3. No recombinations occurred between PYGM and the disease gene, and thus, it
was the favored position for a BSS gene. The confidence interval, based on the I lod
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difference, extended approximately I cM proximal to PYGM and 2 cM distal to PYGM.
At this time, two possible candidate genes were reponed in the critical region of8BS/.
Genes for Best Vitellifonn Dystrophy,ajuvenile macular dystrophy, and ROM/, which
encodes a protein present in the rod outer segment ofthe retina, were both excluded as
BBS/ because they were expressed solely in the retina.
1.5,2 Budd-Riedl Syndrome 2
Not intuitively, the discoveryoflhe BBS2 locus, in 1993, occurred previous to
that ofBBS/ (Kwitek-Black el at., 1993). Two large consanguineous Bedouin families,
containing a total of 21 patients, were utilized to map a BBS locus to chromosome 16q21.
Both families were clinically distinguished from Laurence-Moon syndrome through their
lack of spastic paraplegia and presence of polydactyly and obesity; from Alstrom
syndrome, by lack of deafness; and from Biemond syndrome by absence of iris
colobomata.
Before perfonning a genome wide scan on these kindreds, the authors examined
candidate loci for possible linkage with the disease. Loci included as candidates were
retinitis pigmentosa loci on chromosolT.e 8, 7p and 7q; Usher syndrome loci on Iq, lip,
Ilq, and 14q; the rhodopsin locus on 3q; and the Best Vitelli form Dystrophy locus on
Ilq. Once these loci were excluded, the authors proceeded with the screen. Linkage was
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detected on chromosome 16 in one family. A statistically significant k>d score of 4.2
(8~) was observed at 0/6$408. After furthergenotyping. a region ofbornozygosity was
shown to extend 18 eM. behl.·een D/6S4/9 and 0/6S165. A significant multi-pointlod
score was obtained [5.3 (0-0)) with the best location for the disease gene at 0/6S408. In
conclusion. they presented strong evidence for a BBS gene on chromosome 16q21.
When additional genetic markers became available between D/6S4/9 and 0/6S265 this
family was used to narrow the critical region to 1.5 Mb (Kwitek-Black et 0/.• 1996).
The second Bedouin kindred. genealogically unrelated to the fonner kindred. was
also studied with additional chromosome 16 markers. However. BBS in this family was
excluded from linkage to 0/6$408 and adjacCflt markers by statistically significant
negative lad scores of less than ·2.0 (8=0). Thus. evidence for genetic heterogeneity of
BBS was provided.
With the Bedouin kindred excluded from the BBSliocus above, Sheffield er a/.
(1994) genotyped over 200 microsatellile markers in an efTort to find a third BBS locus.
Success was found with markers on the short ann ofchromosome 3. Microsatellite
D3S1753 provided the highly statistically significant two point lod score of7.52 (6=O).
Additional markers wen:: typed around D3S/ 753. By haplotype analysis, a critical region
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of II cM was obtain~. This interval extend~ belween D1S/254 and D1S/102 on 3p 13-
pl2.
A fourth BBS locus was identified with yet anothcr large, consanguineous
Bedouin kindred (Carmi f!t ai., 1995b). Once again there was no known relationship
betwecn this kindred and the others used to identify the BBSl and BBS3 loci. The three
known BBS loci wcre excluded by haplotype and linkage analyses before a genome scan
was implemented using pooled DNA samples. A statistically significant lad score (4.66
(6=0») was Obl:lined on chromosome IS and the critical interval of BBS4 was estimated at
9 cM. It was remarked that no retinopathy or obesity genes had been idemified in this
region at the time. Confirmation of this locus came in 1997 by Bruford et a/. who
observed 32-3SY. of their 29 BBS families were linked to ISq21.3-q23. Through
recombinations in a single consanguineous family. these authors reduced the BBS4
critical interval to 2 eM. between D/5S/3/ and D/5S//4. Thus, three scparnte genes
caused the same disease in Ihe Bedouin population oflhe Middle East.
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1.6 eliaital Varialioa oraardd-Bitdl S)·.dromt
Although BBS is eh:aracterized by a complex phenotype. lhere has been
documented variation ofaffKted individuals within and between families. The few
studies which have assessed the inter-locus variation have not been conclusive. probably
due to the paucity of families having been genetically categorized to date. Also, there
have been some conflicting results between studies. However, there was some suggestion
that weight, vision, cognitive deficit and limb malfonnations may vary between BBS loci.
Obligate carriers ofBBS genes have also been studied to determine if
heterozygolcs have a panicular BBS-related phenotype. However, once again. these
investigations were inconclusive due to the lack ofavailable molecular data and the small
size of the studies.
1,6.1 I.era-f.milial Varlalto.
The intra-familial variability of Bardet-Biedl syndrome has been noted frequently
(Klein and Ammann. 1969; Bergsma and Brown. 1975; Escallon et al., 1989; Lavyer al.,
1995; Rudling et al., 1996; Leppert et al., 1994). Riise er af. (1997) addressed intra-
familial variation in BBS dirC(;tly by examining II Scandinavian families having two or
more alTC(;ted individuals. Genetic analysis was performed previously (Bruford el al.,
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1997); however. statiSlically significant 100 scores were obtained for only two
chromosome 15 families. All other kindreds were not infonnative. Thus. probabilities
were assigned to each ofthree loci (B8S/. BBS:! and BBS4) which could not be excluded.
Varialion of expression ofobesity, skeletal abnomlalities of the extremities..
hrpogenitalism. short Slature. parnplegia. dental abnonnalities and the course of retinal
dystrophy was ap~ntwilhin families. In particular. the retinal dyslrophy varied widely
with respect to age ofonset and course ofdisease.
A Newfoundland cohon of BBS families was also observed to exhibit intra-
familial variation (Green e/ at.• 1989). Three affected individuals from one family
differed in the degree of polydactyly. mental retardation. endocrine dysfunction and renal
abnormalilies. Similarobservalions occurred in sill. often olher families studied with
multiple affected siblings. Within Ihese families the following features showed less inlra-
familial variabililY: presence ofobesity, Iype of retinal dystrophy and presence of
abnormal renal calyces.
1.6.2 IDler-locus Variatio.
An important consideration in the assessment ofBardel-Bie<t1 syndrome patients
is the degree of clinical variation that can be atlributed 10 different BBS genes. The first
opportunity to consider sueh a possibility came with the discovery of the 8BStiocus
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(Leppert et af., 1994). However. within the BSSI subset. the authors did not observe a
combination oftrnits. variation of particular Ir'ails. or variabilily of severily of a !rail
which could distinguish these families from families mapping to other loci.
In a sludy oflhree large Arab·Bedouin kindreds, three gene loci were compared
[chromosome 16 (BBS]). chromosome 3 (BBS1) and chromosome IS (BBS4)) 10
determine if there weredilTerences among families segregating separate BDS loci. Carmi
el al. (1995) found no appredable differences with regard to renal or cardiac
abnormalities. However, differences were observed among families with regard to
polydactyly. Affecled individuals in the BBS] family had the anomaly in all four limbs:
those in the BBS4 family had polydactyly only on the hands, and those in the BBS2
kindred had a phenotype somewhere belween the tv.·o others. Syndactyly had ~n
reponed previously in alTeeted individuals (Amman et a/., 1970; Grecn el al.• 1989):
however, it was nOI seen in the three families of this stud)'. Therefore. the authors
suggested syndactyly was caused by mutations in BDS genes different than those
segregating in their families.
Carmi et a/. (1995) observed statistically significant differences in the mean 8MI
of the chromosome: 15 and 16 families. Also. the patients in the chromosome 3 kindred
tended to have a higher 8MI compared with those in the: chromosome 16 family.
However. there was 00 statistical significant difference. No sex differences were fouod
within families, although, whe:n males were compared between chromosome 3 and 15
families and betwee:n chromosome 16 and 15 families, there were significant differences
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inmeanBMI.
In summary. Carmi fOr al. (1995) suggested tht'te were significant differences
among families concerning the distribution ofa sixth digit, albeit no statistically
significant results were presented. For the case ofobesity, it was suggested that the
chromosome 16 family was the 'leanest'; thectlromosome 15 family was the most obese.
and the chromosome J kindred had a pronounced progression toward morbid obesity after
puberty. Lastly. because the males in the chromosome 15 kindred were significantly
more obese than in the other two families. which was nOI the case for the females. there
may be a sex-dependent obesity effcct.
A follow-up study of the Canni el al. (1995) paper. by Hean et al. (2000).
concentrated on the retinal characterization of three Arab-Bedouin kindrcds. ERGs were
found to be abnonnal in all affected individuals. Age at which ERG abnonnalities were
noted was variable betwttt\ families. with the chromosome 15 family's retinal function
preserved longer. The authors also regarded the chromosome J family as the mOSl
severely myopic.
In the Beales el al. (1997) paper. one BBS4. three BBS2 and eight BBS1
kindreds. of various ethnic backgrounds, were studied with regard to inter-locus
phenotype comparisons. They found a statistically significant difference in mean age of
onset of night blindness between locus categories: BBS I < BBS4 and BBS2 < BBS4.
Also. a significant difference was obtained between males and females in BBSI families
regarding the mean age ofonsel of night blindness - males had an earlier mean age of
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onset (12.2 years vs. 15.5 years). The authors suggested honnonal influences may have
caused this trend. Polydaclyly was not observed in the chromosome 15 family and there
werc no differences in the distribution of polydactyly between family Iypes. Mention was
also made oflhe lack ofexcess lower limb polydactyly, previously commenled on by
Green el al. (1989).
Interestingly, in this same study by Beales et al. (1997), unlike previous
observations. the height of affected offspring was not significanlly shoner than the
parents, and for BBS 1palients. it was the reverse. Both the affected sons and daughters
were significantly taller than their fathers and mothers, respectively. The opposite was
true for BBS2 daughters. and the sons had no appreciable difference compared with their
fathers. When weighls of parents and affected offspring were compared for both sexes,
there was a significant increase over the parents at all loci except in the SSS2 sons.
BMls were also compared by locus and sex. The overall BMfs significantly increased in
offspring compared with parents. However, sons did not differ significantly from their
fathers, but daughters did. The difference was most pronounced in the BBS4 family.
Beales et al. (1997) also commented that the 28% of their patients who needed special
educational needs were mostly from the BBS2 and BBS4 families, the lauer being more
severely affected. Additionally, the 24% of patients having asthma were all from BBSI
families.
Bruford el al. (1997) studied 29 families from nine eounlfies and found no clinical
distinctions between families linked to BDSI, BBS]. 88S4, or among unlinked kindreds.
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A comparison of two chromosome 15 families indicated no common BBS4 phenotype
(Riise et aI., 1997). In one family, polydactyly was localized to the feet or totally absent.
and obesity was morbid. For the othtt family, polydactyly was isolated 10 the hands, and
the BMI was just above nonna!. This conflicts with the Carmi etal. (1995) findings of
polydaclylyon predominantly the upper limbs in their chromosome IS kindred.
Some observations were similar in the Beales et al. (1997) and Carmi et al. (1995)
pa~. In both studies there was a propensity for Ihe BBS2 group to be the leanest and
the BBS4 families to have the lowest occurrence ofpolydaclyly.
Howevcr, therc has been no statistically consistcnt pattcm of manifestations that
distinguish among BBS loci in the few studies thai havc been perfonnctf to date. This
could be due to the small patient sample sizes employed in these studies.
A study ofone five generation family was undertaken 10 determine ifBaedet-Diedl
heterozygotes are also predisposed to manifestations of BDS such as obesity, renal
anomalies and other symptoms (Croft and Swin. 1990). Medical information for
members of this large consanguineous family with two clinically diagnosed cases was
obtained through questionnaires and examination ofmedicaI records of23 living relatives
and 52 deceased persons (infonnation for these being provided by the closest living
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relative). Because the parents orthe affected individuals were consanguineous, the BBS
gene could be traced through a number orobligate carriers. However, no molecular
analysis was available.
From the data collected.. and the ~ew of previously reponed BBS families. the
aulhors tried 10 determine possible clinical effeclS orthe BSS gene in het:erozygotes.
They extrapolated that the Bardel-Biedl syndrome gene may be a possible candidate for
one of the genes predisposing to obesity in the general population. Also, hypeltension
might be a clinically imponant consequence ofBBS heterozygosity, irthe renal effeclS of
being a heterozygote are milder than in the homozygotes. As well, the observance of
diabetes in seven of the blood relath'es of the affected persons in this study lead the
3uthors to suggest that heterozygosity predisposes to diabetes. In addition, they
postulated that tOe gene either dirtttly caused the manifestations of renal disease.
hypertension and diabetes, or these were secondary to gene·associated obesity.
Funhermore, the authors stated that the heterozygosity frequency in the general
population was likely to be at least 1%.
A follow-up study was undertaken to further investigate obesity in heterozygous
carriers (Croft et al., 1995). Health questionnaires and medical records were assessed on
34 parenlS orBBS patients, all ofwhom were Caucasian. Height and weight infonnation
was self-reponed. The authors compared the proponion ofseverely overweight
heterozygote fathers (26.7%) with that ofa U.s. population group matched for age, sex
and race (8.9%) and noted for BBS heterozygotes there was a three-fold greater
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prevalence. However, only one mother was severely overweight. Heterozygotes were
also significamly taller than men and women in the appropriate control groups. Mean
height ofhomozygotes was greater than for the controls as well, but not significantly. No
excess in h)'J)C:rtension or diabetes mellitus was reponed. Again the authors assumed the
heterozygous prevalence in the general population to be 1%. Using their prevalence ",tio
(3.0) regarding the exeess risk ofobesity for BBS heterozygotes.they inferred that 2.~.
of all severely overweight males in the general population are BBS heterozygotes.
To address the phenotype ofhcterozygotes in the Newfoundland population,
O'Dea et al. (1996) examined the unaffectcd sibs ofBBS patiems and observed 57% of
them had a 8MI greater than 27 (considered obese in this study). Twenty.five percent
were hypertensive by age 49, onlyooc had mild renal impainnent, none had diabetes
mellitus, and there was only a 2% mortality rate by age of50. Meanwhile, 25% of
affected individuals died by the age of44. The authors suggested the rate of hypertension
in the unaffected sibs could be artificially high because they were assessed only once in
the sludy (on repeat testing blood pressure may not have remained elevated). The authors
conduded that heterozygous sibs are unlikely to have a clinically important phenotype.
However, like the Croft ~t al. studies (1990 and 1995), there were no molecular
analyses perfonned, making it impossible to detennine which unaffected sibs were
carriers and which were not. Therefore, a heterozygous phenotype maybe 'diluted out'
by the non-canier sibs. However, Beales et al. (1999) reported no excess of obesity
among obligate carrier parents.
'0
Larger and more complete studies of individuals having molecular testing is
needed to evaluate successfully ifcarriers ofa mutant BBS gene have a particular
phenotype regarding obesity, hypertension, diabetes, or height.
1.7 Identiliution or Disease Causinc Genes
The strategies of positional cloning and candidate gene approaches are most often
employed to locate, identify and subsequently find mutations in a disease causing gene.
In the positional cloning approach, the isolation of a gene Slarts with knowledge of its
genetic or physical location in the genome, and little or no knowledge regarding its
function (Ballabio, 1993). Three main steps are involved in positional cloning: (I)
detennining the chromosomal region that is linked to the disease; (2) identifying all genes
within this chromosomal region; (3) screening these genes for mutations that segregate
with the disease in multiple families.
Linkage analysis is often the first step in positional cloning. A mode of
inheritancc is proposed, then families and genetic markers are chosen to start the study.
Once a region is identified containing the causativc gene, the genes within the candidate
rcgion must be identified. Regions greater than one Mb in size ollen contain an
overwhelming number of possible transcripts; therefore, scientists prefer regions smaller
than 1 Mb. Often this means the DNA region must be cloned. However, with the
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progress of the Human Genome Project, the sequence of interest may be contained within
an appropriate database.
If cloning is undertaken. then one or more cloning vectors (bacterial artificial
chromosomes (BACs). yeast artificial chromosomes (YACs). and cosmids) are utilized to
create a contig map containing DNA fragments from the region of interesL Next is the
identification oflhe genes in the candidate region. Gene isolation schemes include.
among others. sequencing the region. exon trapping. screening ofcDNA libraries and a
candidate gene approach. The latter is theorctically the simplest method of identifying
the appropriate gene. since the gene of interest may have been previously cloned. The
existence of genome databases has increasingly facilitated the candidate gene approach,
as has the completion of the 'rough draft' of the Human Genome Project. Once the gene
is identified, the next phase is identification of mutations in the putative diseasc-causing
gene. Some approaches include direct sequencing. protein truncation testing and the use
ofnon-dettaturing gels to identify single-stranded confonnational pllymorphisms
(Papadopoulos. 1995).
Linkage analysis, using genetic markers such as microsatellites, is almost always
utilized in positional cloning in lieu of very infonnative chromosomal abnonnalities. or,
in the case ofca1lCer genes, loss of heterozygosity. Microsatellites are simple sequence
repeats, consisting ofa series of several repeats OflWo to five nuclcotides. The most
common are CA repeats. There are more than 35 000 infonnative microsatellites in the
human haploid genome, occurring at least once every 100 000 base pairs (bp) (Weber et
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al., 1990). These polymorphic segments are also relatively evenly dispersed throughout
the genome. thus making them very useful in population genetics and the determination
or family relationships (Weissenbach et 01., 1992).
The repeat length oralleles of microsatellite sequences are polymorphic except at
loci with fewer than about five repeat units (Valdes et al.. 1993). Because these repeats
are highly polymorphic, they are iAdispensable for linkage analysis. In many instances. if
a particular microsatelite is completely linked to a gene, all affected individuals will have
the same allele. This should not occur for an unlinked microsatellite marker, as long as
the microsatellite was polymorphic enough. To ensure accuracy in the locus
detennination ofa disease.causing gene, more than one microsatellite is usually analyzed.
Once several markers have been identified in a particular region of interesi, a
'haplotype' can be constructed. A haplotype refers to a set ofalleles ofa group ofdosely
linked loci on the same chromosome. Haplotype analysis is a very useful tool in defining
a critical region within which a disease-causing gene is located. especially in an area
which is densely populated with microsatdlites. Within a haplotype, marlc.m that do not
have the same alleles among affected individuals due to recombination events can be used
to further delimit the critical region. A specific kind of haplot)'pC analysis. homoz.ygosity
mapping. is used 10 detennine whether a recessive disease-causing gene is associated with
a known locus in a consanguineous kindred. One expects to observe homozygosity for an
allele at the disease locus in affected individuals from a consanguineous family exhibiting
a rare recessive disease. In a genetically inbred population. as is the case in pans of
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Newfoundland. a specific allde set is usually passed on through the generations from a
common progenitor. In this case an affecttd individual has a homozygous haplOlype due
to identity by descent (laD) (Sheffield el ai., 1994). Because of recombination, the
further back the common anco;lor is, the smaller will be the homozygous allele set.
Once link.age and haplotype analyses have been executtd successfully, the
candidate gene approach can be used immtdiately if the critical rt'gion has been narrowtd
down sufficiently, andfor there is a very good candidate gene in the genomic area of
interesl. Candidate genes in the critical interval may be selecttd in one of the following
ways: a gene thai shows homology to a gene implicated in an animal model of the
disease; a gene that displays an appropriate expression patlem or function given the
pathogenesis of the disease; or a gene that shows homology, or functional relatedness, to
a gene implicattd in a similar human disease phenotype. Jfno such genes are identified
within the critical region, then positional cloning and database analyses will ha\'e 10 be
undertaken 10 identify all exisling transeripts. Once a candidate is idemifitd, mutation
analysis is performed to detmnine whether or not it is the disease-causing sequence.
Usher syndrome is a genetically and clinically pleiotropic disorda for which the
positional candidate approach has been successful. It is an autosomal recessive disorder
which is characterized by retinitis pigmentosa and sensorineural deafness.
Phenotypically. this syndrome has three major fonns. differing in severity of symptoms
and time ofonset: Usher syndrome type I. II and III. Six genes have been mapptd for
Usher syndrome type JCUSH I), two for Usher syndrome type n (USH2) and one for
54
Usher s)1ldrome type III (USH) (Keats and Corey, 1999). One USH I gene, USHI B, has
been identified as an WlConventional myosin, MYQ1A (Weil et al., 1995). USHIB wu
demonstrated to link to markers on chromosome IlqI3.5. and the critical region was
refined through microsatellite analysis and homozygosity mapping ofa lalEe inbred
Samaritan kindred (Bonne-Tamir et al.• 1994). Previously. a mouse deafness gene,
sllaker-I (sh/). had been mapped to lhe USHIB homologous murine region on
chromosome 7 (Brown I!I al.• 1992) and then was shown to encode an unconvenlional
myosin oflhe type VII family (Gibson el al.• 1995). MY07A was a good functional and
positional candidate for USH IB; therefore. it was cloned. and mutations were found in
USH IB patients (Weit el al.• 1995). Subsequently, mutations in MY01A were discovered
to cause an autosomal rttessive non-s}11dromic hearing impainnent, DFNB2, and also an
autosomal dominant form. DFNAII (liuetal.. 1997; Weil etal.• 1997). It seems lhat
some mutations in MY07A impair the prolein function more lhan others, producing
diseases of varying extent and severity.
Identification of a diseasc-<:ausing gene is the initi.al step in determining the
normal function of the protein and how the associated mutations affect the protein
function. Eventually it is hoped that some method ofcombating the disease can be
identified through drug or gene therapy derived from the functional studies. Also. genetic
testing can be initiated, aiding in family counseling by medical geneticists.
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1.8 Thais Go.1
The purpose oflhis Ihesis is to examine Newfoundland families burdened .....ith
DBS. a rare autosomal recessive di~. in order to classify the genetic variant of the
disease affccting each kindred. 11 is the ambition ofthis thesis to identify a possible
causative gene(s). through positional cloning and candidate gene approaches. and
subscqucntlydemonstratc a mutation(s) in this genc(s) which segrcgatC(sl in these
kindreds. The families studied are from a previously well defined and thoroughly
clinically investigated population (Harnett ef af.. 1988; Cramer et al., 1988; Green et al.•
1989; O'Deael af.. (996).
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Chapter 2 Malerials aDd Melbods
2.1 Asc:er1aiameal ..d eliainl AUlysis of Bardd·BiflIl Sy.drome Families
Thttc~ a total of22 families known to ruwe BBS in Newfoundland. However.
due to the unavailability of ONA in five families, only 17 BBS kindreds were examin¢d
as part of this thesis. In the early 1980s, 160f 17 of these families with BBS were
ascenaincd in one of three ways: from the Ophthalmology Department records of the
Health Sciences Centre, St. John's, Newfoundland; from the Canadian National Institute
for the Blind (CNlB) Regisler, and through addition..1family studies (H3tTlen et al.• 1988;
Green et a/.. 1989). Subsequently, one kindred with BBS was identified by the
Nephrology Unit at the Health Sciences Centre. St. John's, Newfoundland in 1993
(O'Dea el al.• 1996). In total, 34 patients, consisting of 20 males and 14 females in 17
families, we~ included in Ihis thesis. Oflhesc. 32 were completely clinically assessed.
The remaining two were deceased at the time of evaluation; therefore. only medical
records were reviewed. Complete clinical testing was also possible for 45 unaffected
siblings. A total of 111 unaffected family members and 34 patients were genetically
surveyed from these 17 BSS families.
A protocol for clinical investigation was approved by the Human lnvestig:uions
Committee of the Faculty of Mcdicine, Memorial University of Newfoundland. and by
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the Medical Advisory Council oft~e SI. John's General Hospital. Appropriate informed
consent was oblained from participants in this study. Diagnosis of affected members was
based on the following criteria: the presence of retinal dystrophy, obesity or a history of
obesity, dysmorphic cxucmities. and the absencc of neurologiul complications. Further
investigations showed that 100"/. of the BBS patients who were examined by ultrasound
displayed fetal lobulation of the kidney, providing direct evidence that rcna1structur.al
abnormalities arc a cardinal manifestation of the disease. Other manifestations ofBBS
observed included genital hypoplasia in males. and cognitive delicit. but these
manifestations were not incorporated into defining a casc (Harnett et al.. 1988; O'Dea et
al.• 1996). The above di:agnostic criteria :agree with the more recent critena proposed by
Beales el al. (1999).
On each visit to the clinic by BBS patients or their unaffected siblings, blood
pressure was recorded. Blood was drawn for measurement ofserum urea, creatinine.
electrolytes, glucose, glycosylated hemoglobin. calcium, alkaline phosphatase. albumin.
total protein, hemoglobin and complete blood count. Blood was also obtained for
measurement of follicle stimulating hormone, luteinizing hormone, prolactin. testosterone
and estradiol. Urine samples were obtained and analyzed for presence of blood and
protein. Twenty.nine BBS patients underwent ultrasound of both kidneys. and 21 had
serial studies. All ultrasounds were interpreted by one radiologist. Unaffected siblings
did not undergo ultrasound investigation. The height and weight of27 adult BBS patients
(I S females and 12 males) and 42 adult siblings (21 women and 21 men) wcre convened
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to BMI scores (O'Dea f!t al.• 1996). Measurements were also made of the head
circumference, and the length and breadth of the hands and fccl in many patients.
Ophthalmological invesligations included retinal function tcsting (coloc vision
testing. perimetry and dan adaptation Icsling), and when possible electroretinographic
studies., photography of the fundus and fluorescein angiography were perfonned.
Psychologicallcsting was conducled, consisting ofthc administralion oflhc Slandard
Wechsler Adult Inlelligence Scale verbal tests and the Haplic Intelligence Scale. A
skeletal survey and a complete physical exam was also done (Green et al., 1989). tn
addition, medical re<:ords were reviewed for all patients 10 obtain confirmation of
information concerning age of onset of legal blindness, hypertension, diahctes mellitus,
renal impairment and ESRD (O'Dea el al., 1996).
Full family pedigrees were oblained through interviews with individuals in the
extended family, and whenever possible this infOnn3tion was confinncd by archival
research at Ihe Association of Newfoundland and Labrador Archives
(hnp:l/www.anla..nf.caI)and on the Internet in Project 21
(http://www.huronweb.comlgcnweblp21Imain.html). The lalter is the inilialive to secure
the Newfoundland Census of 1921 in a public electronic database fonnal Through these
methods parental consanguinity was identified in six kindrcds and suspected in an
additional six families (Fig 2.1). In five of the six kindreds presumed to be
consanguineous (82.810. Bl1, B 12,815), there were ancestors from both sides of the
family living in Ihe same area and sharing the same surname.
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Fig 2.1 Pedigree strucfure orthc 17 I\"cwroundland families wilh BBS
eumined in this thesis.
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The BBS families are distribuled almost exclusively in small coastal communities
throughout the island of Newfoundland (Fig 2.2). The greatest concentration of BBS
kindreds is in the Conception Bay area. a large bay located on the northeastern portion of
the Avalon Peninsula However. there is a surprisingscanering of families throughout
the rest of the island. The population of Newfoundland is 560 000, with 260000 people
living around the 51. John's area. and the remaining 300 000 distributed in many coastal
communities and in a few larger towns in the interior of the island.
2.2 Extractiod or DNA
1.1.1 Es:tractioD or DNA froln Whotr Blood
All DNA samples but two were extracted from the white cells of venous blood,
which was collected in EOTA tubes and processed within one week of blood letting. A
simple salting-out method was employed for DNA eXlr.1Ction. Forty-live milliliters of
wanned (3'r'C) NH,CI:Tris (9OOm1 of 0.155 M NH.CI; 100ml of0.17 M Tris.HC1, pH
7.65) was added to 5 ml of whole blood in a 50ml tube and the mixture incubated at 37°C
for 5 min. This was centrifuged at 2500 rpm for 5 min (IOOOxg). The supernatant was
poured off. leaving a white ccll pellet at the bottom of the lube. and 10 ml of saline
solution (0.85% NaCI) was added. The 50 ml tube was vonexed briefly and centrifuged
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again under the same conditions. The supernatant was removed and 3 ml of nuclei lysis
bufTer(IOmM Tris.HCI. 400 mM NaCI. 2 mM EDTA. pH 8) was added to the pellet.
This mixture was brieOy vonexed and tr.msferred to a IS ml centrifuge tube. With the
addition of0.2 ml of 10-10 SOS and 0.5 ml of pronase E solution (3 mgfml in 1% 50S, 2
mM EDTA). the mixture .....as incubated overnight in a 37°C water bath. The next day I
ml of saturated NaCl was added and the 15 mltube was shaken vigorously for IS sec,
then centrifuged at 2500 rpm for IS min (Miller et at.• 1988). The supernatant was gently
poured oITinto another IS ml tube and 2 volumes ofabsolute ethanol added to the
supernatant. The tube .....as inverted several times as the DNA prttipitated. A 9" glass
pipelte was melted into a hook and cooled, then used to fish out the DNA. Finally, the
DNA on the hook was washed several times with 70% ethanol and allowed to air dry.
The DNA was dissolved in 300-900 IlITE (10 mM Tris. ImM EDTA. pH 8) overnight
and then gently rotated in an incubator for roughly an hour. DNA samples were labeled
appropriately, registered in a DNA bank book and in a computerized database. and then
stored at 4°C.
1.1.1 Exlraclio. of DNA from Pauma Blocks
Two DNA samples (B3, PlO II; 89, PID 24) were obtained through extraction by
salting out from archival parnffin blocks of the kidney. Sections of5 x 10 microns were
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obtained using a microtome and individual sections were treated with I ml ofloluene in a
55°C water hath for 5-1 0 min. Samples were then microcentrifuged for 5 min and the
loluene decanted. The toluene treatment. centrifugalion and decantation steps were
repeated. Then 1 ml of absolute ethanol was added at room temperalure for 5·10 min.
Again the sample was centrifuged and decanted. These three steps were repeated and the
sample was left to air dry at room temperature for 10-15 min. Digestion with proteinase
K (425111 of 0.5 x TBE buffer; 50 IJI ofI0%505; 251J1 ofO.5llgllll proteinase K) took
place overnight in a 55°C waler bath.
The next day, a 0.27 volume of saturated 6 M NaCI was added and the sample
was centrifuged (2000 rpm) for 5 min. The supernatant was transferred to another tube
and the original tube was discarded. Then 1.5 ml of95% ethanol was added. At this
point the DNA strands appeared in suspension. DNA samples were labeled
appropriately, regislered in a DNA bank book and in a computerized database, then stored
at 4°C. Calculations orONA concentrations were not performed.
2.3 Microsafellite Marker Aaal)"sis
2.3.1 Geaotypiag
The polymerase chain reaction (PeR) was conducled using approximately 100-
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200 ng of template DNA. with primers pun:hased from Research Genetics, [nc. Primm
were for the amplification ofdi-.lri- or teuanucleotide microsatellile DNA (Appeadit:n
8-H). One primer (usually fOlWard) of each pair was end-labeled using T~ polynucleotide
kinase (Pharmacia. Biotech. Uppsala. Sweden) and [y.)!PjATP (Amersham. Ontario.
Canada) (Sambrook et al.• 1989). Standard 10111 peR reactions containing 1.5 pmol of
primer. 200 11M dNTPs. and 0.125 units of Tn DNA polymerase (Promega. Madison.
Wisconsin) were made. Almost all samples were subjected to 33 cycles of94"C fat 30
sec (denaturation). SS'"C for 20 sec (annealing) and n"c for 30 sec (extension). after an
initial denaturing step 0(2 min at 95"C. Thennocyclers used for all microsatellite
amplification procedum: were thc Perkin-Elmer Gene-Amp 9600. MJ Research PTC·200
and the Biometnt Tgmdient. DNA samples which did nOI amplify were subjecred 10 a
touchdown cycle consisting ofa 2 min denaturation step at 9S"C followed by one cycle of
30 sec at 94"C. 20 sec at6S"C and 30 sec ar n"c, then nine additional cycles each with a
decrease ofone degree of annealing lemperature. After these ren cycles. the annealing
retnperature remained at S5"C for 20 cycles. finishing with a S min extension step al
72G C. If!his did not work, !he initial annealing temperatures were adjusted by one degree
in either direction until sua:essful. All cycles concluded wilh a cooling step which was
maintained at 4G C. PCR products were stored in a 4GC refrigerator for up to a week.
Amplified DNA was analyzed on 6%-8% polyacrylamide denaluring gels wirh or
without fonnamide (Litl et al.• 1993). Most often a 60 ml volume of gel solution (6%)
was made using 6ml of lOx TBE. 9m140% acrylamide. 19 ml 95% fonnamide. IOmI
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dH~O, 20g urea and 480J11 of I()OJ. ammonium persulfate. When formamide was used, the
gel solution was filtered through Whalman filter paper #1. Acasting tray was made using
10 ml ofgel solution with the addition of50 p.1 ofTEMED. The casting tray and gel
apparatus were allowed to Sd for 15 min before the gel was poured. Gels were poured
with a syringe into the 21 cm x 40cm x 4 mm gel apparatus (Bio-Rad) and left toSd for
at least one hour. They WCf"C then pre-heated al a constant 42 W until the fronl gel plate
reached 50-55°C (usually one hour). All excessive urea on the gel fronl was washed
away by a pipene and 2.5 1-11 of ei1ch sample was loaded into the wells of a 36 well comb.
Samples were prepared by adding equal amounts ofdye{consisting of95%
formamide, 0.5 M EDTA, 0.05% bromophenol blue and 0.05% xylene cyanole) and
sample into a microtiter plate and heating on a 95°C heating block for 5 min, then
immedii1tdy cooled on ice. Gels were then loaded and ron at a constant 42 W for IWO to
eight hours depending on the size of me fragments analyzed (Appe_di«s 8-H). All
fragment sizes were obtained from The Genome Database (hup:l/gdbwww.gdb.org). The
gels were then placed on \\'natman 3 mm paper and dried in a slab gel drier (Bio-Rad·
Model 583) for Ihree hours at a temperature of80°C. When gels were dry they were put
in Ihe dark al room temperature with autoradiography film (Kodak X-Dmat Blue XB·I)
(Sambrook et al., 1989). Subsequently, the autoradiography film was developed and
analyzed. Alleles were scored relative to each other and not size, as no size references
were prepared. Alleles were also scored blind with respect to disease status.
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2.:U HaplotypeualysiJ
Haplotypc:5 were cons<.ructed manually for each family at each tested locus using
all available microsatellite data. and represented the minimal number of recombination
events. Several criteria were used for locus assigrunentlexclWiion based on infonnative
haplotypes. Sharing ofhaplotype5 between affected and unaffected individuals in the
same family was used to exclude a locus. Similarly, a locus was excluded ifaffected
individuals in the same f:unily had different parental haplotypes. Support for linkage to a
BBS locus was established in consanguineous families if. and only if. the affected
individual(s) displayed homozygosity by descent (HBD) (Lander and Botstein, 1987) in
thc critical region ofa known or SWipccted BBS locus, and thcir unaffected sibJing(sl did
not. In suspected consanguineoWi kindreds. homozygosity by state (HBS), defined as a
homozygous haplOl.ype due to parental consanguinity of unknown degree, was taken as
support for linkage. In families in which there was no indicalion ofconsanguinity,
haplotype sharing (HS) at the h)1Xlthesized or known BBS critical region in affected
individuals. but not in their unaffected sib(s). indicated support for linkage. Using this
haplotype analysis protocol (Fig 2.3), a family could be either e.'(clucied. linked, or not
excluded from a particular locus.
Microsatellite marker orders were obtained from published materials as well as
from various electronic databascs: GeneMap "99
(htlp:llwww.ncbi.nlm.nih.gov/gcnemapl); The Genome Database
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(hnp:l/gdbwww.gdb.orgl); M:ushfield Center for Medical Genetics
(http://researc:h.marshfieldclinic.orgigenelicsl); Stanford Human Genomc Center
(hnp:l/www-shgc.stanford.edul); Whitehead lnstitute for Biomedical Research/MIT
Center for Genome Rescan:h (http://www-genome.wi.mit.edul);andCooperative Human
linkage Consortium (hllp:ll1pg.nci,nih.gov/CHLCI), Using this infonnation, a best fit
map was created at each BBS locus tested for linkage.
2.J.J Whole Genome Screens by HomoZ)'osity Mapping Using Pooled DNA
In instances in which a relatively rare recessive disorder occurs in a genetically
isolated inbred population. homozygosity for an allele at the disease locus is expected in
the affected individuals. due to HBD from a common progenitor. Based on this
assumption. the DNA pooling method is used to facilitate identification ofHBD at the
disease locus. DNA pools are made ofCtjual amounts of DNA from each affected
individual (test pool) and from each unaffccted individual (control pool). The pooled
DNA samples are analyzed with microsatellite marlccrs using PeR. When DNA pools
from controls and affccted individuals are compared there will be no differences in allele
distribution for markers unlinked to the disease locus except by chance. However, there
will be a shift in allele frequencies from the control pools to the affected pools at genetic
markers linked to the disease gene (Sheffield el ai., 1994),
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This method was employed as it was deemed very appropriate for finding BBS
loci in the Newfoundland population. The consanguineous family B9 (Fig 2.1), which
nad been excluded from the four original BBS loci, was used in the initial genome screen
implementing homozygosity mapping of pooled DNA. Two control pools of DNA from
four living parents and II unaffected siblings, as well as a tcst pool of DNA from the four
surviving patients. were subjected to PCR. The total DNA concentrations of each pool
were equivalent. The genomic scan was performed with microsatellite markers from Ihe
Cooperative Human Linkage Consortium human screening set. Weber version 8
(Research Genetics). The screening set was broken into five subsets corresponding 10
microsatellite size to ensure that each gel electrophoresis would contain amplification
products of similar size. The PCR protocol was 33 cycles of94°C for 30 sec
(denaturation). 55°C for 20 sec (annealing) and 72°C for 30 sec (extension), after an
initial denaturing step of2 min aI95°C. Amplification reactions were not multiplexed.
Thermocyclers used for amplification ofsamples were the Perkin-Elmer Gene-Amp 9600
and the MJ Research PTC·Zoo. Each. polyacrylamide gel was loaded with 33 samples.
corresponding to three DNA pools, amplified with I I different primers which gave
products of similar size. Gel electrophoresis and autoradiography were conducted as in
Chapter2.J.1.
A reduction of multiple alleles in the control pool to one allele in the test pool, at
a particular marker, warranted that marker to be run separately on all available pedigree
members. Once a marker looked as if it segregated with the disease in the pedigree,
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additional markers adjacent 10 the original markeT were identified through the
abovementioned databases. These were then tested on me family to create a haplotype at
the putative DDS locus. Once again all microsalellites were amplified as in Cllapter
2.3.1.
Similarly. the consanguineous kindred a 13 (Fig 2.1) underwent a genome wide
scan once it was excluded from all known BaS loci. Three pools were constructed wilh
the two parents in onc «Introl pool. four unaffccted siblings in thc second control pool
and the two affected individuals in the test pool. Thc genome screen and subsequent
microsatellite analyses were performed exactly as with family 89.
Linkage analysis was carried OUI to corrobonte the haplotype analysis. T.....o-point
linbge analysis was performed using the MUNK (v5.21) subrouline of FASTLINK
(v4.0P) and UNKAGE (v5.21) (Lanthrop and laloucl. 1984; Cottingham et al.• 1993:
SchalTeT el aJ., 1994). BBS was modeled as an autosomal recessive disorder with a
penetrance of 0.95. Thediscase gene frequency was adjusted to 0.008. based on the
disease incidence of I:17500 in the Newfoundland population (Green et al., 1989).
However. in the linkage disequilibrium study ofBBSI families. the disease allele
frequency of 0.0032 was used. adjusted 10 reflecl an estimated 40"10 contribution of the
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BBSI locus to the overall population frequency. Suspected consanguineous loops wen::
not considered when conducting two-point 100 SCOf"C$. All microsatellites were assumed
to have nine alleles ofequal frequencies in the study population. Significantly negative
100 scores (~·2.00. 6=:0) for fully informative markers within the critical regions ofBBS
loci, for each of the 17 families. were u~ed as criteria for exclusion. Positive lad score~
were taken as suppon for linkage and 100 scorcs ):3.00 (6=0) were considered statistically
significant for linkage. Mariters wen:: selected for linkage analysis based on the parents
being heterozygous with distinct genotypes. Families with rttombin:llions in critical
regions were assigned on the basis of the haplotype analysis. All marker and family data
were imponed into the FASTUNK (v4.0P) program via marker specific programs created
by Visual dBase. which also contained the BBS database.
Previous to the genome scan on kindred B13, a simulation study to detenninc the
estimated maximum lod score possible in this family was undertaken using SLINK
('12.65), an auxiliary program of LINKAGE (v5.21) (Ott, 1989; Weeks el aI., 1990). The
three seeds for the random number genCl11tor were 25 006, 28 270 and 17 716. The
number of replicatcs was 300, and mey were simulated under the assumption of
homogeneity. Simulation data were analyzed with the MSIM (v2.6S) program using a
disease penetrance of0.95. eight equal marker alleles and a disease gene frequency of
0.008. Subsequently, analysis was run on all five families (B3. 84, B5, B6 and 813)
unlinked to the five known BBS loci to determine a cumulative estimated lad score.
Simulation and analysis conditions were the same as for the run using only family 813.
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l.S Mut.tio••1 A••lysis
Once the gene for McKusick-Kaufman syndrome was published, the cDNA
gquenc:e for MKKS was screened through the high-throughpul genomic sequence
dalabase using the BLAST algorithm (HTGS;
hup:llwww.ncbi.nlm.nih.govIBLASTJblasl_databases.hl1Tll). RAC clone RPII-368H14
(ALI58197) exhibited >99.5% identilY to the eDNA sequence. Although this clone was
annolated 10 map 10 chromosome 22, electronic PCR (ePCR;
http://w,,"w.ncbi.nlm.nih.govI5TSI)identified 28 chromosome 20p sequence tagged sites
(5T5s). It was concluded that this BAC contained the true MKKS locus. The BAC
sequence was downloaded and aligned to Ihe MKKS eDNA with programs from Ihe GCG
sofiware package (Katsanis er al., 1997). The sequence flanking all coding exons was
idenlified and primers were designed to amplify both exons and intronic splice junctions
with the Primer v3 program (http://www.genome.wi.mit.edulcgi-binlprimer/primer3.cgi).
Initial PeR on all individuals and conlrOls were conducled in 2S loLl reactions
conlaining approximately 100-200 ng oftemplale DNA; 2.5 loLl each of lOx PeR Buffer
and 2mM dNTPs; 0.1 loLl of each forward and revene 100pm/1l1 primer, 0.15 loLl ofTaq
(0.75 units) and filled to \'olume wilh dH~O (17.65 loLl). Amplification was performed on
a MWG Primus 96 Plus using a touchdown cycle as follows: 9,S"C for 7 min; 10 eyclesof
95°C for 30 sec, a 1°C stcp-down/cycle from 6S-S's°C fo~ 30 sec each, and nl>c for 4,S
sec; 30 cycles of 95°C for 30 sec, 551>C for 30 sec and 72I>C for4's sec; 72°C for 10 min;
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and finally cool to 4°C. Samples were Ihen run on a 1.2% agarose gel to ensure that the
product was successfully amplified. Agarose gels were loaded dry with a mixture of 5 j.ll
ofPCR product and 2j.l1 of stop solution dye. Gels were run in buffer al 100 V for I hr.
Successfully amplified PCR products from all available family members and controls
were purified with the QlAquick Mulliwell PCR Purification kit (Qiagen). Purified PCR
products were then cycle sequenced on a PTC·225 DNA Engine Tetrad (MJ Research)
using 1.2j.l1 of purified PCR product and 4j.l1 of cither A,e,G, or T Big Dyes (Applied
Biosystems) per individual sample. The following cycle sequencing prolocol was used:
15 cycles of 95°C for IS sec. 55°C for I sec and ?ZoC for I min; then IS cycles of 95°C
for IS sec and 70°C for I min; and finally a cool down step to 4°C. Products were
subsequently pooled by mixing 50 jJl of 100% elhanollo each sample consisting of four
ddNTP cycle sequencing products. Pooled products were chilled for 15 min at _20°C and
spun down for IS min at 3000 rpm in a vacuum sealed centrifuge. The ethanol was
discarded and the pellet dried in vacuum sealed centrifuge and resuspended in 5 jJ[ of AB!
loading buffer. The mixture was thcn heated for 5 min on a 95°C heating block and
immediately chilled on ice. A 1.25 jJl volume of each sample was loaded into a 96 well
comb on an AB! 377 automated sequencer (Applied Biosystcms).
PCR products wcre also cloned using the Original TA Cloning Kit (Invitrogen)
and sequenced 10 separate Ihe different alleles. The competent cells used were E. coli
DH5a. grown in LB broth containing ampicillin. Sequencing was perfonned using the
17 and exon 3 primers. Resulting sequences were aligned and mutalions were evaluated
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by the Sequencher sequence alignment program (ACGT Codes). MKKS exon
amplification primers are lista:! in Appe_dix I.
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Chapter 3 Results
3.1 I.ilial Gn.ttic S.n·ey orl~~ FotIr Bard~t-Biedl S)..dromt Loci i.
Newfou.dla_d BRS Families
To investigate the high incidencc ofBBS in the Newfoundland population, and in
particular to detennine if it is the result ofa founder eITect, members of 17 previously
untested Newfoundland BBS families were gcnotyped using polymorphic microsatellite
markers spanning the relevant critical regions of the four known BBS loci (Fig 3.1).
3.1.1 families Assil_ed to BBSI
Three families (88. BIOand B19) were assigned 10 the 88S1 locus (Table 3.1)
using the haplotype and linkage analyses criteria for inclusion (see Chpter 2J.2). In the
consanguineous family 88. the affected individual, personal identification 10 (PlD 10),
was HOD for the entire critical region of BBSJ on chromosome II (Fig 3.2). A 100 score
of 1.29 (6 = 0) al DJ /S/883 further supported linkage ofkindrcd 88 to the BBS/locus.
This family was excluded from BBS] and BBS3 because the affected individual shared
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haplot)'pd with an unaffeeted sib, PID 12 and PlD II, respectively. Also,linkage
analysis };elded negative 100 scores at these loci (Table 3.1). For 8854. the affeeted
individual in family 88 had an identical paternal contribution as two unafTeeted siblings.,
but the qler portion of her maternal contribution was unique. Thus. this region., qter to
DIJSI11, could not be excluded. Nonetheless. because the offspring oflhis second
cousin union is homozygous by dtSCent (HBD) for the entire BBSI critical region. family
B8 was assigned to this locus.
Family BIO is a large kindred in which there is suspeeted consanguinity.
Haplotype sharing (HS) was observed at BBSI between the two affected individuals
(PlDs 9 and 22), but not with any ofeighl unaffeetcU siblings (Fig 3.3). The assignment
ofBBS/l0 this kindred was supported by a positive lad score of 1.54 (e = 0) for
DIISI881 (Table 3.1). This family was excluded from B8S2, 8BS1 and 8BS4 based on
haplotype5 and significantly negative 100 scores. For B8S2, the affected individuals have
different maternal contributions and PID 9 shared haplot)pCS with an unaffected sib (PID
14). For BBS1, both affected individuals had different maternal and paternal
contributions. Also, PID 22 shared her haplotypes with una!Tce:l).l sibs PIDs 17 and 19.
Also, PlD 9 shared her haplot)'pd with unaffected sib PID 13. For 88S4, the affected
patients have different paternal contributions and PID 22 shared her haplotype with the
unaffected sib PID 19.
In the consanguineous family B19. the affected individual (PID 13), exhibited
HBD for all five markers typed at the 88S1 loci. and none of his unaffected siblings had a
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similar haplotype (Fig 3.4). Linkage was funher supported by a positive 100 score of 1.48
(8 - 0) at 01154095 (Table 3.1). Family 819 could be excluded from BBS] since the
affected individual had the same haplot)-pe5 as an unaffected sib (PID 10). As well, a
statistically significant negative 100 score was observed at 0151251. Exclusion of this
family from 88S2 and 8BS4 was not possible because the only affected individual
contained a unique non-homozygous haplotype. However. because there was observed
homozygosity at IIql3 in the BBS patient oflhis known consanguineous family, the
kindred was interpreted to be a BBSI family.
3.1.2 Family AssiC_ed 10 8BS2
One family. B14. was assigned to the 8BS11ocus. Haplotype analysis revealed
that the affected individual was homozygous in Ihe critical region of88S1 from
016$1039 [0 016$165. inclusive (Fig 3.5). Additional microsatellite markers were later
tYJled betWeen 0165408 and 0165526 (Fig 3.6), and this region was homozygosity by
slate (HBS) as well. However. this observed homozygosity is not explained by parental
consanguinity, because the patient (PID 18) received one of his maternal grandmother's
chromosomes, and she is not known to be pan of the consanguinity loop (Fig. 3.6). Two-
point linkage analysis yielded a negative lad score at the BSS2 locus (-0.33 (6 '"' 0) at
016S408} because the possible maternally inherited disease hap[ot)pe was derived from
82
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outside the consanguineous loop. However. it is suspected that the affecled individual
received two copies of an ancestral chromosome. This family was excluded from 88S/.
88S3 and BB$4 on the basis of haplotype analysis. The affected person (PID 18) and
unaffected sib (PIDI9) share haplotypes a188S/ and B8$4. If this kindred was a BBS3
kindred we would expect to observe HBD in this region; however. the affected individual
was heterozygous within the BBS3 critical region.
J.I.J Family Assigned to BBS]
One large multiplex family. B2. with five affected individuals in IWO sibships.
was assigned to the 88S3 locus. All affected individuals (PIDs 14, 15.22,23 and 24)
were HBS for a minimum of four consecUlive markers at the 8BS3 locus (Fig 3.7), each
with a lod score greater than 2.10 (6 = 0), 885/. BBS.? and 88S4 were all excluded on
the basis of haplotype analysis and statistically significant lod scores (Table 3.1). At the
OOS/Iocus. PIDs 14 and 15, in sibship A, had different contributions from one of the
parents. Also, in sibship B. the affected individuals had different haplotypes. For 8BS1.
the affected sibs in sibship A had different maternal and paternal contributions. while one
affected person in sibship B. PID 23, had different haplotypes than both olher affected
sibs. Although the affected persons in sibship A shared the same contribution from one
parent, and some of the other parent's contribution at the 8B54 critical interval (due to a
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FigJ.7
recombination in PID IS). there was no region ofhomozygo.sity. In addition, the
haplotypes were different lhan those in the affected sibs in sibship B. Also, in sibship B.
PID 22 had both malcmal and patemaJ contributions which were different than in the
other two affected siblings in the sibship. For thc:sc reasons kindred 82 was considered a
BBS3 family.
3.1.4 Exdusion of ramilies 10 Kao"'G BRS Loci
Remarkably. 6 of the 17 families (B3. 84. B5. 86. 89 and BI3) were excluded
from all four known BBS loci. suggcsting the presence ofat least one other B8S locus
(all haplotype data i.s .shown in Appeadix A for the following analyses). In the
consanguineou.s kindred B3. markers at !he four loci generated negative 100 score! (Table
3.1), with none of the marlters analyzed being homozygol1l (as would be expected in a
second cousin marriage at a linked locus). Though there was no sharing ofhaplotypes
between the affected .sib and his unaffected brother al the four known BBS loci. all loci
were excluded by haplotype analysis due to the lack of homozygosity in the affected
person in this consanguineous family.
In kindred B4. at the BBSI locus. both affected individuals had different paternal
contributions and onc affected sib (PID 13) had the same haplotype as two unaffected
siblings (PrOs II and 12). At the BBS2 locus. both affected sibs had the same haplolype5
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as one unaffected sib (PID 12) and the same was observed at BBSJ and BBS4. However,
at the BBS] locus, one affected sib (PID 10) had a recombination pter to the most
centromeric marker, but she shared the remaining parental genetic contributions with PID
9. At the four BBS loci examined, negative lad scores (6 = 0) for appropriate markers
were obtained. and at aUlaei the haplotype analysis suggested exclusion (Table 3.1).
The affected individual (pro 14) in family 85 shared identical haplot)'pes with
four unaffccted siblings (PIDs 9, 10, 15 and 16) at the BBSI locus, thus excluding this
locus. The BBS] locus was also ruled out because the affected person shared complete
hap[ot)'pes with an unaffected sibling (PID 10). At the BBS2 locus, the affected sib had a
recombination at the pter portion orthe maternally inherited chromosome. However, pter
to this he shared his hap[otypes with one unaffected sib (PID 13), and qter to the
recombination he shared his haplotypes with two unaffected sibs (PIDs 9 and 15). A
similar recombination had OCCUlTed at the BBS4 locus, but the ptcr portion of the
haplotypes were shared with two unaffected sibs (PIDs 13 and 16), and the qter portion
with one unaffected sib (PID 9). These loci were excluded becausc of this compound
haplotype sharing in combination with negative [ad scores (Tab[e 3.1). There is a remote
possibility that these recombinations occurred in a critical area of the respective BBS
genes, but such an occurrence seemed too remote to weigh heavily in the analyses.
Family B6, with two affected siblings (PIDs 10 and II). was excluded from BBSI
because both patients had different paternal contributions. Also, one affected person
(prO II) shared haplot)'pCS with an unaffected sib (PID 12). Different paternal
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contributions were inherited by the affected sibs at thc BBS2 locus, excluding this locus.
Additionally, one affected individual (PID 10) had the same haplotype5 as two unaffected
sibs (PID 9 and 14). At the BBSJ locus, both affected sibs shared identical haplot)'pCs
with an unaffected sib (PID 15). Paternal contributions were also differcnt in the BBS4
critical region in the affected sibs; one affected person (PID 10) shared haplotypes with
an unaffected sib (PID 15); and the other affected sib (ND II) shared haplotypes with
two unaffected sibs (PIDs 9 and 14). Thus, the BBS4 locus was excluded in this family.
For three of the four loci examined, statistically significant negative lad scores (8 = 0) for
appropriate markers were obtained (Table 3.1).
In the large multiplex 89 kindred, BBSI was excluded because the two affected
individuals in one sibship (PIDs 28 and 29) had di fterent paternal contributions. Also,
one affected person (PID 28) shared haplotypes with an unaffectcd sibling (PID 26),
whilc the other unaffected person (PID 29) shared haplotypes with unaffected sibling PID
27. In the other sibship tested, the two affected sibs (PIDs 21 and 22) had different
genctic contributions from their mother, and two of the t~ chromosomes segregating in
these two patients were distinct from those in the affected sibs of the other sibship. For
BBS2, only one sibship was typed. However, this locus was excluded because both BBS
patients (PIDs 28 and 29) had dHferenl maternal contributions. Also, PID 28 shared
haplot)'pCs with an unaffected sib (PID 26). For BBSJ, one affected person (PID 28) had
a recombination in his maternally inherited chromosome, creating a combination of
haplotypes thai were uniquc to the two affected individuals in this sibship. However, the
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other sibship. with [wo BBS patients. did not share any chromosomes with these patients.
Also. both affttted sibs. PIDs 21 and 22. had different maternal contributions. Also. PID
21 shared haplot)pCS with an unaffected sib (pm 34). For these reasons this locus was
excluded based on haplotype analysis. At the BBS4 locus. both affected siblings in one
sibship (PIDs 28 and 29) had different genetic contributions from both parents. As well.
pm 29 shared haplot)pCS with two unaffected sibs (PIDs 25 and 27). Using the limited
results obtained in the other sibship. it seemed that the affected brothers (PIDs 21 and 22)
have different paternal contributions. Regardless, this locus can be excluded solely on the
analysis of the fully informative sibship. At all loci examined, statistically negative lad
scores (6 =' 0) for appropriate markers were obtained (Table 3.1).
Finally, a consanguineous family, B13. provided negative lod $Cores and
haplotype analysis results which indicated exclusion of the four known BBS loci (Table
3.1). At the BBSIIocus. the two affected individuals (PIDs 12 and 13) recei"ed different
paternal contributions and one (PID (3) shared haplotypc:s (except for the pter most
marli::er· DIISI198) with an unaffected sib (PID 17). At the BBS1Iocus. both affected
sibs shared haplot)'PCS with an unaffected sibling (PID 18). At the BBSJ locus. the BBS
patients received different paternal contributions. and one affected sib (PID 13) had the
same haplot)'pe as three unaffected sibs (PIDs 15, 17 and 18). Also, at the BBS4 locus,
the affected sibs had different paternal contributions; one affected sib (PID 13) shared
haplotypes with unaffected sibs (PIDs 15 and 18), and the other affected individual shared
haplot)'pCS with an unaffected sib (PID 17).
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Three of these six k.indreds (B3, B9 and 813) are known 10 be consanguineous.
and family 89 has five alTect~ individuals. in thrtt lineages. that are interrelal~by three
consanguineous and two marriage loops. Both families 89 and 813 were considered
good candidates to conduct a genome-wide screen on. 10 identify other BBS loci.
3.1.5 Families ~'''05e BBS Status eould 1101 be AssiCII~
It was not possible to assign six families (BI, 87. B11. B12. BI5 and Bl6)with
confidence 10 a panieular locus or exclude them from the four known BBS loci (all
haplolype dala is sho....'T\ in Appeadix A for the following analyses). Families BI, B11
and B16 contain two alTccted individuals with no unalTccl~ siblings. These families
could only be excluded from a panicular locus if the two afTect~ individuals received
dilTerent parcmal chromosomes. This was the case for: familyBI at the DDS! andBBS3
loci; family BII at the BBSlloc::us; and family BI6 at the BDSI. BBSl and DDS4loci
(Table 3.1).
In family B12. there are onlyt.....o children, one afTect~ and one unalTected (the
other alTect~ individual. in a previous generation. was unavailable). Due to the pedigree
structure, only aaS] could be excluded, sioce the affccl~ and unaffected individuals
shared haplotypes.
Kindred B7 was excluded from both 8BS] and BBS4 on the basis of haplot)'pC
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analysis (Fig 3.8). At Ihe BBS] locus, the affected siblings (PIDs 9 and 15) had different
palernal contributions. As well, PID 9 shared haplolypes with one unaffected sib (PID
16), and PID 15 shared haplotypes with two unaffected sibs (PIDs 13 and 14). At the
BBS4locus. both affecled siblings had different paternal contributions. Also, PID 15
shared haplolypes with (wo unaffC(;led sibs (PIDs 13 and 17). Allhe BBSl locus, the
affected individuals in family 87 shared haplotypes and a region of homozygosity.
Linkage at this locus was supported by a positive lad score of 1.07 (8 = 0) at D16S165.
In the region of BBSI, the two affecled individuals shared the same non-homozygous
haplotypes. which was not observed in four unaffected siblings. As a result, a positive
lad score of 0.96 (6 = 0) at DIISI88J was generated. Thus, there was evidence to
support the assignment of family 87 to both the BBS/ and BBSlloei.
Family B15 is a suspected consanguineous kindred, and the only affected
individual (PID 15) was H8S at the BRS/locus. The BBS210cus could not be excluded
because the affC(;ted individual contained a unique pair ofhaplotypes among the
offspring. Family SIS was excluded from the BBSJ locus since Ihe affected individual
shared haplotypes with two unaffected siblings (PIDs 12 and 17). The BBS4!ocus was
also not excluded, as the affecled individual had a unique pair of haplotypes pter to
D/5SI/4. Thus, there was evidence to support the assignment of family 815 to BBS/,
8BS2 and BBS4. However, because HBS was observed at the BBS/locus in this
suspected consanguineous kindred. BBSI was considered the most likely candidate to be
causing the disease.
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Based on II families with unambiguous Ioc:us assignments 10 this point. it WiI$
cakulated that 27% (3) of the families are linked to BBSI. 9"10 (I) to BBS] and 9% (I) to
BBS3. and remarkably. 55% (6) ofthc:sc families are linked to a yet unIcnown locus or
loci.
J.2 TIle BRSJ Crittul Rqioa was Reducrd "'jlb rlmily OJ
In an attempt to reduce the critical interval of BBSJ. which was originally II cM
(Sheffield elol.• (994). additional microsatellite markers were typed within this region
using family 82, the only putati\'e BBSJ family in Newfoundland. Two-point linkage
analysis provided strong support for linkage between BBS and chromosome 3 (BBSJ) and
the exclusion of linkage to BBSI, BBS] and BBS4 (Table 3.1). Additional haplotype
analysis with microsate!lite markers spanning the BBSJ critical region sho.....ed thaI all
8BS patients were homozygous for a ponion ofthc BBSJ critical region (Fig 3.9). Three
affected sibs (PIDs 22. 23 and 24) were homozygous for all t)lled markers. They
inherited two copies of tile BBS1 haplotype, pter·7·5-19.7.9.7-4-4-qter. Affected persons
PIDs 14 and 15 were homozygous for the same alleles as their affected cousins at marker
loc:i in the qter ponion of the BBS) critical region. The finding of identical, homozygous
haplotypes in the affected relatives suggested that their parents share a common ancestry.
The smallest region of homozygosity in an affected relative was found in person PID 14.
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Fig 3.9 Family 82 witb marken spanling tbe 7 eM BaS1 critical interval. HBS is
obsen'ed between D1SJ25J aad 01SJ751 la all affeeted individuals
(boxed). reducing tbe erllicaJ inlervalto 6 eM. Haplotypes for PIDs 1 aad 8
"'ere not distinguisbable therefore were arbilrarily assigned. 'R' represents
a reeombination eVellt. Alleles in parentheses were inferred. '?' indicates no
informatioa was oblai,ed or inferred.
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This region includes the microsatcllite markers 03S1151, 03S1752, OJSll71 and
OJSI75J. corresponding to the pter.9.7-4-4-qter haplotype. This interval is 6 cM in size
(Fig 3.10). If we assume that the 88S patients in this family were H8D for the crilical
region. then the BBSJ gene is located on the qter side ofOJS/595. pter to OJSI753. the
delimiting marker in the original B8SJ linkage paper (Sheffield el al.• 1994). Two-point
linkage analysis provided a lad score 0£2.86 (9 '" 0) at OJ$1751 (Table 3.1). This was
not a statistically significanl l"CIult, but it did strongly suggest linkage of family 82 to the
BBSJ locus.
).3 A Fou.dtr Errtd Reduced the BBSI enciul Recio. co I eM
In an initial study by Leppert eI al. (1994). the putative 88S1 gene was tightly
linked to two loci on chromosome Ilql3: the gene for human muscle phosphorylase
(PYGAl) and DIIS9IJ. BBSI was localized to a 13 eM interval betw~DIISI]98 and
FGFJ (Fig 3.1). A more precise genetic and physical map of BBSI was requirttl if this
gene was to be positionally cloned.
Of the 17 Newfoundland families, three (88, B I0 and B19) were assigned 10 the
BBSI locus and three were not excluded (87, Bll and BIS) because they yielded positive
lod scores and haplol)pes consistent with linkage to BBSI. However, only family 8 10
was excluded from all other known loci (Table 3.1). Of these six families, parental
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Fig 3.10 Location ofmicroucellile markers spanning Ihe BSS) crillcal interval
on chromsome 3. TIt!s reeion was narrowed from 9 ci\t 106 eM vslne
recomblnanu in kindred 82. Marker order and dlslaRces were oblained
from the Marshfield sel-.veraged linbat maps and Genethon linkaee
maps (GDB).
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consanguinity was documented in families 88 and 819, and suspected in families 810,
812 and 8 IS on the basis of progenitors with the same surname originating from the
same community (Fig 2.1). Extensive genotyping with markers mapped to the BBS!
critical region was performed in the six families. representing eight B8S patients and 44
first- and second-degree relatives.
Five ofthe six possible B8St families lived along the south and southwest coasts
of Newfoundland (Fig ].11). Obligate recombinations involving the disease haplotypes
(OHs) were detected in several families and used to refine the BBSI interval. In family
810. an unaffected individual, pro 14. inherited a non-recombinant DH from his father
and a recombinant from his mother (Fig]. 12). The presence of two DHs for the
centromeric ponion of the BBSI critical region (D11SI198 to DllS1883) in an
unaffected individual suggested that marker DI 151883 was the new cemromeric
boundary for 8BSI. Similarly. a recombinant paternal haplotype inherited by an
unaffected sib in family 88 (PID 12) suggested that 8BSI was located centromeric to
FGF3. Intra familial recombinations within DHs reduced the 8BSI interval from a I] eM
region to approximately a 7.5 cM interval between D! 151883 and FGF3 (Fig 3.13).
Extensive genotyping at the 88S1 locus focused on markers within the new 8BSI
interval. between Dl ISI883 and FGF3. At this point the B7 kindred was taken out ofthe
analysis because ofthc lack oftemplatc DNA available. The distribution of alleles at 14
polymorphic loci in disease and nonnal chromosomes is shown in Table 3.2. Linkage
disequilibrium (LO) between marker alleles on OHs was observed across the families.
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Fig 3.12 Tbree ramilies wilk linka&e to BSS} (88, 819 and 810) and three
uu.ssi&lIed ramilies (87, BI2 and 815) haplotyped ror six markers
spaanin& the BBS} critkal interval. Oal)' (ore pedigrees shown. Boxed
hapmtypes (solid and dashed lines) indlc:ate DRs. 'R' indic:ates hapmtype
is recombiunt.
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Fig 3.13 Refinement oflhe 8RSI internl by r«ombinallonaland LO mapping.
The markers Ind Iheir positions were .eleeled from the map of the
MEN I region on 11q13 (Mankk.lm et al., 1997; Sixth Internalional
sew II Workshop 1998) and the Cenelhon and Marshfield sn-
averaged linkage maps. Markers In bold were homozYl:0us in all
affeclfdilldivlduals.
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specifically at D1 154205, D1151883, D1 154945, prGM and D/ 154946.
All disease chromosomes segregating in BBS1 families contained the pter.9·g-5-
qtersubhaplotype at D11S4945, prGM and D1 154946, respectively. The evidence
suggested that the pter-9-8-5-qter subhaplotype represents either the remnants ofa
founder 8851 chromosome imported. from England, or the background haplotype that
sustained a BOS1 mutation (le /lOVO in the gennIine of a single English settler.
LD mapping supported a position for the 8851 gene within a I eM region
between markers D1 151883 and D1 /54940, surrounding the PrGM locus. The
D11S/883 boundary is also supported on the basis of inIrafamilial ~ombination (Fig
3.13). This I cM genetic interval represents a physical dislanceofabout 2 Mb (NCBI.
Map Viewer; http://www.ncbi.nlrn.nih.gov/cgi-binlEntrezlmaps.cgi?org=hum&chr=I 1)
within a region of the genome that is gene rich.
3.4 A Fifth 88S Locus on Chromosome 2qJI
In the initial genetic survey ofBBS in Newfoundland (Chapter 3.1.4) there was
evidence for at least one other BBS locus, as six kindreds were confidently excluded from
the four known BBS loci. As well, there were two additional population surveys which
found several unlinked BSS families, providing convincing evidence for at least a fifth
BBS locus (Beales el al.,1997; Bruford el a1.,1997).
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Family B9, the largesl of the six Newfoundland kindreds excluded from the four
known BBS loci, had five affecll:d members who were the products of three
consanguineous unions interrelated through ~·o founding couples. Employing this
family, a genome.wide scan of pooled DNA samples was perfonned with microsalellite
markers. Two control pools of DNA from four living parents and II unaffected siblings,
as well as a lest pool of DNA from the four surviving patients, were amplified.. Of the
first 322 markers successfully amplified. six showed a reduction in the numberofallcles
in the test pool, compared with the control pools. Subsequent genotyping of these
markers on the extended family proved that they were not linked to BBS, as HBD was nOI
evident, resulting in a false positive rate of 1.9%. However. the 323'" marker, D1SIJJJ,
showed a 4:1 allele shift, from the control pools to the test pool. Genotyping of D2S1J5J
on the pedigree showed it 10 be exclusively homozygous in patients with BBS. AI this
time an archival sample of one affected individual (PID 24) became available and was
added to the analysis. Two-poinllinkage analysis showed significant linkage [5.59 (6 '"
0)] between BBS and D1SIJ5J. with no recombination (Table 3.3). Genotyping of
markers flanking DlSlJH confirmed linkage 10 2q31 and showed an ancestral haplotype
that was HBD in all affected relatives (Fig 3.14). This extended haplotype is flanked by
D1S1561D1S1J53 and D2S1238, a distance of approximately 13 eM (Fig 3.15). identified
by the observation oftwo key recombinants in two unaffected parents (PIDs IS and 12).
A recombination occurred in pm 12 between D2S3J5 and D1Sl1J8. that was inherited
by an affected individual (PlO 24) who was HBD between and including D1Sl141 and
lOS
Table 3.3 Two-poiDllod scores between the BBS Iniland lq31 marken in
ramilyB9.
Two-poiDllod scores a' e:lll
Marker" 0.00 0.01 0.05 0.10 0.10 0.30
D25442 -2.96 -1.40 -1.20 -0.69 -0.22 -0.05
D251399 -4.36 -0.49 0.91 1.26 1.31 0.67
0251353 5.59 5.48 5.00 4.40 3.17 1.94
015124 3.97 3.92 ].62 ].19 2.22 1.28
0181330 4.99 4.88 4.42 3.85 2.72 1.65
0281176 4.61 4.50 4.05 3.48 2.33 1.25
0151391 0.84 2.08 2.65 2.62 2.05 1.28
" Llsled according to phYSIcal order (pter-qler) on chromosome 2q31.
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Chromosome 2 eM
025442
0251399
0252241
025142
025418
2.5
0251J53
025156'
0252380
025124 BBSS
0252330 13cM
4\""""025335
D2S1238·
0252314
0251391
38.5
fig 3.15 Location ofmnken spaDDiag Ihe BBS5 internl o. 2q31. By haptorype
aulysls on family 89 • criliul rqion of 13 d\1 was evident. Marker
dlslancn and positions were oblained from Mlirshneid sex averaged and
Genelhon IInkaKe maps.
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D2S33J. The other critical recombination, occurred in PID 15, between
D2S/561D2S/353 and D2S/24, inherited by two affected offspring (PlDs 28 and 29),
who had a region ofHBD between and including D2S/24 and D2S/39/. These results
provided strong evidence for a fifth BBS locus (BBS5) on 2q31.
),4.1 Analysis of the Remaining Unlinked DDS Families at tbe BBSS Locus
Although family B9 was geographically isolated from the remaining families
excluded from BBS/·4 (B3, 84, 85, 86 and 813; Fig 2.2), theBBS510cus was still
considered a good candidate locus for these kindreds. Therefore, the flanking markcrs
and those within the critical region of BBS5 were tested on these families as well as on
families which could not be assigned exclusively to any of the original BDS loci (Bl, 87,
811,816). Also, the putative BBSl kindred (BI4) was tested to ensure it could be
excluded from the BBS5 locus, in order to provide greater support for its present
categorization.
Both consanguineous families. 83 and B13, were excluded from BBS5 by
haplotype and linkage analyses (Table 3.4). The two affected individuals (PIDs II and
12) in family 83 inherited different genetic contributions from each parent within the
BBS5 critical region (Fig 3.16). Also, the affected sib (PID 12) shared haplotypes with
his unaffected brother(PID 10). A lad score of ·10.41 (e = 0) at D2S2330 also supported
109
TableJ.4 Summary of liDkage aId "aplotype aDalysis It tIte BBS5 lotus for
flmilies whick eould Dot be speeifieally assi.lled ODe of tbe four
kaown BBS lod.
BBSS
"'0
No. Marker LOO HAP
BI 0252330 0.60 HS
B3' 0252330 -10.41 X X
B4 0252330 -9.98 X X
B' 0252330 -1.90 NE NE
B6 0252330 -0.11 X X
B7 D25156 -4.68 X X
BUb 0252330 -2.92 X X
BU' 0251353 -12.45 X X
814' 0252330 -0.33 X X
BI6b 025124 0.49 HS
'Confirmed consanguineous unton.
b 5uspected consanguineous relalionship.
110
111
exclusion of family B3 from the BBSJ locus. Two affected sibs in kindred B13. PlDs 12
and 13. inherited different chromosomal regions within the BBSJ critical region from
their father (Fig 3.16). PID 13 also shared his genetic contributions from both parents
with an unaffected brothff{PID 17). The led score of -12.45 (0 s 0) at D1S1JJO also
supported exclusion of family BI3 from BBSJ (Table 3.4).
The non-consanguineous kindred, 84. contained two affected siblings (PlDs 10
and 13), each of which had inherited different genetic cOnlributions from both parents
(Fig 3.17). Also, PlO 10 shared haplotypes with unaffected sibs, PlDs II and 12. This
family provided a lod score of -9.98 (0:: 0) at D1S13JO, supporting the haplotype
artalysis (Table 3.4).
The affected individual in family 85 was recombinant for both parental
chromosomes; however, the pter recombination in the maternally inherited chromosome
was outside the BBSJ critical interval (Fig 3.17). The recombination in the paternally
inherited chromosome was within the critical region of BBSJ. and the combination of
parental gCfle(ic material in this region was unique in the affected individual. Therefore,
this region of the BBSi critical interval (4 cM), qter to D1S/776, was not ruled out using
haplotype analysis. However, the rest of this region was excluded because the affected
person shared haplOlype5 with two unaffected sibs (PIDs 12 and 16).
Family 86, containing two affected siblings, was also excluded from the BBSJ
locus. Both affected individuals (PlOs 10 and II) shared the same genetic contributions
from the parents within the critical region; however. these haplotype5 were also shared
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with one unaffected sibling (PlD 15: Fig 3.17). The lod score at the most infonnative
marker in this region. 01S1)30. was .n.11 (6 .. 0).
Three famili~ (BI. B11 and 816), which were not assigned to any one of the first
four BDS loci because ofpedigree structure, were tested for linkage to the BBSS locus.
For kindred BI, there was HS between the two affected brothers (PIDs 9 and 10) for the
pter portion of the BBSS critical interval (Fig J.18). However. a recombination in one of
the patients resulted in the qter portion of the paternally inherited chromosomal region
being different between the two brothers. Thus, the region distal to 02523)0 was
excluded. Within the region of HS. a lad score of 0.60 (6 • 0) was calculated at
01S23JO. Therefore. this locus could not be excluded in this family. However. in the
similarly structured BII kindred. exclusion of the B8S51ocus was possible. Haplotype
analysis demonstrated that the affected siblings (PlDs 8 and 9) inheriied different paternal
genetic contributions (Fig J.18). Exclusion ofthe 8855 locus was further supported by a
statistically significant 100 score of -2.92 (6 "" 0) at 0151330. Family 816, having only
two affected sibs with no unaffected brothers or sisters. coold not be excluded from
88SS, as both affected brother! seemed to have inherited the same genetic contributions
from both their mother and father. Family 816 generated a 100 score of0.49 (6 =0) at
015114.
Family BI4, which was suggcstiveoflinkage to BBS1, was t~led for linkage at
the BBS5Iocus. The 87 kindred was also examined at this locus. The consanguineous
kindred BI4 was excluded from BBSS due to the absence of homozygosity in this region,
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in the affected individual. Family B7 was excluded from this locus since both affected
sisters (PIDs 9 and 15) had inherited different maternal genetic contributions (see
Appendix A for haplot)'pCs). Linkage analysis generated a lad score of -4.68 (6'" 0) at
02S156, indicative ofexclusion at this locus (Table 3.4). The exclusion of family B14
from BBS5 increased the likelihood that this was a BBS2 kindred.
Surprisingly, all of the families excluded from the lirst four BBS loci (except B9)
were also excluded from BBS5, with the exception of the qter 4 cM of the critical inlerval
in family B5. This indicated that there was yet another BBS gene segregating in the
presumed homogenous population of Newfoundland.
3.5 Analysis of Chromosome 18pI I,] I-pi 1.2 for a Possible RRS Gene
On the suggestion ofa close colleague (Dr. P.L. Beales. personal communication),
the region ofchromosome 18pI1.31-p11.2 was analyzed by microsatellite markers for
linkage to BBS in families which could not be assigned to a single known BBS locus (B [,
B3, B4, 85, 86, 811, BI3 and BI6). While performing a genome wide scan with a large
consanguineous Indian B8S kindred. Dr. Beales had observed a region of HBD with
markers DI8S458 and DI8562 in three affected patients, but not in the fourth unaffected
sib. [n addition. there were two small Kurdish families which were HBD in this region.
These and other microsatcllites were typed in the above mentioned Newfoundland BBS
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k..indreds (Fig. 3.19).
Families B3, 84. BS, B6 and B13 wereinvesligated for linkage 10 BBSon
chromosome 18p. lntereslingly, in family B3, the parents had the same haplotype for four
consecutive markers in this region, which was likely inherited from a common
grandparent (Fig 3.20). This haplotype had at least been partially inherited by each of the
affected individuals (PIDs II and 12) from each parent, but not by the unaffected sib
(PlD 10). Eadt affected sib was homozygous for the two fully infonnative pter marlc:ers.
DI8S481 and DI8S63, while the lone unaffected sib was nol. However, in one affected
penon (PID 12), there \lo'llS a recombination in the paternally inherited chromosome
prollimalto DI8S63, but no more data were obtained for the other affected sib (pro I J).
Unfonunatcly. the tissue sample from which DNA was ex.tracted for this deceased
individual was of poor quality. The lad score at D/8S63 [1.80 (6 '" 0») renected the HBD
in Pros 11 and 12 (Table 3.5). If this chromosomal region contained a BBS locus. it
would reside qter to D18S52, according to the haplotype analysis in this kindred.
Family BI3 was excluded from the possible chromosome 18 BSS locus by
haplotype analysis. Both affected patients analyzed (PIT>s 12 and 13) sh~ cornmon
pamltal haplotype5 (except for the most distal marker) which they shared with an
unaffected sib (PlD 17). Also, haplotype5 were shared with the unaffected sib PID IS
pter to D/8S62 (Fig 3.20).
Kindred 84 was excluded from a possible BBS locus in this region since the
affected individuals (PIDs 10 and 13) had different paternal contributions (Fig 3.21).
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FigJ.19 Locatio. or marken sp...illg a rqioa ofHBD fOilllld ia a large
coa$"&UiD~U5IDdi.D kladred willa BBS txdu.ded (rom du~ (in .....ow.
BBS loci (Dr. P.L. BtalK, perso...1rommulliutioa). Marker order and
dis•••cts were oblai_cd from the l\"'nhfield sex-AVerage aDd
GcattboD Illlk_gt maps.
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Table 3.5 Summar)' or linkage aad haplotype aul)'sis ror chromosome
18pll.31- pll.2 ror ramilies which could not he specifically
assigned ODe or Ihe five kaown BBS loti.
Kin
No.
Chromosome 18pll C
b
Marker LOD HAP r
'8
81 0[8562 -6.43 NE
83' 018563 1.80 H8D
B4 0185471 -6.77 X X
85 018563 -).20 X
B6 018562 -0.11 X X
BUb 0185458 0.60 HS
813' 018562 -0.52 X X
I Conlinned consanguineous union.
bSUSpecled consanguineous re[alionship.
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Also. an unaffected sib (PID 12) shared haplotypcs with an affected sib (PID 10). A
signifICantly n~gative 100 score also supported exclusion of this putaliv~ BBS locus in
this family (Table 3.5).
Family BS had a single affected male (PIDI4) who shared his malcmal and
paternal genetic contributions within this region with thrtt unaffected sibs (PIDs 9. 12
and 13; Fig 3.21). A statistically significant 100 score of -3.20 (8'" 0) at the fully
infonnative marker. DJ8S6J. further supported the exclusion of this region as a candidate
BBS locus in this kindred (Table 3.5).
Two affected patients (PlDs 10 and II) in kindred B6 shared both parental
haplotypes within the region studied; however. they also shared th~s~ hap[otypes with an
unaffected sib (PID14). excluding this region by haplotype analysis (Fig 3.21).
For the three families (BI. BII and 816) that could neither be categorized to one
sp«ilic BBS locus. nor excludt'd from all BBS loci. haplotype and linkage analyses were
pcrfonnt'd with chromosome 18p marker data (Table 3.5). Unfortunately. in family BI.
due to the uninfonnative nature orth~ markers analyzed and the problem of marker
amplification in PID 10 (Fig 3.22). this family was not excluded nor assignt'd to this
putative BBS locus (Table 3.5). In PID 10. it was uncertain which paternal haplotype was
inherited. except at a single marker. DI8S61 (Fig 3.22). This marker provided a 100 score
of -6.43 (8 = 0). indicating exclusion. However. the maternal haplotype could nOI be
detennined. Thus, B I was uninfonnative at this putative BBS locus.
Like kindred 8 (. kindred B(I was also uninfonnative for most markers in this
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region (Fig 3.22). However. if we assume the least numberofcross-<l\'efS, none. then the
only two sibs, both of whom are affected. shared parental hapIOI)l)CS. At the only fully
infonnative marker (DI85458). the family generated a 100 score of 0.60 (8" 0).
suggesting linka~.
Finally, kindred B16 was not assessed because DNA from one of the two affected
sibs (PlD 6) did not amplify for any of the chromosome 18 markers tested. and there were
no unaffected siblings to analyze (Fig ].22).
In conclusion. it was possible 10 exclude families B4, B5. B6 and Bl3 from a
putative BBS locus on chromosome 18p. However. it was not possible to categorize
families BI and B16. primarily due to the pedigree structure of these two families.
Interestingly. there was some evidence for the assignment of families B] and Bllto this
putative BBS locus.
3.6 [vickacc for a Sixt~ BBS Lotus (6BSi) 011 Cllromoso_ ZOpIZ i_ 813
With five BBS families excluded from all identified and putative BBS loci. there
was significant evidence for a sixth BBS gene. Therefore. family 813 was used for a
genome-wide scan implementing DNA pooling and homozygosity mapping.
Unfortunately. family BI3 was not as large a family as B9, but it was composed ofa third
cousin marriage and two affected individuals with four unaffected sibs. When a
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simulated linkage analysis was performed, using SLINK (v2.6S) and MSIM (v2.6S). the
maximum estimated lad score was calculated as 1.85 (6 - 0). Although lhis simulation
analysis indicated that a s;gnifiant result could not be obtained by linkage analysis at a
truly linked locus to a BBS gene. it was hypothesized that all remaining families which
were unlinked to all known BBS loci would be linked to the sixth B8S locus. Therefore.
a simulation study was performed on the five unlinked families to determine if a
statistically significant 10<1 score could be obtained. The estimated maximum cumulative
100 score was calculated at 6.46 (6 :: 0). Therefore, a genome-wide screen was perfonned
on kindred BI3 to locate a sixth BaS locus. with the intent of typing the remaining four
families with any candidate markers which provided a positive lod score and exhibited an
extensive region ofHBD in affected individuals in family 813.
The genome scan was begun on chromosome 22. Ten of the first 153 marters
tested exhibited a reduction to one in the number ofalleles in the test pool. These
markers were examined more closely by extensive typing ofadditional adjacem marlc:ers
on all available family members in family B13. Additional markers were obtained if the
marker was homozygous in the affected individuals and not in the unaffected sibs. These
additional microsatellites were tested on family 813 to determine if an extensive region
ofhomozyg05;tywas detectable in the affected sibs [as would be expected in a third
cousin consanguineous marriage at a locus associated with the disease (Gcnin et al.,
1998)]. These markers were also tested on the other unlinked families to determine if
linkage was suggestive at these loci. Also. any possible allele sharing between families
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was examined, since a founder efTect may be observed, as was the case for BBSI.
The 154'" marker typed was D20S189, on chromosome 2Op12, which displayed a
reduction ofalleles from three to one, from the control pools to the test pool. When this
marker was typed for each family member individually, it was fully infonnative and
homozygous in afTected persons, but not in the four unafTected sibs (Fig 3.23). Therefore.
additional microsatellite markers were obtaim:d and tested in this region. Subsequently,
an extensive region of homozygosity was observed between D20S192 and D20S189, a
distance of approximately 8 cM (Fig 3.24). A lad score of 1.98 ce '" 0) was generated
with D20S85 I.
),6,1 Aualysis oflbe Remainillg Unassigned DDS Families atlhe PUlative BBS6
Locws
To funher investigate this putative B8S locus, D20S189 and adjacent markers
were typed on kindrcds 83, B4. 85 and B6, and used for linkage analysis. These markers
were also typed on families 81, Bll and 816, which had not been categorized as yet.
The results of haplotype and linkage analyses in these families (except Bll) are shown in
Table 3.6.
The consanguineous kindred B3, in which only one afTected member was
available for haplotype analysis, generated a lod score of 0.95 (6 = 0) at D20S917,
indicating suppon for linkage at this locus. More significantly however, the affected
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Table 3.6 Summary or liakage aad haplotype aaalysis ror dlromosome lOp I1
marken ia ramities whie" could DOC be assigned to ODe or clle fh'e
kDown BRS lod.
BBS6 8
IU. 8
N•. Marker LOD HAP S
6
81 0205917 0.57 HS .I
8J' 020S917 0.95 H8D .I
B4 020S917 0.96 H8S .I
BS 020S85I 0.71 UH' .I
86 020S917 -4.93 X X
Bll b 020S115 -6,43 X X
B13' 0205851 1.98 H8S .I
B16b 020S162 0.56 HS .I
Confirmed consangumeous union.
b Suspected consanguineous relationship.
• Unique Haplotype. Different from six unaffected sibs.
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person was HOD for the markers qter to D20S900, but the unaffected sibling was not (Fig
3.25). Also, the disease carrying chromosome was shown to have originated from one of
the founders, P[o I or 2. since the affected person's parents inherited their copies of this
chromosome from their parents, who were siblings.
Kindred B4. with two affected sibs. also gave a positive lod score at D205917
(0.96 (8 = 0)]. The haplotype analysis was also supportive of [inkage ofDBS to this
locus. Both affected individuals shared hap[otypes at the three most proximal markers
(D205917, D20S189 and D20S186). which were not shared with the three unaffected sibs
(Fig 3.25). Interestingly, one affected individual. P[O [3, was homozygous for all
markers typed in this region. indicating he may have rcceived two copies of part of an
ancestral chromosome. However. the other affected person. PID 10. had a recombination
in her patemal chromosome, between D20S851 and D20S91 7. Therefore. she was only
homozygous for markers proximal to D20S851.
There was one affccted individual and six unaffected siblings availabie for
analyses in family B5. which provided a positive lad score of0.71 (8 = 0) at D20S851.
PID 14, the affected son ofPIDs 6 and 7, had unique parental hap[otypes between
D20S192 and D205162 when compared to his unaffected siblings (Fig 3.25). However,
both PlDs 13 and 16, who share full paternal, but not maternal contributions with PID 14.
had recombinations between D205162 and 020S189 on the maternally inhcrited
chromosome. Therefore, they shared hap[otypes proximal to these cross-overs with PID
14.
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Unlike the other four families excluded from 8BSI.5, kindred 96 did not show
e\'idcnce of linkage at the putative BBS locus on chromosome 2Op. At 010S917 the Iod
.score was -4.93 (6:: 0). The haplotype analysis a150did not suppon linkage at this locus.
since the two affected persons. PIDs 10 and II. have diffcrmt matcmal contributions in
this region. Also. PID 10 shared both parenlal contributions with an unaffccted sib. PID
12. Additionally. the other affected sib (PID II). shared his parental contributions with
an unaffeetcd sib (pro 9). Thus. this locus was excluded in family 96. Remarkably. this
family can now be excluded from all six known B9S loci. indicating evidence for a
another BBS locus.
Of the ttlree other families not yet assigned to a locus. two. families Bl and B16,
were not excluded from this BBS locus. Family BI was not excluded from this locus
because the only two sibs. which are both affccted. share the same haplotypcs (Fig 3.26).
Linkage analysis generated a lad score of0.57 (6 "" 0) at 020S917. A similar result was
obtained for family 816, where there are two affccted brothm but no unaffcc::ted
individuals in the sibship. Haplotype analysis of kindred 816 (Fig 3.26; Table 3.6)
indicated that bom afTcc::tcd sibs shared paternal and maternal contributions in this region.
However. proximal to 0205162, one of the brothers had a recornbinatioo in his
maternally inherited chromosome. The third family in this category, 811. could be
excluded from this locus since the onlylwo sibs. both alTcctcd. have different
contributions from their father. as well as from their mother between D205/15 and
0205162 (Fig 3.26). A lod score of -6.43 (6 "" 0) at D20S115 funher supponed exclusion
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ofa aas gene at this locus in family BII.
Through haplotype and linkage analyses. the disease in four of five families
excluded from all five known BBS loci, and two of three families that could nOI be
exclusively calegorized, was highly suggestive of being linked to a BBS gene on
chromosome 2Opl2 (8856).
3.6.2 Aaalyzes of a CaDdidale GeDe (MKKS) in Ibe Delimited Critical Region of
BB$6
To delineate the BBS6 crilical interval. haplotypes offamilies BI, B3, B4, 85 and
Bl3 were examined (Table 3.7). Haplotype analysis idenlified a potential 2 cM critical
interval between Dl0S851 and D20S189 supported by several lines of evidence. The
distal boundary was determined to be Dl0S851 on the basis ofa recombination in
individual PID 10 of family B4 between 010S851 and D20S917 (Fig 3.25). Also, in
families B3 and B4, all affecled patienls shared a pler-9.I (}.qter haplot)'pC for D20S189-
D10S186, but not for Ihe distal markers. The proximal boundary was delineated by a
recombinalion in two unaffecled sibs, PIDs [3 and 16, in family a5 (Fig 3.25). These
individuals had the same paternal contribution as Iheir affected sib and the same maternal
contribution proximal to D20S189. Therefore, the causative gene had to be distal to
O10S189 if this family was linked to a BSS locus in this region. This boundary was
supported by the loss ofHBD of markers proximal to D205189 in both affected
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individuals in family BI3 (Fig 3.23).
There appeared 10 be t,,'o separate founder effects in these families (sec: Figs 3.23,
3.2S, 3.26 and Table 3.7). One orthe disease haplotype5, in families BI and BS, the pler-
7-6-S-4-.S-S·9-I6-qter (Dl0S/91·//J-900-85/-/75·162-I89-J86), was panially the same
as in family B3, pter-4-5-9·IO-qter (D20S851·/62-/89-186), and family 84, pter.9-IO-
qter (Dl0SJ89-186). In addition, the DH found in family BI3, the pler·7-7.7.13·8·9-11-
qter(DZOSI91-900-1IJ-851·917./61-/89), was identical 10 one of the DHs in family 81.
These data suggested that BBS6 maps to an approximalely 2 cM region between D20S851
and D20S189 (Fig 3.24). Also, il indicates there are multiple mutations in this one gene
segregating in Newfoundland.
Previous 10 the aoo\'e analyses, a gene for McKusic:k-Kaufman syndrome, MKKS.
was idenlified in the same region of20p12 (Stone el 01., 1999; see Chaplers 4.3 and
4.4.1 for more detail concerning MKKS and its putative protein function). Given the
overlapping dinical phenotype of the two syndromes (Cllapler 1.3.2) and their
concordant mapping position, it was hypothesized that MKXS was a candidate for BBS6.
To investigate this hypothesis, primers were designed (Appe_diI I) to amplify all the
coding exons ofMKKS. Sequencing of these amplicons. which included the exons and
splice junctions, identified several coding region alterations (Table 3.8). All affected
individuals from pedigrees B3, 84 and B16 were homozygous for the deletion 2816T
(numbering begins with the first base of the start codon), which resulted in a frameshift
after amino acid F94, tenninating Ihe protein al amino acid 103 (F94fsXI03; Fig 3.27).
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Table 3.8 Malaliog. foud ig ltfKKS in HVUI Newfo.adlalld 8DS pedigrees.
Familia Number of Newfo.adl..d Nortb
willi Disease Coatrols Amerk..
M.lalions l\f.lalio.s ClirontOSOma ClHIIlrols
fl' ·F94f.XI03 BLBJ, 76 172
(1816T) 84, B5 and
816
fll -Dl4JfsXIS1 B1 and 84 168
(4196CT/4336AG) 813
L111P BS 80 154
(T819C)
A241S B14 7. 166
Tolal 13
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The same alteration was also found in the heterozygous state in patients PIDs 9 and 10 in
family BI, and in PID 14 of kindred B5. The 2816T alteration segregated with the
haplotype-inferred prediction ofa common ancestral chromosome in four families (BI,
B3. 84. B5). This alteration was not found in 172 European or 76 Newfoundland
unrelated control chromosomes (Table 3.8). The second disease associated allele in
family B5 was a T--C transition at the 829t!l base, that was not found in 234 control
chromosomes. resulting in the missense substitution L277P (Fig 3.27; Table 3.8). A
complex 429o.CT/4336AG allele (Fig 3.27) was also detected that co-segregated with the
disease in pedigrees BI and BlJ, resulting in a f'rameshifi (DI43fsX57; Table 3.8). Onee
again the alteration segregated with the haplotype-inferred prediction ofa common
ancestral chromosome in these two families. Cloning and sequencing of the PCR product
from subject PlD 12 in family B[3 indicated that both deletions were on the same strand.
Additionally. a single alteration was identified in family B[4, which had
previously been linked to the 885210(05. A G-T transvef'3;ion at the 723«1 base resulted
in an A242S missense mutation. This alteration was reported previously in an MKS
patient as part ofa complex allele. segregating with an H84Y alteration (Stone et al.,
2000). Both the affected and the unaffected individuals in the Newfoundland kindred
inherited the alteration from their mother, and she from her mother. [n family 814, no
other alterations were identified.
Finally. after eight years and the discovery of six BBS loci, the first gene to cause
Bardet-Biedl syndrome was identified.
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Chapter 4 Discussioa
The colonization of the island of Newfoundland in the 18· and 19'" centuries
resulted in many small isolated communities arising around its coast. These were often
founded by a few families. originally from the same part of the West COUnlry of England
or southeast Ireland. The stability of the communities. combined with large families thaI
often inlennarried. provide an increased opponunity for otherwise rare autosomal
recessive diseases to manifest themselves (Davidson. 2000). In these cases. it is expecled
that the disease allele came from a single ancestral founder and has been duplicated in the
offspring of consanguineous marriages ofhislher descendants. The disease in question is
usually localized to a specific geographical area (Bear et aJ.• 1987 and 1988). However.
me lack ofclustering of BBS in Newfoundland is slriking (Fig 4.1). suggesting that a
single founder event did not occur in this instance unless the mutation was very old and
had spread mOf'e recently. The results ofme current research reveal that mere have been
at least eight founders who have brotJght aboulthe disease: on the island. Funhennore.
despite non-clustcring ofcases. the prevalence of BBS is very high.
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4.1.1 Genelic: Calegorizalions of NewfO"DdlaDd 8DS FamlJin
It was possible to identify mutations in a causative gene for six BBS6 families
(BI, B3, B4, B5, B13, 816) and to categorize another eight of 17 Newfoundland families
to a BBS locus lhrough linkage and haplotype analyses (B2, 88, 89, BIO, B12. B14, 815,
B19). One family (B7) suggested linkage to two BBS loci. and a small non-
consanguineous family (8 II) was excluded from three loci only. Remarkably, one
kindred (B6) was excluded from all six known BBS loci and the possible BBS locus on
chromosome 18.
In the initial genetic survey of Newfoundland BBS patients, three families (B8,
BIO and B19) were considered BSSI kindreds and three others (B7. B12 and 8(5) were
not excluded from this locus (Cbapter 3.1.1; Woods el aI., (999). Using additional
microsatellite markers within the BBSI critical interval, nve of these six families with
DNA available (all but B7) exhibited a founder effect. Five of these six families (all but
B15) originated on the south and southwest coasts of the island (Fig 4.1), a region that
was settled predominantly by the spread of settlers by sea in an east-west direction
(Mannion, 1986). In the absence of mutation analysis, the identification ora single
founder effect required that all patients were homozygous rorspecific alleles at marker
loci tightly linked to BBSI. rt was shown that all BBSI patients, available for fine
mapping, were homozygous for a relatively me haplotype spanning a 1 cM region
centered around the PYGM gene on chromosome Ilq 13 (Chapter 3.3; Young el aI.,
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1999b).
Confinnation of this region as the 8851 critical interval was made by Katsanis et
al. (1999) by the usc ofa large cohort ofBBS patients. The localization of 8BSJ between
DJ 151883 and DJ JS4940 was small enough to allow positional cloning to be attempted.
Unfortunately. however. although this is not a large region for a candidate gene approach.
it is a transcript rich interval (>30 transcripts) (Katsanis et al., 1999). Despite extensive
searching, the 8BSJ genc has not been identified (Or. Nicholas Katsanis, personal
communication).
One family was linked to the 8BS21ocus (BI4) and one to the 88SJ (B2) locus
(Chaplers 3.1.2 and 3,1,3; Woods elal., 1999). Family BI4, a small consanguineous
kindred, exhibitcd HBS in the 8BS2 critical region but it did not delimit this interval.
The discovery ofa BBS] family (B2) was rather surprising, because this fonn of
the disease had not been observed in previous surveys ofBBS kindreds of northem
European descent (Beales et al., 1997; Bruford el 01., 1997), and indeed, previously it had
only been described in a single Bedouin family (Sheffield et 01., (994). The initial
linkage ofBBS 10 chromosome region 3p13-p12 localized the putative 8BS3 gene to a II
cM region (Sheffield el 01., 1994). Haplotype analysis with the 82 family showed
homozygosity, presumably HBD, in all affected members for markers in the 8BSJ critical
region. One affected individual inherited one copy ofa recombined ancestral haplotype
that retained the qter side of the BBS] critical region. Because all the parents originated
from a small fishing village on the Avalon Peninsula of the island, it is probable that they
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shared the same ancestry. This was apparenl from the haplOl}'peS of the affected children
in this extended family(Fig 3.7). On the basis of homozygosity mapping in this kindred
and the BoS3 Bedouin pedigree (Sheffield et al., 1994), it was predicted that the BBS3
gene is located within a 6 cM interval on chromosome 3p (Cbpter J.tJ; Young et al.,
1998). Additional confirmations of the BoS3 locus were published recently from families
oflranian and European descent (Ghadami et 0/., 2000; Beales el a/., 2001). Also, the
critical region was refined to a 2 cM region between D3S/603 and D3S/25/ (8eales el
0/.,2001), which is within the BBS3 critical interval delimited by the B2 family.
Six families (B3, 84, B5, B6, B9, BIJ)were excluded from the four heretofore
identified 88S loci. Family B9 was a large kindred with five affected members who are
the result of three consanguineous unions interrelated through two founding couples.
This pedigree structure lent itself to a genome scan of pooled DNA samples and
homozygosity mapping. Consequently, a fifth BBS locus was identified on 2qJ1 between
markers D2SJ 56 and D2S1238 (C"apter 3.4; Young el af., 1999). Subsequently, the
other five unlinked families were tested to determine if they 100 were linked to the BBS5
locus. Two small families (81 and 8 I6), each of which contained two affected offspring,
with no unaffected siblings, exhibited haplotype sharing at this locus (Chapter J.4,1).
Thus, linkage analysis resulted in small positive lod scores. These kindred.s, therefore,
suggested linkage to B8S5. The eight other families tested (B3, B4, B5, B6, 87, 811,
B13, 814) were excluded by a combination of haplotype and linkage analyses. Reeenlly,
there has been a report of three North American!European BBS families associated with
144
the BBS510cus (Beales I!l al.. 2001). However, these kindreds did not narrow the BBS5
critical interval.
Surprisingly, five families (B3, B4, B5, 86, B13) were excluded from all
identified BBS loci. One of these kindreds. a consanguineous family (B 13), was utilized
in a genome-wide screen using homozygosity mapping ofpooled DNA samples. By
itself, family B13 would not yield a statistically significant led score at a true BBS locus.
However, in conjunction with the other unlinked families, a putative BBS locus was
determined through haplotype and linkage analyses. The microsatellite marker D20S/89
suggested a sixth BBS locus on 2Op12. Subsequent testing of this marker on three
additional unlinked families (B3, 84, B5) and two unassignable families (Bt and B16),
further suggested a BDS gene at this locus. The affected individuals in kindreds B3 and
84 (and one of the affected siblings in 816) were homozygous at D205/89. Surprisingly,
however. a different allele was observed in the BBS patients of the B 13 family.
Additional microsatellite marker typing showed an extended region of HBD in family
B13 and in kindreds B3 and B4. Once again, however, the alleles at the homozygous
marlcers closest to D20S189 were different in the lalter two families than in kindred B13.
Interestingly, family BI had one haplotype identical to kindred Bl3 and one identical to
the B3 kindred. As well, family 85 shared a haplotype at2Opl2 with familyB3, but the
affected person in family B5 also had one unique haplotype. By comparing haplotypes
between families and using the observation ofa few key recombinations within families,
the BBS6 critical interval was delimited to a 2 cM interval on 2Op12. Interestingly.
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previous to the identification ofa sixth BBS locus, the MKKS gene had been isolated
wilhin this region (Stone et ai.. 2000). Since mutations in this gene cause McKusick-
Kaufman syndrome (MKS), a disorder which has phenotypic overlap with BBS, it was
considered a good candidate gene to screen for mutations in BBS patients. Shortly
thereafter. mutations were identified in MKKS causing Bas in six Newfoundland families
(BI, B3, B4, B5, 813, BI6). This was the first gene identified which has proven to be
responsible for Bardet·Biedl syndrome. Three different mutations, all in exon 3, were
identified in the six Newfoundland BBS6 families (Chapter J,6,2; Katsanis et ai.. 2000).
Two were alterations causing frameshift mutations, resulting in a premature stop codon in
exon 3 (F94fsXI03 and DI43fsXIS7) and the other a missense mutation (L277P). This
indicates that multiple founder mutations were present. Affected individuals in families
B3, B4 and 816 were homozygous for the same frameshift mutation (F94fsXI03l, and
the affected person in kindred BS was heterozygous for this frameshift. The laller
kindred also segregated the missense alteration. These observations agree with the initial
haplotype analysis. These families were located on the Conception Bay coast. within
relatively short distances by sea from one another (Fig 4.1). Using haplotype analysis it
was possible to approximate how these families were related to one another (Fig 4.2).
For instance. it can be assumed that the parents of the affccted individuals in family B4
are related. although this was not presumed previously, and both were related to the
parents of families B3 and B16, since all had the same disease-causing mutation
(F94fsXI03). [n addition, the affected person in kindred BS also inherited this mutation
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in a heterozygous state. This affected individual inherited the frameshift alteration from
his mother. Therefore. it was the mother who was pl'CSwnably disunlly related to the
parents ofthc affected persons in families 83, B4 and 816. Thcothcr affected persons
heterozygous for the F94fsXI OJ mutation were in family 81. The two affected
individuals in family 81 received this frameshift mutation from their father. Thus, their
father is likely related to the mother of the affected penon in family as and both parents
of the patients in families 8J, 84 and 816.
The other founder effect was observed with families 8 I and S 13 which have the
other identified frameshift mutation in MKKSJ88S6(DI4JfsXI57). The affected
individuals in kindred BI were heterozygous for the DI43fsXI57 mutation. They
received this framcshift from their mother. who, therefore. is probably related to the
parents ofthc affected persons in BIJ. Through these complex relationships all BBS6
families were linearly linked to one another (Fig 4.2).
Evidence for a SC'venth BSS locus (BBS7) was demonstrated in family 86 where
all known BBS loci were ruled out, as well as a possible locus on chromosome 18. This
implied there were at least six different BSS genes segregating in the Newfoundland
population (BBSJ, DDS1. 8BS]. BBSJ. 88S6 and B8S7)· five more than originally
hypothesized. In family B6 there arc two affected siblings who had five unaffected sibs.
This kindred was not known or presumed to be a consanguineous family. Perfonning
linkage analysis on this family alone. at a fully informative loeus linked to a BBS gene,
would not provide a statistically significant lad score. However, Beales et aJ. (200 I)
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noted that 14% (most of which wereofTutkish and Pakislani origin) of their 92
pedigrees studied did not show linkage of the disorder to any of the six known loci, and
one kindred could be statistically excluded from BBSI-6. tn the future, a genome wide
scan using family B6 may suggest a possible BBS locus which could be confmned in a
linkage study using multiple pedigrees excluded from 8851-6.
Unambiguous assignment of a single BBS locus or gene to a family was not
possible in two instances (B7 and BII). BBS in family B7 was initially considered to be
caused by mutations in 8851 because of the similarities in haplotypes with the other
8DSI families (Chapter 3.3; Young et al., 1999). Unfortunately, the DNA collected
from this non-eonsanguineous kindred was exhausted, and lhe additional markers utilized
in the LD study were not studied. However, on close inspeclion of the BBS210cus in this
family an extensive region ofhomozygosilY in the affected palients was noticed. between
DI6S3039 and DI6SJ089, inclusive (Fig 3.8). This - 6 cM interval contains the recenlly
identified B8S1 gene (Nishimura et at.• 2001). Once again. because of the lack of
available DNA. the additional markers tested on lIle pulative BBS2 family, B14 (all of
which were within the BBS] critical interval), were no! amplified in family B7. When
compared with kindred BI4, there was no sharing ofhaplotypes around or within the
8BS2 locus. Nonetheless. this does not exclude this locus. As was observed in the BBS6
families. there may be more than one disease haplotype at a single BBS locus in
Newfoundland. For these reasons, it was difficult to calegorize family B7 to just one
BBS locus. It is possible that the affecled member of family B7 had inherited mutations
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in both BBSI and BBS2. Now that BoS] has been identified, it should be possible to
categorize this family more specifically.
Kindred BII, presumed to be consanguineous and containing two affected
individuals with no unaffected siblings, could not be excluded from BB52-4 by haplotype
or linkage analyses, since both affected sibs shared haplotypes at these loci (CbapCer
3.1.5; Woods el at.. 1999). Therefore, haplotypes orthe BBS2 and BBS3 markers in
familyBl1 were compared with haplotypcs in families BI4 (B8S2) and B2 (B8S3).
Additionally. family Bl1 was compared with family B7, a possible BBS2 kindred. at this
locus. Adjacent to BBS2. there was only a single allele in common between families Bll
and 814 -the 10 allele at D/6S3057 which is homozygous in 814 but heterozygous in
B7. Also, a single allele was identical in the possible BBS2 family, B7. and Bl I families
at DI65408 (allele 3). Again, the allele was heterozygous in the Bil kindred. This
similarity was on the opposite chromosome than the 10 allele ofDI653057 in BII.
Theoretically. this eQuid indicate BII shares different disease chromosomes with both B7
and 814 at BBS2 if this locus is responsible for the disease in these two families.
Haplotype comparisons between families BII and B2 at the BBS3 locus are even tess
convincing, as there is only one allele in common between them (allele 4 at D3SI753).
and this is in the heterozygous state in famity 8 II. Since there were no putative BBS4
families identified on the island. the haplot)pes at this locus were not compared.
Evidence that the disease in kindred BII is caused by BBS2-4 is relatively unconvincing,
which may mean that this kindred could be associated with a yet unidentified BBS locus.
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However, since 88S2 and BBS4 have recently been identified (Nishimura et aJ., 2001;
Mykytyn et al., 2001) they can now be screened for mutations in kindred B\1.
Additionally, when markers at the putative BBS locus on chromosome 18p were tested in
this family, haplotype sharing was evident. Ifi! BBS gene is categorized on 18p, then it
could a.lso be screened for mutations in kindred BII.
4.1.2 Distribution or BBS loci ia Newrouadlad
The distribution ofBBS loci in the 17 Newfoundland families is different than
that observed in a recent large Nonh American and north European survey of BSS
families (Beales et al., 2(01). The most notable difference was the contribution ofB8S6
to the total proportion of BBS families. In Newfoundland, 35% of BBS families were
categorized as BBS6 by mutation analysis ofMKKSlBBS6 (Fig 4.3). The Beales el al.
(2001) study showed that in only4'Y. of92 BBS families could the disease be a1tributed
to mutations in BBS6. Less striking differences in frequencies of the other BBS loci .....ere
observed between the two studies. BBSI contributed to approximately 30"/. of the disease
in Newfoundland and 390'10 in the larger study. The frequencies of BBS3, B8S4 and B8S5
are small in both this and the Beales et aJ. (2001) investigations. In NewfOUndland, one
(6%) of the 17 BBS families was unlinked to anyoflhe six known loci and 14% of
Beales et al. (2001) families were unlinked to any of the known loci. A large proponion
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(28%) ofthc: North American/northern European survey BBS families were unassignable.
This latter proportion was larger than identified in the Newfoundland studies (11%).
probably because the pedigree structures (e.g. the large size and frequency of
consanguinity) of Newfoundland kindreds made them more amenable to haplotype and
linkage analyses.
However, the astonishing facls about BBS in Newfoundland were the high
frequency and the genetic heterogeneityofBBS segregating in this small population.
Newfoundland was settled by a relatively small number of migrants from the West
Country of England and southeast Ireland. Interestingly, all BBS families in
Newfoundland are Protestanls. indicating their aneeslors were English. Because of the
lack ofadmixture between Proteslants and Catholics. religious segregation organized the
BBS families into an even more delineated population. Thus, it was originally suspected
that all BBS palienls in the province originated from a common founder. The first clue
that this was not the case was the lack ofclustering cfBBS families all along the coast.
However, it was not until genetic analyses were performed that the true heterogeneity of
the syndrome was realized.
Since a single founder haplotype was evident in BBSI Newfoundland families
(presumably corresponding 10 a single founder mUlation), the population structure of the
small, isolaled communities along the south coast, from where these families originaled.
may contribute to the high frequency ofBBS in Newfoundland. However, Ihere were
tl1ree mutations in MKKSlBBS6, presumably one each for BBSi, BBS; and BBS5, and at
153
least one for BSS]. Moreovcr, the likelihood ofa sevemh BBS locus has been raised.
This suggests [hat the Newfoundland population is not a homogeneous genetic isolate,
but comprised of multiple genctic isolates.
From a genetic perspective, the surprising number of BSS genes segregating in
Newfoundland could be explained by a high mutation rate at these genes due to
environmental circumstances. Namely, a mutagen was presem in the environment
causing DNA at BBS genes to become altered. Alternatively, BBS heterozygotes may
have a survival advanlage. Both hypotheses are highly sp~ulalive and not mutually
exclusive. Although there was a report that suggested BaS heterozygoles were more
obese than non-carriers (Croft el al., 1995). there have been few studies ofaBS
helerozygotes. Not until an in·depth investigation is undertaken, comparing BBS
heterozygotes with their non-earrying siblings, can a heterozygote phenolype, if present,
be established. Only then could one postulale a possible advantage for this genotype.
The phenomenon of multiple founders ofa rare recessive disorder, in a small
isolated population, is nol unique 10 Newfoundland. The island of Reunion, located in
the Indian Ocean off the east coast of Madagascar, has approximately 700 000
inhabitants. Limb-girdle muscular dystrophy type 2A (LGMD2A). an autosomal
recessive disease charncterized by progressive symmetrical atrophy and weakness, has an
estimated global prevalence of I:100 000. But, on the small island of Reunion. its
prevalence is over four fold higher. AlllGMD2A patients on La Reunion belong to a
small genetic isolate, presumed to have derived from a single ancestor who arrived in the
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1610$ (Richard et at., 1995). However, when microsatellite marker analysis was
perfonned on LGMD2A families within the putative lGMD1A critical interval. haplotype
analysis demonstrated six different haplotypc:s segregating in the population. When
CALP3 was identified as the LGMD2A causing gene, mutation analysis showed six
different mutations segregating in affected families (Richard f!l at., 1995). Each mutalion
segregated with a differenl haplolype. This appareTll contradiction ofa disorder with a
relatively low prevalence rate and multiple mutations in a single disease-causing gene.
occumng in a small genetic isolate. was lermed the 'Reunion paradox' (Richard et at.,
1995).
Several models to explain Ihe 'Reunion paradox' have been put forward. As
memioned above. a high mutation rale at thcdiseasc gene may be Ihe cause oflhis
phenomenon (Zlotogora et al., 1996). Two autosomal recessive disease genes are known
to have mulliple mUl.iIlions. segregating in a small populalion in the region of the Galilee
in Israel (Bach et al., 1993; Heinisch et at.• 1995). In 14 families affected with either
Hurler syndrome or metachromatic leukodystrophy. the parents of the affecled were
related. However. there was no known interfamilial relationship. Multiple homozygous
mutations were demonstraled for each disease gene. These large consanguineous families
originated from 13 villages that include a total of I50 000 inhabitants. Due 10 this
population s(ructure, Zlotogora et al. (1996) calculated that some of the disease mUlations
were recent and some more ancient However, the etiology of the high mutation rate and
of the mutation diversity is unknown. The authors suggest there could be a selective
ISS
advantage for heterozygotes.
An alternate model is that digenic inheritance accounts for the 'ReWlion paradox'
(Richard et ai.. 1995; Beckmann, 1996). [n this model. mutations at two unlinked genes
are required to produce a phenotype. Specifically, a 'suppressor gene' is required that is
active in thc wider population but is inactivated by mutation in the isolated population.
This hypothesis predicts that the population frequency of mutant alleles should be higher
than the frequency estimated on the basis ofdisease prevalence alone. Second. several
independent mutations are expected and there should be some families which have
individuals with pathogenic mutation(s) but no clinical symptoms (Beckmann, 1996).
For BBS, additional mutation analr-;es on controls in the Newfoundland and other
populations would need to be perfonned to detennine if unaffected individuals are
carriers of BSS mutations. For the case of MKKS/BBS6 in Newfoundland, independent
mutations have been identified. Also, in the original study identifying MKKS, there were
three individuals who were homozygous for the H84Y/A242S allele who did not present
with the disease phenotype (Stone et ai., 2000).
4.2 Possible Digeaic laberilance orRBS ia Newroundlaad?
True digenic inheritance, defined as the inheritance of heterozygous mutations at
two unlinked loci resulting in a human disease, is thought to be uncommon. This
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phenomenon has been illustrated by mutational analysis in retinitis pigmentosa
(RP)(Kajiwara et aI., 1994; Jacobson el al., 1995). However, in the literature, the term
digenic inheritance is often used to describe circumstances whereby two independent
mutations at one locus and an additional mutation at an unlinked locus causes an
autosomal recessive disease. This type of inheritance has been sho\\'Il, by mutational
analysis, to occur in Waardenburg syndrome t}pe 2 with autosomal recessive ocular
albinism (Morell el a/., 1997) and injunctional epidennolysis bullosa (JEB)(Floeth and
Bruckner-Tuderman. 1999). Additionally, this latter definition ofdigenic inheritance is
suspected 10 occur in non-syndromic hereditary hearing loss (Balciuniene el aI., 1998);
Usher syndrome (Adato et al.• 1999); and Antley-Bixler syndrome (Reardon et al.• 2000).
IEB is an autosomal recessive disease usually caused by mutations in COLI7Af or
UMBJ. The authors above described a proband with IEB who was a compound
heterozygote for two COLI 7AI mutations and heterozygous for a LAMBJ mutation. The
Adato el al. (1999) investigation of digenic inheritance of Usher syndrome. also a
recessive condition, indicated that one affected individual who had a heterozygous
mutation in Mf07 (which causes Usher syndrome when two independent mutations are
inherited), also had haplotypes suggesting two defective USH3 alleles. Kajiwara et at.
(1994) described RP patients who had heterozygous mutations in two autosomal
recessive RP genes (peripllerin/RDS and ROMf). Interestingly, a study of a large
mulliplex Newfoundland family with autosomal dominant polycystic kidney disease
(ADPKD) demonstrated bilineal inheritance of PKDI and PKD2 in affected family
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members (Pei et ai.• 2001). This indicated that segregation of two unlinked mutant genes.
causing a similar phenotype. in a single kindred has occurred in Newfoundland.
Imereslingly. there is one Newfoundland BBS family. B14, in which Ihe affected
individual has a single MKKS/88S6 alteration (A242S) and was also HBS at the 88S2
locus. Both genetic and mutational data suggest that the A242S alteration may not
conform to a Mendelian model ofdisease transmission. First, a second mutant allele at
this locus was not idemi lied. Second. and of greater importance. both affected and
unaffected sibs have the same chromosome 20 haplotype5 and MKKS/88S6 alteration.
One explanation for this might be that the A242S allele (and possibly other missense
mutations) acts in conjunction with mutations at another locus. which would explain the
family Bl4 haplotypes around 8852. the inability of researchers to identify a substantial
proportion of the second disease allele in patients with MKKS/8BS6 mutations (Beales et
ai., 2001). and pedigrees that cannol be assigned to any locus (family B6; Beales et a/.,
2001). This model would not constitute true digenic inheritance· since there must be two
mutations in BBS2. which, by themselves, are expected to cause the disease - but rather a
modifier effect for some MKKS/BBS6 mutations. Family B14 does exhibit a severe
phenotype, since the patient presented with classic BBS features with an early age of
onset of obesity and retinal disease. However, given the substantial heterogeneity of the
syndrome, the interpretation oflhese data is circumspect until additional BBS genes and a
substantial number of pedigrees exhibiting this complex pallem of inheritance are
recognized. Interestingly, there are two published BBS families in which only a single
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MKKSIBBS6 mutation was identified; both families demonstrated linkage to the BBS4
locus (Beales et aI., 200 I).
Another explanation of this observation is that the A242S allele does not cause
BBS but is a rare neutral polymorphism. In the original study isolating MKKSlB8S6, the
A242S alteration was identified as pan ofa complex mutation in an Amish MKS patient
in which the other alteration was H84Y (Stone et a/., 2000). The authors concluded that
the H84Y component of the complex allele in MKKS is also required for the phenotype.
To detennine if family 86, which was excluded from all six BBS loci, possibly
exhibits digenic inheritance due to the inheritance of a single mutation at two different
BBS loci, disease haplotypes were e.~amined and compared between BBS loci. Two
scenarios were identified in which digenic inheritance of BBS was possible in the 86
kindred (Table 4.1). One possible scenario was that the affected siblings inherited a
mutant maternal B8S/ allele and a mutant paternal BBSJ allele. However, when the
complete haplotypes at these loci in family B6 were compared with those of the BBS I
and BBSS families, little similarity was observed, although one allele in each haplotype
within the critical regions was identical (Table 4. I). This could have occurred by chance,
or perhaps because these markers were closest to the B8S genes, and these alleles were in
linkage disequilibrium with the BBS gene (e.g. if family B6 was very distantly related to
aUBBSI families and the BBSS family on the island).
A second digenic scenario was that the affected individuals in famBy B6 inherited
a mutant maternal BBS3 allele and a mutant paternal BBS6 allele. For the BBS3 locus,
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there was only a single allele in the affected sibs of family B6 identical to an allele in the
BBS3 kindred (B2). and this allele was a marker outside the newly defined DDS) critical
region (Table 4.1). Again. one allele was identical between the paternal BBS6 haplotype
of the affeeted sibs in family B6 and the affected individuals in the 85 family. This allele
was at a marker within 0.5 cM of BBS6. Unfortunately, it will not be possible to test for
digenic inheritance until all BBS genes have been identified. Moreover, proving digenic
inheritance will require knowledge about how the BBS gene products interact, if indeed
they do, and how observed alterations affect the gene products. Like the Bl4 kindred, the
B6 kindred may have alterations in more than one BBS gene, but still suggest linkage to
an unidentified BSS locus (c.g. BBS7).
4,3 The MKKSIBBS6 Gene Product· A Putalive Cbaperonin
The role of molecular chaperones in the cytoplasm is vital for the proper folding
of various proteins. Correct folding of a protein inhibits aggregation which can cause
proteins to become non-functional. However, this is a difficult process because the
cytosolic environment is fraught with potential impediments to proper folding. For
example, the folding ofa protein is coupled with ilS synthesis, thus the amino acid
sequence becomes available sequentially. This may not be a problem for secondary
structure fabrication, but it is inhibitory to tertiary structure fonnation. as only domains
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that rely on contiguous segments of sequence can be folded. A topological restraint is
also present.. since there is a span of- 30 C-terminal amino acids within the ribosomal
machinery \\-'aiting to exit at anyone time. These cannot panicipate in folding (Agashe
and Hartl. 2(00). It is during the synthesis of proteins that chaperones may protect
polypeptides from mis-folding and a~ing with other c:ytosolic proteins. The highly
crowded cytoplasm also has an inhibitory effect on proper folding. Because the
cytoplasm is dense with proteins. those which escape mis-folding during synthesis may
still aggregate with other non-native proteins if they do not rapidly fold. Proteins which
cannot fold quickly and independently are probably the ones which rely heavily on
chaperonins.
The chapmJnins, a family ofsequence related chaperones of - 60 kDa., fonn
double-ring complexes that enclose a central cavity in each ring. They are cylindrical.
oligomeric complexes which have been shown to promote protein folding in conjunction
with ATP hydrolysis (Braig. 1998; Wickneret al., 1999). To promote proper folding, the
chaperonin captures the substrate by hydrophobic contacts with multiple subunits in a
ring. Then it displaces the protein imo the inner central cavity, protecting it from the
hostile environment outside (Agashe and Hanl, 2000). II has also been suggested that
necessary forced unfOlding, before proper folding, of the non-native polypeptide occurs
(Shtilennan et al., 1999).
There are two familics ofchaperonins: type I, including the bacterial GroEL, the
mitochondrial Hsp60 (heat shock protein 60 kDa) and Hsp70. and the RuBisCO
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(ribulosc.bisphosphate carboxy/oxygenase) subunit binding protein from chloroplasts;
and t)pe n, consisting oflhe thcrmosomcs from arcnaea [e.g. TF55 (lhermophilic factor
55)] and the chaperonins found in eukaryotic cytosol [e.g. ccr (chaperonin containing t·
complex pol)'pq)tide I) also named c-cpn (cytosolic cnaperonin) or TriC (TCPI-ring
complex)]. The extensively studied GooE group (type 0 have 7-fold symmetry and
provide an enclosed chamber for protein subunit folding (Schoehn el 01.. 2000). The
central cavity is closed by a co-protein called GroES (Langer el af.• 1992). The type II
chapcronins lack this cap-like co-protein. instead having a long insertion in the substrate
binding domain which acts as a built-in lid. Recently, a hetero-oligomeric protein
complex called prefoldin (or GimC, for genes involved in microtubule biogenesis
complex) has been found to participate in type II chaperonin-mediated folding (Vainberg
eral., 1998; Leroux el 01.. 1999). Type I chaperonins are homo-oligomeric with seven
subunits per ring. while type 11 chaperonins in the eukaryotic cytosol are hetero-
oligomeric. containing eight distinct, but related, subunits.
The human MKKS!BBS6 protein (570 amino acids), which is 76% identical to a
homologous mouse protein (Stone et aI., 2000), shows closest similarity 10 type U
chaperonins. A search oflhe prOlein sequence databases using the BlASTP algorithm
(v2.1.2)(AllSChul et ai., 1997) indicated that, apart from the mouse homolog ofMKKS
(Mkks; AF254074; score '" 358, E value: ge-98), the most similar sequence to the
MKKS protein (AAF73872) was the thermosome chaperone prolein lhsA of Pyrodictillnl
occuirunl (AJ006549) (score'" 77, E value: &-13). The same query idenlified
163
sequences corresponding to 39 species ofeukaryota, archaea and bacteria including
human, chicken, goldfish, torafugu, fruit fly, round wonn, yeast and numerous
thermophilic bacteria. As well, the Conserved Domain Database (COD)
(hllp:l!www.ncbi.nlm.nih.gov/StructureJcddlcdd.shtml) identified a 493 amino acid
consensus sequence, cpn60rrCP I (pfamOOI18), contained in the chaperonin type II CCT
proteins. This conserved domain was found in 17 species of fungi, archaea and bacteria.
Also, the putative folding pattem of MKKSlBBS6 was most similar to the thennosome
from Thermoplasma acidophilllm (Stone et al., 2(00).
Unfortunately, little is known about the mechanism and substrates of the type II
chaperonins. However, the £. coli GroEL structure has been widely studied and is
considered the archetypical chaperonin. It is made of two stacked back·ta-back
heptameric rings (nol octameric as in type [l chaperonins) which create two cavities.
Each of the two subunits contains three domains: (I) an ATP·binding equatorial domain;
(2) a hinge-like domain in contact with both the ATP-binding and apical domains; (3) an
apical domain which has an opening to the environment and exposes some hydrophobic
residues towards the cavity for the binding ofa non-native polypeptide (Agashe and
Hartl,2ooo). Unlike the case for the type II chaperonins, a second structure, GroES,
attaches to the apical opening after the addition of ATP, fanning a cage-like structure
which traps the non-native polypeptide within the ring cavity. Folding occurs when the
ATP hydrolyzes. With additional ATP binding to the adjacent inoperative ring, the
GroES "cap" is released and the "cage" is opened. The folded protein can now leave.
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Presumably, the cycle can start again in the adjacent ring structurc once a non-native
polypeptide attaches (Agashe and Hartl, 2000).
In E.rofi. approximately 10% of new polypeptides are folded by the GroEL-
GroES complex, and over 50 of these have been identified thus far. They include
proteins involved in transcription. translation and metabolism. These proteins may
initially be bound by chaperones co-translationally and then relayed (0 a subset of
chaperonins where folding takes place, in what is called the 'pathway model' of assisted
protein folding (Thulasiraman et al., [999). In this model. some chaperonins could be
specific for relatively few substrates. This would result in the minimization of non-native
polypeptides entering the cytosol, which would reduce aggregation. AltemativelY,lhe
'network model' contends there is a competition rarthe substrate at all times, implying
that non-native polypeptides are often released and caplUred again for additional folding
(Farr et a/.. 1997).
Recently. more information has been gathered on type II chaperonins. Eight
subunits (a. p, -t, 6. E, 1'1, e and C) with 30% identity to one another make up the TriC
chaperone. One subunit, C, has a slightly different composition in mammalian testes than
in other tissues, perhaps indicating an interaction with tissue specific substrates (Kubota
et af., 1997). In general, TriC is abundant in the testes and leukocytes, and weakly
expressed in most other tissues (Gutsche et 01., 1999).
The structural features of the thermosome, the archetypical type II chaperonin, is
similar to GroEL in many respects but there are documented differences. For example,
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the inter-ring contacts differ between the two types, with each ring having different
secondary structures in communication (GulSChc et al., 1999). Also, as mentioned above,
the GroES subunit associates with GroEL; however. there is no type nhomolog. Instead.
the latter protein complex contains a long protrusion which may act as a lid-like structure
- holding the sequcstered protein inside the ring cavity. Additionally. it has been
suggested that GroEl only recognizes Ihe overall hydrophobicity of ilS targets, but for
TriC the pattern of hydrophobicity may be important (Rommelaerc et af.• 1999).
Though there could be many possible substrates for the type Uchaperonins, as
approximately 10-15% of all newly made proteins interact with TriC (Thulasiraman et
01., 1999), the cytoskeletal proteins and the actins and tubulins arc by far the most
prominent substratcs identified thus far (Kubola et aI., 1997; Lewis et 01., 1996). Other
substrates include cyclin E (Won el aI., 1998) and G.-transducin (Farr er al., 1997) and up
to 70 different polypeptides were found 10 lIansiently interact with TriC during their
biogenesis in mammalian cells (Thulasiraman et al., 1999). Because Iype Uchapcronins
may fold a wide range of polypeptidcs, spatial confonnation is likely 10 be critical to
these molecules,. and disruptions may reduce the efficiency or abolish the ability to fold
targetpIOteins.
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4.3.1 Result5 or Mu._lion! io MKKS/BBS6 00 Put_live Protein Funclioa
The frameshifi mutations, discovered in MKKSlBBS6 in Newfoundland BBS
families, result in the truncation of the polypeptide at amino acids 103 and 157.
Therefore, only 18% and 28% of the protein would be produced, respectively. (tis
predicted that a non-functioning product is formed in each case. The pathogenic effect of
the missense mutation, l277P, is more difficult to interpret in the absence ofa functional
assay. But, any point mutations may potentially cause a structural abnormality that could
result in a functionally null prOlcin, especially if that amino acid position is essential for
proper function. According to one three-dimensional model of the protein (Stone et al..
2(00), this mutation would disrupt an a-helix potentially altering its struclUre. It is this
a-helix along with two (3-shects in the r acidophilunl thennosomc which protrude
outward from the end of the subunit, blocking the entrance to the central cavity by
forming a lid domain. Normally, this residue is part ofa hydrophobic core which fixes
the apical domain to the thermosome (Ditzel et aI., 1998). The additional kink at this
position in the polypeptide could destabilize the lid structure, interfering with substrate
binding andlorcompartmentalization of the substrate. Additionally, this position is
conserved within the conserved domain consensus sequence, cpn60ffCP I. These
observations strongly suggest that this missense mutation causes the protein function to
be abolished, or, at least, severely impairs the performance of the MKKSIBBS6 protein.
The result of the A242S alteration on the protein function, if any, is much less
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obvious. As stated previously, A242S was originally identified in an MKS patient with a
complex allele composed oflhe H84YIA242S alterations (Stone et aI., 2000). The
authors contended that the A242S "variant did not appear to alter the intermolecular
interactions within the molecule". However, the alanine at this position is identical in T.
acidoplJi/llm and in the cpn60rrCP I consensus sequence, indicating that it perhaps is an
important amino acid rcgarding the protein structure and function. This residue is part of
a ~-sheet in the a-subunit of the T. acidophi/lim thennosome, very near to the apical
domain; however, there has been no report of the importance of this secondary structure
in the function of this protein (Ditzel el af., 1998). Due to its proximity to the lid area, it
could playa role in substrat~ contact or lid mobility, but this is uncertain at this time.
Initially, there was a suggestion that all mutations causing BaS would be severe,
causing obvious deleterious effects on the protein (e.g. frameshifts) (Katsanis el al., 2000;
Slavotinek el aI., 2000b), while those causing MKS would be less catastrophic (e.g.
missense) (Stone el aI., 20(0). However, more recently, missense mutations have been
associated with aas (Table 4.2). The cITect of these mutations is more difficult to
predict. although they likely affect either local polarity or the secondary or tertiary
slructure of the protein (Beales el al., 2001). Notably, three of these mutations lie in exon
6 of MKKSlBBS6, which contradicts the hypothesis that exon 3 mutations are more severe
and thus cause BBS rather than MKS (Katsanis et al., 2000; Slavotinek el 01., 2000b).
Polymorphisms within MKKSlBBS6, or variations in the promoter region, may influence
the phenotype. Polymorphisms or mutations at other loci could also be causing the
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Table 4.1 MKKSltltlS' mulaUons kienllned thus rar uuslna BBS and MKS.
Alteratloa Eton Disorder Rdere.c:e
F94rsXI03 3 BBS Chapler 3.6.1; Kalsanis el fl/., 2000; Siavolinck cl (II., 2000
D14JrsXI57 3 BBS Chapter 3.6.2: Katsanis ell/I., 2000: Siavolinck ell/I.• 2000
U77P 3 BBS Chapin 3.6.1. Kalsanis el l/I., 2000,
Y37C 3 BBSlMKS I KalsanlS el ul.. 2000; Stone el (d.. 2000
T57A 3 BBS Katsanis cl (/1., 2000
132M 3 BBS 8calcsc/(/I., 2001
QI.7X 3 BBS Beales el 11/., 2001
S135P 3 BBS Bealcscll/I., 2001
D185A 3 BBS Beales el 1//., 2001
G51D 3 BBS Slavotinek c/ {II., 2000
Y164X 3 BBS SlavOlinek CII//.. 2000
H84y l 3 MKS Stone el 111.,2000
1223-11:24 deiCe S MKS Slone cf IIf.. 2000
C499S 6 BBS Bealcs ci (/1.. 2001
S511A 6 BBS BealCSCI al., 2001
R51811 (, BBS BealeSI'll/f.. 2001
'"
'"
A241S I 3 I BBSIMKS 1 Chapter 3.6.1; Slone ci (/1.• 2000: Beales cl (II., 2001
I Ilomozygous in BRS patient and hc:leroZYb'Ous in MKS palknt;) Identified as I part or a complel1llllc1e with 1\2425 in MK5 patic:ms
differences in phenolype belween MKS and BBS patienls. Once Ihe function of tile
MKKSlBBS6 prolein has been elucidated, it may be possible to identify genotype·
phenotype comlations, Additionally, novel mutations in a single BBS gene may account
for the ,'ariation oflhe disease in general.
4.4 Candidate GCDes forlbc BBSI, BBSJ and BBSS Lod
The identification of MKKSlBBS6 as a cause ofBBS should expedite the isolation
ofother BBS genes. Based on the sequence of MKKS/BBS6 and the putative structure
and function ofthe MKKSlBBS6 protein, olhercandidatc genes may be ascertained,
Some understanding about when and where the BBS gene products are expressed in the
developing fetus may also aid in identifying possible candidates.
With the availability of sophisticated databases containing cnonnous amounts of
continuously updated genetic data. it is possible to perfonn a significant amount of ill
silica research. The nucleotide and protein sequences of MKKS/BBS6 were analyzed for
sequence similarities in order to search for possible BBS candidate genes.
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First. the eDNA sequences of the two splice isofonns of MKKS!BBS6 .....ere used
to perform a ~hofthe non-mlundant nucleotide databases at the National Cenler for
Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.govlBlASTl)usingthe
BLASTN algorithm (v2.1.2) (AllSChul el 01.• 1997). The 1;1. splice isoform of
MKKS!BBS6 (AF221992) was queried. resulting in 74 BlASTN hits consisting ofsmall
sequence identities of less th3ll 40 bp (scores s46. E values 2:0.05). other than the human
and mouse MKKS genes. One hit of interest (score :l< 46. E value'" 0.095) was a
sequence contained in Ihe filamin gene's (FLNB) exons IS. 16 and 17 (AfI91606) An
MKKS!8BS6 splice isofonn lb (AF221993) BlASTN query returned the same results
and two additional hits. consisting ofa mouse sequence and a 21 base human sequence on
chromosome 16 (both score = 44. E-valuc = 0.40). When this 21 base human sequence
was queried. 59 sequences of little similarity resulted.
Because filamin is an actin-binding protein. and actin is onc of the principle
substrates ofcytosolic chape:ronins. it was considered a reasonable candidate. This
filamin isofonn is found in lhe cytoplasm ofall non-muscle tissues cells (Chiang el 01.•
2000). FLNB was mapped to chromosome 3; however. il was recently localittd to the
3p14.3 band (Brocker Itt al.. 1999).tcrminal to the BBSJ gene on 3pI3-pI2. Therefore. it
was ruled oul as one of the known BaS genes on the basis orchromosomal position.
No other nucleotide sequence results or significance were identified using
BLASTN and. interestingly. only the mouse had a homolog orthe human gene in the
databases. Thus, the MKKSIBBS6 nucleotide sequence was partitioned into smaller
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segments and queried. When overlapping sequences of 100. 200 or 500 bases were
queried the results were the same as with the entire sequence - only small sequence
identities ofless than 40 bp (scores s.46, E values <:0.10) were identified. other than the
human and mouse MKKSlBBS6 genes.
A BLASTP search was also performed to determine if the amino acid sequence of
MKKSIBBS6 was similar to any other known proteins. As mentioned above, the most
similar sequence was the chaperone protein, thsA. from the thermophilic p}'rodictillm
ocC'lIlwm. Otherchaperonin proteins from an array oforganisms were also identified.
These organisms had a conserved domain called cpn60n-CPI unique to the t)'pe II
chaperonins. Unfortunately. no other human proteins were similar to the MKKSIBBS6
protein. The cpn60ffCPI conserved domain spanned about 470 of the 570 N-terminal
amino acids of the MKKS/BBS6 protein. The 100 C-terminal amino acids were not part
of the recogniZed consen'ed domain. Therefore. another BLASTP query was performed
with this sequence. but no similarities with other sequences were identified.
Additionally. when the MKKS/BBS6 protein sequence was queried in the Cluster of
Orthologous Groups (COGs) database (http://www.ncbi.nlm.nih.gov/COGI).COG0459
was identified. COG0459 [Chaperonin GroEL (HSP60 family)] represents 80 proteins in
40 prokaryotic species.
Since the MKKS amino acid sequence was most similar to t)'pe II chaperonins. all
chaperonin-like genes in the human genome were possible candidatcs. Therefore. all
genes reported to have chaperonin function or those associated with chaperonins were
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investigated to detmnine if their chromosomal positions mapped within the critical
intervals of any BBS loci.
The most obvious candidates were the en family ofgenes. which are the
eukaryotic equivalents of the thennosomes of the t)l)C II chaperonins. There are eight
CCTgenes. corresponding to lIle eight subunits of the functional chaperonin. None of
these genes are located in anyoflhe known BaS critical intervals. As well. the six
subunits ofthe prefoldin protein comple:t, which escorts non-native polypeptides to the
type 11 chaperonin. were considered putative candidate genes for BBS. However, again,
none of these genes mapped to the six BBS loci.
Homologs of the heat shock type Ichaperonins are also present in the human
genome. Over 75 human heat shock related genes have been identified and these were
also considered possible candidates. due 10 their function as chaperones. One Hsp40
homolog. DNA./C4. maps 10 II q13 and was examined for mutations in 88S1 families.
However, no alterations were found in splice sites or eXOM (Dr. Nicholas Katsanis.
perwnal communication). No other Hsp40 subunits mapped to BBS loci. The
mitochondrial heat shock protein homologs. HSPDI and HSP£ I. are found on
chromosome 2. Interestingly, HSPDI contains the cpn601TCPI domain; however, its
specific chromosomal location is unknown. HSPEJ, the 10 kDa subunit which associalcs
with the HSPDI gene product, resides on 2q32, qterto the BBS5 locus.
little is known about the substrates which interact with the type n chaperonins.
However, a few such proteins have been characterized including tubulins, actins, cyetin
I1l
E, a-aystallin and a·transducin. Therefore. all genes known to encode these proteins
.....ere investigated to detmnine chromosomal location. A number ofthc:se are located
wilhin the critical intervals of some BBS loci. KlFCJ. a tubulin cytoskeleton·associated
gene found in the retina. retinal pigment epithelium. kidney and lung is located on 16q21
(Hoang et al.• 1998). It was screened for mutations in BBSl families. However, no
alterations were identified in the splice sites or coding regions (Dr. Nicholas Katsanis.
personal communication). Another tubulin·associated gene which also maps within a
BBS loci is ARL!. ARL2 (ADP·ribosylation factor·like 2) is a GTP·binding prolein
which aidJ in the folding Oflubulin and maps to the BRSI interval. It is a small protein of
184 amino acids having ubiquitous expression (elarlc: et al.• 1993). It is not known to be
folded by chaperonins. but it is small enough to fit inside the innercavityofa TCp·1
protein complex and it is probably functionally important in vesicular transport. like its
ARF (ADP·ribosylation factor) relatives (Arnor el al.. 1994). None of the numerous
actin·as.sociated genes (other than FWB) map within the critical regions of known BBS
loci; nor did the cydin E. a.crystallin or the a-uansducin genes.
4.4.2 Olher Positionl C..didate Ge.es
Thus far in the published literature. six genes (excluding MKKSlBBS6. BBS} and
BBS4) have been screened for mutations in BBS patients (Table 4.3). In five of these. no
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Tablt 4.3 Candidatt gtnts p...tviously 5cr~ntd ror mutations in BBS patitnts.
Gene LCKUS RdertDCt
myo5in IXA (!\'IY09A) ISq22-q23 Gonnan et of., 1999
Immuaoglobuli. suptrfamlly 15q22-q23 Nagasawa et aI., 1999
containiag LeudDt--rich Rtptat
(ISLR)
Nudtar R«tptor subfamily Z. group 15q22-q23 Haider el 01.• 2000
E. membt... J (NRlEJ)
EH-Domaia roat.i.iag I (EHOI) Ilql3 Haider el of.. 1999
Reronria 17pl3.1 Parminder et 01., 1997
peripberi.JRDS 6p21 Sohocki el 01., 2001
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mUlations were identified. Interestingly. recently. a mutation (RI3W) inperipherinlRDS
on 6p21 was identified in a BBS family (Sohocki et al., 2(01). However, it was not
stated if the patient was heterozygous or homozygous for the mutation. No information
describing clinical evaluations. family history or other genetic testing on the kindmt was
provided. [t was difficult, therefore, to interpret whether the mutation was suggested to
cause BBS or was co-segregating with a BBS gene. More infonnation is needed in order
to characterize peripllerinlRDS as a possible BBS gene. Funhennore, no BBS locus has
yet been identified on 6p21.
ldcnti fication rood mutation screening of 24 transcripts within the I cM region of
the BBSI interval was not successful in characterizing this elusive gcne (Dr. Nicholas
Katsanis, personal communication). With the continuing cataloging of new genes. thanks
in large pan to the Human Genome Project. other candidate genes have been identified.
but remain unscreened. Some of these candidates, located within the critical regions of
the BBS genes. are expressed in the appropriate tissues andfor have a function which
could cause the manifestations encountered in this s)'Tldrome.
One such gene, located in the small but gene-rich 88S1 critical interval, is
MAP4K2 (GeK/RAB8IP). By Nonhero blot analysis, a transcript was observed in all
adult tissues tested, including kidney, hean, brain, pancreas, skeletal muscle, lung. liver
and placenta tissues (Katz el al., 1994). Cell fractionation and immunofluorescence
analyses indicated MAP4K2 is present both in the cytosol and as a peripheral membrane
protein, concentrated in the Golgi region and basolatera[ plasma membrane domains
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(Tibbles and Woodgett. Im~ MAP4K2 is composed of 32 eXOM and is qter to PYGM
(KedrH'tal.,1997).
First identified in the germinal center of B l)l11phocytes. MAP4Kl encodes a
mitogcn-:activated protein kinase kinase kinase kinase. It was initially detennined to bind
to RAB8IMEL, a member of the RAS superfamily, which comprises small
GTP/GDP-binding proteins, The latter may playa role in the transport of proteins from
the endoplasmic reticulum 10 the Golgi and the plasma membrane. Two 0(MAP4K1's
substrates are casein and mydin basic protein (Katz et 01.• 1994); neither of these map to
a known BBS locus. Thus, RAB-rcgulated protein phosphorylation by MAP4K2 is
possibly important for vesicle targeting or fusion. MOreQ\'er, MAP4K2 may SttVe to
modulate secretion in response to stress stimuli (Katz et 01.• 1994). Interestingly, Beales
e/ at. (1999) noticed that 25% of t~ir patients had asthma - three times thc national UK
prevalence - and these were exclusively B8S 1patients, It is known that allergic asthma
is dependent on an IgE (immunoglobulin E) response controlled by T and B lymphocytes
and activated by the internction of antigen with mast cell-bound IgE molecules. MAP4K2
is expressed in germinal center Bcells where Ig genes hypmnutate. acquiring somatic
mutations in heavy and light Igchains that may alter the specificity/affinity ofB cell
antigen receptors (Katz et 01.• 1994).
MAP4K2, a serine-threonine protein kinase, is also known to modulate other
mitogen activating protein kinases (MAPKs). It is associated with the SAPK (stress
activated protein kinase), p38 and ERK (extracellular signal regulated kinase) pathways
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(Tibbles and Woodgen. 1999). Mammalian MAPK pathways regulate an extensive range
ofcellular processes including gene ttanseription. cytoskeleul organization. cell gro....1h.
immune activation. development and apoptosis. MEKKs (MAPK and ERK kinase
kinases) and MLKs (mixed lineage kinases) are regulated by MAP4K.2. These. in tum.
phosphorylate the next protein kinases in the above pathways. ultimately leading to the
regulation of transcription factors.
There are also upstream regulators of MAP4K1. Upon receptor binding at the cell
surface. MAP4K2 can be rttruited by TRAF2 (tumour necrosis factor a receptor·
associated protein 2). TRAF2 is capable of binding to numerous members of me TNFR
(tumour necrosis factor receptor) superfamily and was hypothesized to be the point of
bifurcation of the signals to the NFICB (nuclear factor kappa B) tr.mseription factor and
the activation ofSAPK (Tibblcs and Woodgett. 1999). Interestingly, the gene for
TANKIJ·TRAF (TRAP family member associated NFkB activatorffRAF·interac:ting
protein). a molecule which has been shown to augment or block NFICB activation
mediated by TRAF2 (Rothe et al.. 19%). is located on 2q31. within the BBSJ critical
interval. Thus, two possible positional candidates genes, MAP4K2 and TANK. are linked
in a common pathway.
These two genes could be members ofa novel molecular pathway incorporating
all BBS proteins (Fig 4.4). Binding ofa theoretical cell membrane·bound receptor by its
ligand could initiate the intracellular pathway. The receptor and agonist could be prolific
members of a known family of receptor.ligands that act in the systems affected in BBS.
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Fig 4.4 Possible molecular pathway Involved In the causation of 885, Incorporating candidate
genes known to be In Ihe MAPK pathways af known and putative 885 loci.
such as TNFR \ and TNFa. This interaction could auraet a receptor-associated factor
such as TRAF2 which subsequently recruits MAP4K2 (BB5\?) and TANK (BBSS?).
PtThaps additional associated factors are also recruited in a cellt}-pe and temporal
manner. This combination of molecules would initiate a specific kinase dependent
pathway which could uhimatdy lead to the activation ofa transcription factor (TF). This
TF may activate transcription ofa gene{s) needed in response to environmental cues in
development (e.g. the joining of the collecting tubules and the secreting tubules resulting
in decreased proliferation of renal cells in the developing kidney). The putative
chaperonin. MKKSlBBS6. may fonn a homo-multimeric protein which would properly
fold the TF. the protein transcribed by the TF. or another pathway specific polypeptide.
The other BBS protein products not mentioned - BBS2. 8BS3. BBS4 and yel unidentified
B8S gene(s} - could be incorporated into such a model as protein kina.ses. accessory
proteins. other transcription factors or target genes. or chaperonin-related members.
A repon was recently published of six BBS patients in a multiplex kindred who
inherited a pericentric inversion (PEl) of chromosome I (p36.3q23) (Tayel et al.• 1999).
The two mothers of the affected individuals also carried the PEl but were not affected.
However, none of the five unaffected sibs in the two sibships tested carried the
rearrangement and neither did the only father tested. The correlation between BBS and
this PEl may be coincidental. However, tp36 contains no less than five TNFRs and Iq23
contains two ligands ofTNFRs. One of these ligands. a transmembrane protein called
TNFSF18/A/TRL (tumor necrosis factor (ligand) superfamily member 18!activation
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inducible TNF family member), has its receptor. TNFRSFI8/AITR (tumor necrosis factor
receptor superfamily member 181activation inducible TNFR family member), on Ip36.3.
Thus far. AITR and its ligand Sttm to be imponant for interaction between activated T
lymphocytes and endothelial cells (Gurney et al.• 1999; Kwon et al.• 1999). However. to
date. only the two studies which initially identified these two TlO\'e1 proteins have been
published. Although the breakpoints are not mapped in this PEl. it is interesting that a
receptor and its ligand could be affected by the rearr.ulgement. PEls are mostly balancei1.
but familial translocations and inversions can predispose to the formation of uniparental
disomy. whereby autosomal recessive mutations can be reduced to homozygosity
(Cavenee el aJ.. 1983; Spence et al., 1988; Pentao et aJ.. 1992). Perhaps if uniparental
disomy did occur and either one of these receptors or ligands, or possibly both. were
affected by the PEl. then such a phenomenon may cause BBS in this family.
On 18pll.3. within a putative BBS locus (tested in C••peer 3.5). there is also a
mernberofa MAPK pathway' RAUBPIIR/PI (ROllA bindingprolein l!Ral-interacting
protein I). This serine/threonine kinase interacts with Fas and TNFRI. stimulating
apoptosis via the SAPK and NFICB pathways in vitro. ripJ deficient mice appear nonnal
Oil birth but fail to thrive. displaying extensive apoptosis in both the lymphoid and adipose
tissue (Kelliher el al.• 1998). RiPI is known to interact with TRAFI. 2 and 3 (Arch and
Thompson. 1998). Bet:ause of the already known complexities and intricacies of the
MAPK pathways, it is feasible that alterations in proteins confined 10 specific cells at
specific times during development. and possibly during adult life. in a novel but related
lSI
pathway. could lead to the BBS phenotype.
Other good candidate genes. presently unrelated to the MAPK pathways. are also
localm within the \'llJious BBS critical regions. TheDU1T1 gene is a member of the Ig
superfamily and a new member of the cell adhesion molecule family NCAM. It is located
on 3p12. within the BBS) critical region. It contains multiple fibronectin III domains and
putative trar.smembrane and intracellular domains (Sundaresa.n et ai.. 1998). Adult
human tissue expression is evident in all tissues tested. but weaker in kidney. Also. when
mouse embryo tissues were tested. there were identical expression pallems as in adults.
with the ma.1Cimal expression on day II. but none on or before day 7 (Sundaresan et al..
1998). This pattern was similar to the pattern found with the mkks transcripts in mice
(Dr. Nicholas Katsanis. personal communication). There is also some evidence that
DUTTI is involved in dimer formation. providing other opponunities for priJtein
interaction (Sundaresan et al., 1998). Such a gene. expressed in many tissues during
development. localized to the 8BS) interval and putatively part ofan unknown pathway.
makes an appealing BBSJ candidate.
Another interesting candidate. positioned within the BBSS region on 2'131, is an a·
integrin gene. ITGA Y (Femandcz-Ruiz and Sanchez-Madrid, 1994). It undergoes
post-traJlslation:lI cleavage to yield disulfide-linked heavy and light chains that combine
with multiple integrin I}.chains to form various integrins (Sims et al., 2000). Among the
known associating I}-chains (I}·chains 1,3,5.6. and 8) each can internet with
extracellular matrix ligands. The most studied ligands arc associated with the avl})
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heterodimer and include fibrinogen, thrombospondin. von WilJebrand factor and
vitronectin; none of these are known 10 map to 885 loci. This a-inlegrin is Icnown to
function in angiogenesis and vasculogenesis (Sims et al.• 2000). Notably, Nro other a·
integrin genes map 10 2q31 • ITGA6 and fTGM - possiblycompris:ng a clusler of such
genes (Feman<lez-Ruiz and Sanchez-Madrid, 1993).
Initially, the BBS5 locus was assigned in close proximity 10 the HOID-gene
cluster on chromosome 2q3 t. This led to the suggestion thai these nine homeobox genes
of the Drosophila ametlllapec/ia class, and other closely located genes (EYX2 and
DLX/lDLXl) that arc involved in patterning of the embryo. were candidate genes for
8855. Recent findings that duplication of the HOXDI 3 gene causes synpolydaclyly
(Marsu ct a/., 1996) earmarked it as a promising gene candidate, given thai syndactyly
and/or polydactyly arc congenital manifestations ofBBS. Howe\'er, refined mapping of
BB55 within the 13 eM interval 015156-0151238 placed it $Cveral centimorgans up-
stream from the HOXDI3 gene that is positioned at the proximal end of the HOm·gene
cluster (Spurr el al., 1996). Refined mapping of the recombinant ancestral chromosome
excludes all genes within the HOID-gene cluster as being candidate genes for BBS5.
Though the identification ofMKKSlB856 has directed ~archcrs to specific
candidates that arc possibly related to chapcronins themselves or their function, no clear
candidates genes have been assessed. More information about the function of
MKKSIBBS6 and with what it interacts with is required before other candidate genes can
be put forward with certainty.
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During the writing of this thesis, BBS2 and BBS4 were identified on 16q21
(Nishimura et al.• ZOO I) and 15q23 (Mykytyn el al., 2001), respectively. The open
reading frame of the BBS2 gene (AF34Z736) is composed of2163 bp comprising! 7
exons. Two frameshift. one substitulion and two nonsense mutalions were identified in
five unrelated BBS families. One frameshift and the two nonsense mutalions were in
exon eight. When Ihe BBS2 protein sequence was compared to other chaperone or
chaperone-like proteins. no significant similarity was found to any other genes with
known function. It was coneluded that 8BS2 is a novel gene whose function could not be
determined by comparison of primary sequence with any other known gene. Also. no
ohvious possible interactions wilh MKKSJ88S6 were identified. Due to Ihe identification
ofBBS1 it will now be possible to screen families B6. B7. BI! and BI4 for mutations.
The identification of BBS4 came not long after that of BBS2 (Mykytyn et al.•
2001). BBS4 (AF359281) consists of 16 exons spanning 52 kb with an open reading
frame of519 codons. Mutations were found in five consanguineous families and
consisted ofa two exon deletion (exons 3 and 4), a substitution mutation (R295P), and
two splice site alterations. Inlercstingly, the 6kb delelion was found in both an Italian
family and an unrelated Israeli Arab family. Furthermore, the deletion breakpoints were
within Alu repeat elements in introns 2 and 4. Also, in an additional non-consanguineous
family, only a single mulation was identified (585-586insTG) and no mutations were
found in a consanguineous family in which there was evidence for homozygosity OIl the
8BS4 locus. It was also shown Ihat BBS4 is ubiquitously expressed, with the highcst
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level of expression found in the kidney.
The BBS4 predicted protein sequence (AAK58868) is most similar to O-linked N·
acetylglucosamine(O-GIcNAc) transferase (OGT; Mykytyn ~t 01.. 2001). OGT in
Arabidopsis. called SPINDLY. has been sho'ollm to be a signal transduction protein
involved in a variety of developmental processes (Jacobsen C!t 01.• 1996). OGT is a
nucl~ytoplasmic glycosyhrmsferase which adds a single GIcNAc to hydroxyl groups of
serine and threonine residues. Proteins that arc modiifed byOGT include transcription
factors. kinascs. C)'1oskcletal proteins. and nuclear pore proteins (Roos and Hanover.
2000). This posltr.tnslational modification may prevent protein interactions required for
transcription activation and protein degradation (Han and Kudlow. 1997; Su el al.. 1999).
Panicularly. OGT may function in glucose metabolism since it has been shown to act
upon proteins im'olved in this pathway. including glycogen synthase kinase 3 (GSKJ).
casein kinase II (CKII). and insulin receptor substr1lte I and 2 (lRS I and 2)(Lubas et al..
1997; Paui et al.• 1999). Thus. OGT has~ implicated in insulin resistance and may
playa role in diabetes (Lubas et 01.• 1997; Hanover et al.• 1999).
Like the OGT protein. BBS4 contains a structural motifcalled the
tctratricopcptide repeat (TPR). The TPR matifis a degenerate. 34 amino acid repeat that
is found in proteins involved in a wide range ofcellular functions with the majority of
them participating in cell cycle control. transcription. protein transport. protein folding
and regulatory phosphate turnover (Blatch and Lassie. (999). This motifhas been shown
to be important in protein-protein interactions between a TPR protein and one or more
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non-TPR proteins. One oftne major types ofcomplexes that involve TPR proteins is the
molecular chaperone complex. The co-chaperone STIPI (stress-induced·phosphoprotein
I) is an Hsp701Hsp90 organizing protein., perhaps forming a 'bridge' between the two
chaperones (Smith et al.• 1993). Although BBS4 contains only one TPR motif. and
multiple TPRs~ needed for protein-protein interactions (Scheufler f!t 01., 2000). it is
possible that BBS4 oligomerizes to bring multiple TPRs together. Therefore. BBS4
could possibly oper.1le in a chaperone complex. However, TPR domains interact with
carboxy EEVD motifs (Scheufler et al.. 2000) which are not present in the BBS2 and
BBS6proteins.
4.5 Possible Cuu of 8BS
Clues to the cause ofBBS may be ascertained by considering human embryology,
espc:ci~lyduring the time of organogenesis in the second and third month of
development. At five weeks of felal development, the hand plate forms, the optic cup and
lens vesicle begin to invaginate. the cerebral hemispheres~ well marked. the
metanephros begins to develop and the cloacal folds and genital tubercle have appeared
(Larsen, 1997). Subsequently, in the sixth week, the foot plate develops and the hand
rays form. The major and minor calyces fonn and the kidney begins to ascend. Genital
ridges appear, the neurallaycrofthe retina begins 10 develop and pigment appears in the
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outer layer of the optic cup (Larsen. 1997; Sadler, 2(00).
By the end of the eighth week. the mesenchymal core of the peripheral part of the
platelike enlargement at the extremilY of lite limb bud has become increasingly condensed
to oul1ine the digits. and the thinner inter'{ening areas break do....'" from the circwnference
toward the centre. This apoptotic process. occurring in the nttrolic zones between lite
rays. may be carried OUI incompletely. causing the s)1ldaclyly and brachydactyly present
in BBS patients, Eventually. the blind ends of the secreting tubules in the developing
kidney must establish communication wilh the blind ends of the collecting tubules
derived from the metanephrogenic cap of the ureteral diverticulum. Failure to do so leads
to the fonnation ofcalyteaJ CysIS. a characteristic renal finding in BBS patients (Parfrey
etal.• 1997).
Although the definitive layers of the retina do not develop until late fetal life.
there is some differentiation observable in the stratification oflhis tissue. The inner and
outer neuroblastic layers are evident. as are the pigment retina, nerve fiber layel'". and Ihe
internal and extemallimiting membrane (Larsen. 1997). The disarray of this stratification
and Ihe malfunclioning of the photorec:eptors. which are evident in the retinal dystrophy
in BBS. could begin around this lime in embryonic eye fonnation.
The male and female genitalia are vinually indistinguishable in lheir development
up to this juncture. but after the twelfth week they begin to differentiate more
recognizably. The shan of the penis grows and the scrotum fonns. and in the female. the
vaginal plate elongates and canalizes. opening up into the uterus (Larsen. 1997; Sadler.
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2000). Lack of growth in the genitalia during this period, or previous to this, could lead
to the hypogonadism observed in male BBS palients. In females, the structural
malformations causing hydrometrocolpos would most likely occur at this time. as the
ulcrus and vagina are developing.
The time between when the fingers form and the blind ends of the tubules and the
COllecting ducts join in the kidney is a relatively long duration. How, when, and if the
systems affected in BBS intersect is difficult to determine. However, between the eighth
and tenth weeks after conception, the hands and feet, the layers of the retina. the genitalia.
and the kidneys have significantly developed and the cerebral cortex is differentiating. It
is possible that a fundamental developmental pathway that should be operational at this
time, during the maturation of severaI organs, may be defective in BBS. This prediction
by Parfrey et ai. (1997) is supported by preliminary results on the expression of
MKKSlBBS6 during development. The MKKSlBBS6 gene was ubiquitously expressed in
humans after week seven of gestation. In the mouse, mkks transcripts were detected by
stage 8.5 in the hem. in limb buds and forebrain by stage 9.0, and in every tissue by stage
11.5 (Dr. Nicholas Katsanis. personal communication).
An alternative hypothesis is that the BBS genes are regulated at different times
during development. For example, they could be turned on in the hand during week six
to seven when the fingers are differentiating, and in the kidney at week ten when the
forming nephron joins the collecting tubule· a tissue and time specific system. Such a
process seems more complex than the possibility that the affected systems have a
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tempor.l.l inters«tion during their development. However. even if such an overlap does
not exist, a mishap at some time previous to the fonnalion of some affected systems, but
during the development ofothers. could result in a chain reaclion that would eventually
cause the malfonnalions observed in these later fonning lissues. When and where the
defecl in the putative developmental pathway resulting in BBS occurs will remain
speculali\'e until studies on the function of BBS genes are undertaken.
4.5.1 Furlher Resunb into the Cause of DRS
The observation that mutations 011 anyone ofa minimum ofsix independent BBS
loci can result in nearly identieal phenotypes suggests thai the products of these genes an:
involved in a common biochemical or developmental pathway or that they are related as
part of a mul!i-subunit complex. The apparently unrelated pathologies characleristic of
BBS made it difficult 10 pmiict potential candidate genes unlil the discovery that
mutations in MKKS can cause BBS. This should accelerate the identification ofother
BBS genes through the identification ofproteins thai cooperale with MKKSlBBS6. 88S1
andfor 8854 to fonn a multi-subunit chaperone. or that require these genes for correct
folding.
One commonly used technique to identify proteins that interact with a protein of
interest is the yeast two-hybrid system. In this library-based method. in order for
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transcription ofa reporter gene to occur. then: must be altadunent ofboth a DNA-binding
protein and an activation protein to an upstream promoter region. The binding protein is
attached to the gene of interest and the activator domain attaches to a number of test
proteins. Only a protein that binds to the test protein will result in the transcription of the
reporter. Another commonly implemented method is phage display technology. Again
this is a Iibrary-based method in which members of a eDNA library are cloned into a
phage gene whieh encodes a phage coat protein. The recombinant gene will be displayed
on the virus' outer covering. The protein of interest, with a reporter molecule auached,
can be used to screen the recombinant phage library and any proteins interacting with the
probe-reporter molecule can be purified. A less sophisticated. but robust, approach to
identifying proteins interacting with MKKs/88S6, 88S4 or 88S1 is the classical co-
immunoprecipitation method. Celllysates are gcnen.ted, antibody is added, the antigen is
precipitated and washed. and bound protcins are eluted and analyzed.
An important technology that could be utilized in the study of BBS gene
expression and function is the crcation of genetically modified animals. By gene
targeting using homologous recombination, it is possible to alter or inactivate a gene and
monitor the effect ofthc mutation on the de\'elopment of the animal. The Cre-lo.tP site·
.specific rccombin3.tion system is a powerful tool in this type of gene targcting. The
function of the ere rccombinasc is to mediate recombination between two loxP sequcnces
th3.t are in the same orientation, leading to excision of the intervening sequence between
the two loxP sites. Using gene targcting., ImP sequences can be positioned into a desired
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gene or chromosomallocalion. When the Cre product is provided. an anificially
generated slte-direc:ted recombination event will occur. Because of the imponant nature
of the BBS gene products during development. the c~tion ofan mtks knock-out mouse
may result in an organism which is unviable. Therefore, cell type- and tissue.spccific
knock-out mice may be required. Mice with a Cre recombin.ase gene linked 10 a tissue
specific promoter arc mated with mice containing the sequence of inlCf'('5t flanked by /O.lP
sites. Offspring which contain both the /O.lP flanked sequence and the Cre gene will
express the Cre gene in the desired tissue type, resulting in the tissue specific inactivation
of the target locus. By using a tetracycline responsive promoter to express Cre
rccombinasc. a temporal as well as a tissue specific expression pattern can be created. In
this way, it would be theoretically possible to detennine the effects of mutations in mJcks
in the kidney, extremities. bl1lin and any other desired tissue at different periods of
de\·elopment.
Additional clinical infonnation from BBS families in Newfoundland may also
accelerate the accumulation of knowledge regarding the etiology of BBS. Several
in\,estigators have compared the phenotypes among and between families with different
fonns ofBBS. Carmi el al. (1995) tried to identify specific clinical features thaI wert
indicative of a particular BBS locus using the original three Arab-Bedouin lcindreds
linked to BBS2. BBS3, and BBS4. They concluded that mutations in BBS3 was associated
with polydactyly of all four limbs, whereas in BBS4 patients, polydactyly was usually
limited to the hands. They also indicated that the BBS4 fonn was associated with early-
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onset morbid obesity while BBS2 appeared to present the "leanest" fonn ofBBS. The
identification of BBS] revealed that this association docs not hold outside the Bedouin
population (non-Bedouin BSS patients with obvious obesity were homozygous for BBS}
mutations (Nishimura et at., Zool)}. Also. the "B8S3 phenotype" described by Carmi rt
af. (1995) was not observed in any of the five affected members of the Newfoundland
BBS3 family (Young et of.• 1998). Additionally, in a survey of 44 Scandinavian
individuals with BBS. Riise rt al. (1997) were unable to find any distinctive clinical
features that could separate individuals linked to BBS4 from those unassigned to a
panicular locus. Finally, only subtle phenotypic differences were noticed in a study of 18
BBS familics linked to BSSI. 8BS2 and B854 (Beales el al.. 1997). The most striking
difference was that affected offspring were laller than their parents in the BBSI category.
whereas affected subjects in the BBS2 and BBS4 groups were significantly shorter than
their parents. This led Beales et af. (1997) to speculate that the different genes
responsible for BBS may influence gro.....th characteristics such as height.
Because enviroruncntal ronditions and the genetic background of the
Nev.'foundland population are probably more similar lhan in other such studies. a
comparison of the clinical and phenotypic features ofaffected individuals with BBS on
the island may detennine the extent of variation within a locus and betwttn loci. Also. a
study of the possible phenotype ofheterozygolcs may be ascertained more readily in
Newfoundland for the above reasons and because of the availability of large families with
multiple affected and unaffected siblings.
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Identificalion of additional BBS genes should also aid in determining the
molecular basis of BBS. More candidate genes must be screened. Determining the
location ofalleast one additional BBS gene (BBSn should also expedite this process.
like the BI3 family, the B6lcindred. which \lo"aS excluded from all kno\lol1 BBS loci,
could be used in a genome-wide scan. Although it will not provide statistically
significant evidence for linkage. it could be used in conjunction with other unlinked
families identified by collaborating groups. If a putative locus for BBS7 is identified. it
could be tested in Ihese families for confirmation and for possible refinement of the
critical region.
Using Newfoundland families. it was possible 10 chanacter1ze the first gene to
cause Bardel-Biedl syndrome (MKKSlBBS6). Initially. a genetic SlllVey of 17 BBS
families with DNA markers linked 10 four known BBS loci (BBS/·4) was undertaken. As
a consequence of this survey, evidence for a fifth BBS locus (BBS5) was established.
Subsequently. this locus was mapped 10 2q31 in a large consanguineous Newfoundland
kindred. The 88S1 locus was also narrowed to I cM and the BBS) locus was confirmed
and funher delimited to a 6 eM interval. Six BBS families were excluded from all five
known BBS loci. One oflhese six families was used for a genome-wide scan,
193
implementing homozygosity mapping of pooled DNA samples. Through this method. a
sixth BaS locus (BBS6) was identified on 2Opl2 and subsequent[yconfirmed by five
other BBS families. A candidate gene. MKKS. was idenlified within the 2 eM BBS6
critical region and was screened for mutations in affccted individuals from six families.
All six families were shown to segregate BBS6 alteralions causing the disease in affccled
individuals. Surprisingly. three different mutations were: identified. One kindred was
excluded from BBS1-6. indicating a seventh BBS gene (BBS1). further demonstrating the
genetic heterogeneity ofBBS in Newfoundland. [t was possible to categorize 14 of the
17 Newfoundland BBS families to a single known BBS gene or locus.
One practical application of this work is that it gives individuals from BBS6
families the option ofcamer stalus testing. This will allow more accurate genctic
counselling.
The infonnation gathered in this thesis on the genetic basis of Bardet·Biedl
syndrome. using Newfoundland kindreds. should assist in the elucidation ofother BBS
genes and their products. In addition. such information ....ill aid in the unravelling of the
mechanisms which govern the regulation and distribution of body fal. as well as retinal.
limb. and kidneydevelopmcnt.
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Addendum
Eleven days prior to the oral defense of this thesis, an article by Katsanis ct al. (2001) was
published penaining to an alternative model of inheritance in Bardel-Biedl syndrome (Science
293: 2256-59). Specifically, the authors demonstrate that the BBS phenolype is due to triallelic
inheritance in some families. Thus, they conclude BBS may not strictly have an autosomal
recessive mode ofinheritanee, but one that spans the gap between classical Mendelian disorders
and complex traits.
In this paper, eight families, mapping to the BBS11ocus, were initially identified with
having only a single mutant allele within the open reading frame and exon-intron boundaries of
B8S2. Microsattelite analysis was also performed to determine ifany of these pedigrees
indicated linkage to 88S1, however only one of six informative families was consistent with
linkage to this gene. Also, when additional microsattelite markers were tested on Ihe five
families unlinked 10 BBS}, three of these families were excluded from all BBS loci exeept BDS/,
one family was consistent with mapping to BBS] only, and one to BBS6 only. This suggested
Ihatthere could be mutations in two different BSS genes in affected persons from these families.
Therefore, they screened [9885 families which had one or two 88S2 mutations, for mutations
in BBS6 (at this time only BBS) and BBS6 had been identified). Interestingly, four pedigrees
contained three mutant BSS alleles - two families with two BBS} mutations and one B856
mutation, and two families with onc BBS2 mutation and two 8BS6 mutations. One
Newfoundland family (814), characterized in this thesis, which was shown to be HBD at the
BBSliocus and also having a A242S alteration in BBS6, was one oflhese four triallellic
kindreds. In addition, the argument for triallelic inhcritance was augmenled by the faellhat in
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one family. an affected individual and an unaffected sib had two nonsense mutations in BBS}.
but only the affected palienl had a mutation in BBS6.
Thus. Katsanis et al. (2001) provided some mdence for a lrialleic mode of inheritance in
this di~. However. it remains uncenain if such a mechanism is required to cause BBS in all
circumstances, or ifit is exhibited only with a certain combination(s) ofBBS loci and/or
mUlations.
In Newfoundland, lriallelic inheritance maynol be an important BBS.causing
mechanism. Ifconsidered a true autosomal recessive disorder. then 25% ofoffspring of parents
who carry a BBS mutation. at a single BBS gene. should be affected with the disorder. In the 22
BBS families in Newfoundland, there I1re 43 affected individuals and 137 unaffecled sibs, giving
a segregation frequency of3\-;0 (95'/0 CI of23.6 - 39.2). This value is similar to the expected
frequency. lfthree individual mutations were necessary to cause a phenotype, than this
frequency for an autosomal recessive condition should be lower than 25%, and closer to 12.5%.
lnterestingly, the B14 kindred was homozygous for a BSSl mutation (Y24X) and heterozygous
for a BBS6 mutation (A142S) which was also found in the unaffecled sibling. It is uncenain
whether this BBS6 missmsc mUlation is truly a mutation or a rare polymorphism (it was found on
one Newfoundland comrol chromosome). As well. it was originally identified in both affected
and unaffected sibs in an MKS family in the homozygous form, as part ofa complex allele with
H84Y (Slone et at.. 2000).
In order to accul1ltcly assess the occurrence oftriallelic inheritance in Newfoundland,
mutation screening of all families for all BBS genes must be performed. Such an endeavor
should begin by screening the three characterized BBS genes (B8S2, BBS4 and BBS6).
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Appendix A
Pedigrees and Haplotype Data on 17
Newfoundland BBS Families
Legend
o UnatTecled person
• Person with BSS
rn Number of siblings
0' Deceased person
<> Unknown sex
= Known consanguineous relationship
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'i1
D155216 (6) (5)
D155131 (8) (2)
D155204 (5) (6)
0155114 (4) (4)
9 10 11 12 13 14 15
D155125 10 ~ 4 9~ 4 10~ 4 1~U~ 9~r 10~ 4 9~ 40155216 5 9 6 9 5 9 6 6 5 9 6 90155131 2 4 8 4 2 4 2 14 8 14 2 4 8 4
0155204 6 7 5 7 ~ O~ 8 5 6 7 6 7 5 70155114 4 04 4 04 4 4 4 4 4 04 4 04
Chromosome 11
Numbef:B6
501151298 (8)181(8)785(12) (12)011 5480 (9) (5)01154205 (4) (4)01151883 (5) (10)
PYGM (4) (4)0115913 (6) (7)011 5FGF3 (8) (9)
61
7
1
912 5
9 6
4 4
9 12
(8~ ~8)
01151298 81916765 12 12
011S480 9 9
011S4205 4 4
01151883 5 9
PYGM 4 80115913(8) (5)
011SFGF3 8 4
10
'!Ill' 1~1"1~2 1~1'21~2 1~1131; 1~1'4Ii10 9 10 9 10 12 5 12484848487575776794949585 81
15
1
912 5
5 8
4 4
10 12(1 t
Chromosome 3
Number B6
6 7
0351776 (7)Ir7) 6' 80351251 (9) (8) (4) (5)0351752 (7) (11) 6 70351271 (3) (4) 3 3
0351753 (6) (5) ? I?
9 10 11 12 13 14 15
0351776 7 i 0 8 ii~~ ii~~ ~im 1~i~~ 1~i~~ n~~03512519 503517527 7 11 70351271 3 03 4 0303517536 5 5 5
Chromosome 2
Number: B6
0282241 (3)161(9)1353 9 7
028124 (3) (3)
0282330 (5) (8)
0281776 (6) (8)
028335 (3) (5)
028'238 (5) (13) 1rI!
028224'31
9
1
'0
91
'01'0 31"1
'0
31
'2
1'0 31'31'0 31
'4
1
4
91
'5
1'002813539 6 7 6 7 6 9 6 9 6 9 5 7 6028124 3 7 3 7 3 7 3 7 3 7 3 5 3 702823305 5 8 5 8 5 5 5 5 5 5 6 8 5
02817766 6 8 6 8 6 6 6 6 6 (6) (5) 8 6
028335 3 4 (5) (4) (5) (4) 3 4 3 4 3 7 5 4
02812385 4 13 4 13 4 5 4 5 4 5 7 13 4
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Chromosome 15
Number: 88
7
0155216 81 50155131 1 8
0155204 1 7
015511oi" "
015521115 18
61
6
1"
6 '5
1: ~6
"
0'5521" 61"i"0155131 1 15
0155204 1 8
0155110i (") (6)
0155211 15 16
5 10i"6 67 6• •18 14 6
11
i"6 "1~1 t 61'2i", 151~ t
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Chromosome 16
Number: 810
40 41 5 6
0165419 (4)11(')0165390 (12) (10)
0165408 (2) (4)
0165265 (14) (16) !1
7
1!'
" .
37 J8
2<
01."''' .I~.168390 7 12
0168408 3 2
016826514 7
(7)
(7)
(7)
(7)
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Chromosome 20
Number: 811
0205;92 61615 517190205115 8 7 5 8
0205900 7 5 8 8
0205851 11 11 5 13
0205917 15 6 6 6
0205162 6 6 5 5
0205189 10 8 6 8
0205192 61819 519190205115 8 5 7 8
0205900 7 8 5 8
020585111 5 11 13
0205917 15 6 6 6
0205162 6 5 6 5
020518910 6 8 6
10
Chromosome 18
Number: 811
018J811'1619018563 7 ?
0185471 10 10
0185452 8 6
0185458 5 7
018562 6 6
0165464 5 3
1217 12? 7
10 10
6 8
3 7
9 9
4 4
10
0185481 11
01856318
0185471 10
0185452 8
0185458 5
018562 6
0185464 3
8~1218
10
6
7O~
"19~ 12? ?10 0
(8) (8)
5 7
6 09
5 4
Chromosome 16
Number:B11
5 6 7 10
-"'II' ·r0165390 6 14 12 501653039? ? 9 60165408 3 3 4 4016S52610 8 5 7016S26514 6 7 15STRP3 5 7 5 7STRP1 5 7 10 11
5TRP2 9 11 5 12
0165305725 25 4 10
0165503 7 7 14 14
6 9
"'~'l10165390 6 12 6 1201653039 6 9 6 90165408 3 4 3 4016552610 5 '0 5016526514 7 14 75TRP3 5 5 5 5STRP1 5 10 5 '05TRP2 9 5 9 50165305725 04 25 040165503 7 14 7 14
Chromosome 15
Number 811
5 6 7 100156216 5113
'i1lI5
0155131 5 16
0155204 3 6
0155114 4 5
015521126 21 21 21
6 9
0156216 31r 'n~~70155131 16 170155204 6 60155114 5 4015521121 21
Chromoaome 11
Number 811
5 6 7 10
."",. 'II'
ill!'
0118480 9 5
01184205 4 4
0118188312 12
PYGM 8 8
0118913 6 6
01181889 6 6
0118FGF312 9
01181369 8 6
6 9
o"..~ 'Ii'
'llil
0118480 9 5
01184205 4 4
0118188312 12
PYGM 8 8
0118913 6 7
01181889 6 6
0118FGF312 9
01181369 8 5
Chromosome 3
Number: B11
5 6 7 10
0·'='11' 'l'0381251 5 303817524 5 11 1103824195 5 7 903812714 7 4 503817536 4 ? ?0383652? ? 11 9
8 9
0"""'11' I'0381251 3 1003817525 11 5 1103824195 9 5 9381271 7 5 7 503817534 6 4 603836529 9 9 9
Chromosome 2
Number: 811
5 6 7 '0
·"='1
9
'1111
D2S2241 9 9
D2S13535 4
D2S1247 5
D2S2330 5 3
D2S17765 6
D2S335 ? ?
D2S12386 9 13 6
8 9
="·'11' t'D2S2241 9 7D2S13535 6D2S1247 7 5 7D2S2330 5 4 3 4D2S17765 5 6 5D2S335? ? 9 9D2S12386 6 9 6
Chromosome 16
Number: B12
15 80185419 51190165408 7 2
0165526 7 7
016526514 6
7(5)1 11)(3) (7)
IS) (1)
(7) (1)
10
016541991 501654082 3
0165526? 7
01652653 8
11
l~IU
13
01654195 1501654083 3
0165526 4 5
01652656 7
"~IU
19
Chromoaome 15
Number 812
1501552'6 91
6
150155131 6 16
0155204 4 6
0155114 4 4
015511113 23
7
~I m~ m
~ m
~ m
0155216 91'3160155131 7 6
0155204 6 5
0155114 3 4
015821122 19
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5
7 16
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Chromosome 2
Number: 814
10 9 24 12 11
0281353411' ~~Il028 56 6 160281245 502523309 40253359 702512385 13
13 14 15 16 17
0281353 Sir (6)lr0251 6 16 4 (16) (16)025124 5 7 (7) (9)
0252330 4 3 (5) (6)
025335 7 7 (3) (9)
025123813 7 (7) (6)
18 19
0281353 511' ~ili60281 6 16 16028124 5 70252330 4 5025335 7 3
0251238 13 7 13 6
j
Chromosome 15
Number: 815
5 24 25 6 7 6 • 10 11
,,".. "II'
"II' "Ir l0155216 5 6 5 5 (6) (5) 5 50155131? ? 4 6 (7) (6) (4) (6)0155204 6 6 6 7 (6) (7) 4 601551050 6 11 ? ? (11) (11) (5) (5)01551026 5 10 5 11 (10) (7) 5 100155114 4 4 1~ ~4 (4) (3) 3 4015521112 25 (24) (21) 11 23
12 13 14 15 16 17 16 ,. 20 21
""'" 'II'
'II' "Ii" T' "Ii" "Ii' "Ii" .!Iil 'II'
0155216 6 5 6 5 6 5 6 5 6 5 6 5 6 5 5 5
0155131 7 4 7 4 7 4 7 6 ? ? 7 4 7 4 6 4
0155204 6 4 6 4 6 4 6 6 6 4 6 4 6 4 7 4
01551050 11 5 11 5 11 5 11 5 11 5 11 5 11 5 11 5
0155102610 5 10 5 10 5 10 10 10 5 10 5 10 5 10 5 2~ ~10155114 4 3 2: ~1 2~ ~1 4 4 2: ~1 2: ~1 k~ W 4 4015521124 11 24 23 24 23
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Chromosome 18
Number: 816
018548' 91'1'2018563 6 18
018547' '0 10
0185458 7 3
018562 5 6
0185464 5 4
~ 121~29 10
7 7
9 9
4 7
3
0'85481 (9)1 (1)018563 (6) (1)
0'85471 (10) (1)
0185458 (7) (1)
018562 (5) (1)
0185464 (5) (1)
(6)
(8)
(8)
(7)
(5)
(4)
(7)
(7)
(1)
(1)
(1)
(1)
5
018548' 91018563 6
018547' 10
0185458 7
018562 5
0'85464 5
Chromosome 16
Number: 616
1
0165419 ? I,?
0165390 12 12
0165408 3 3
0165526 6 9
0165265 ? I ?
1;1
2
1~4
25 13
7 3
3
016541911 °14016539012 _ 14
0165408 3 3
0165526 6 25
0165265 70 7
(4)141(8)? ?
(6) (2)
(9) (25)
(8) (7)
501654194114
0165390? 0 ?
01654083 6
01655266 9
016526570 8
11 n61812 12
3 2
6 25
70 7
Chromosome 15
Number: 616
1
0155216 61190155131 16 11
0155204 4 4
0155114 4 4
2
1iUi6
3
0155216 7~~70155131 16 16
0155204? ?
0155114 4 6
4(5)li<?)(16) (3)
(5) (7)
(5) (4)
5
0155216 6~J' 50155131 16 '16
0155204 4 . 5
0155114 4 5
6
1i~j!
Chromosome 11
Number: 816
D11S1298 4,1
18
D11S480 5 6
D11S188310 12
PYGM 4 8
D11S913 6 7
D11SFGF3 8 5
D11S1314 8 8
D11S1369 7 ?
~ 121~25 128 4
5 5
5 9
8 8
5 5
D11S1298 8~3'9D 1S480 6 3
D11S1883 (12) (5)
PYGM (8) (8)
D11S913 7 5
D11SFGF3 5 5
D11S1314 8 8
D11S1369 6 5
(12)1
4
1(12)(7) (5)(10) (11)(8) (2)
(7) (5)
(12) (5)
(9) (9)
(7) (7)
D11S1298 9
D11S480 3
D11S188312
PYGM 8
D11S913 7
D11SFGF3 5
D11S1314 8
D11S1369 ?
12
5
11
2
5
5
9
?
8!6~ 121~ ~O
5 12
8 9
6 7
11
2
11"5 11
Chromosome 3
Number 816
0351776 81115251 9 9
0351752 4 7
0352419 7 5
0351271? 7
0351753 6 6
0353652 11 11
0351776 B~3110251 9 5
03517524 5
03524197 7
03512715 4
03517536 8
03536527 7
(5)1
4
(7)(6) ( )
(11) (7)
(5) (7)
(3) (7)
(6) (7)
(13) (7)
0351776 B~515251 9 6
0351752 4 11
0352419 7 5
0351271 5 3
0351753 6 6
0353652 11 13
B~B~59 64 11
(7~ ~5)
11 13
Chromosome 2
Number: 816
1 2
-'1
'II'
0251353 5 5 4 6
025156? ? 5 16
0252380 8 10 6 6
025124 7 3 ? 7
025233011 5 3 3
0251776 4 4 5 9
025335 5 5 ? 7
0251238 5 1 13 1
0252314 8 8 13 13
3 4
·="'1
(7)
'''I
(7)
0251353 (5) (7) (3) (7)
025156(14) (7) (16) (7)
0252380 (10) (7) (8) (7)
025124 (3) (7) (5) (7)
0252330 (5) (7) (8) (7)
0251118 (4) (7) (4) (7)
025335 (5) (?) (5) (7)
0251238 (1) (7) (1) (7)
0252314 (8) (7) (7) (7)
5 6
.,,"' 'II"
'11
0251353 5 3
025156 14 16
025238010 6
025124 3 5
0252330 5 6
0251776 4 4
025335 5 5
0251238 1 1
0252314 8 7
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Appd'diIB Mitrosaldlite marker i.r.....tioII r.,. dlromose-e 1. AU data were
obtalHd r..... Tile GeHIM Database ud Ranrdl Gnctia. IH.
Mit,.,.ldlile Repeal Type Siu<bpl "-pPIy
N••e
025442 T~tranucleotide 198-?
0251399 T~tranucletide 137-173
0252241 Oinucleolid~ 76·92 0.77
D25142 Dinucleotide 254-266 0.77
025418 Dinucleotide 216·226 0.53
0251353 Trinucleotide ISS·?
025156 Dinucleotide 168-198 0.86
0252380 Dinucleotide 159·175 0.63
025124 Dinucleotide 157·163 0.69
0252330 Dinucleotide 153 ·171 0.81
D251n6 T~tranuc:leotide 288·308
025335 Dinucleotide 98·114 0.79
0251238 Tetranucleotide 261-? >0.95
0252314 Dinucleotide 102·118 0.86
0251391 Tetranucleotide 124·?
8-1
AppndisC Mitrosatdlife ••ril.er iIIr.....no. ror cllre.GIOme 3. AU d.ta were
obCai-.l rl"Ol8 THG~ o.tabue aDd Rnardl GNdics. lac.
Microsaldlite RepntType 5in(bp) Helerozycosity
Na...e
D351776 Dinucleotide 205 -217 0.79
0351276 Dinucleotide 190- 202 0.72
0351663 Tetranucleotidc 360-7 0.80
0351595 Dinucleotide 295 -317 0.83
0351251 Dinucleotide 125 -139 0.77
0351752 Trinucleotide 201·7
0352419 Trinucleotide 213-225
0351271 Dinucleotide 146-158 0.75
0351753 Tetranucleotide 297-309
0353652 Dinucleotide 152·160 0.69
C-I
Appc:ltdis 0 Microsatdlile ••rbr iIIr.....1iH r.r dlrnBlOlHle 11. AI dara were
obtaiHd r,..11wee.o.e DaIabue.1Id M.1cb. d.t IIWT\.
MicrosaIldIiIe Repeal Type -!bp) Hdenzypity
01151298 Teuanucleotide 180·240 0.86
0115956 Teuanucleotide 241·303 0.88
01154191 Dinucleotide 111·135 0.88
01151765 248-?
0115480 Dinucleotide 189·201 0.77
01154205 Dinucleotide 194·200 0.31
01151883 Dinucleotide 250·266 0.74
01154945 Dinucleotide 223·'? 0.58
PYGM Dinucleotide 156- 190 0.90
01154946 Dinucleotide 154·? 0.73
01154940 Teuanucleotide 199·? 0.63
01154938 Tetranucleotide 159·? 0.54
01154941 Teuanucleotide 185·? 0.89
0115913 Dinucleotide 220 -? 032
01154095 Dinucleotide 193 ·205 0.65
01154113 Dinucleotide 218·262 0.81
01151889 Dinucleotide \ll:3·20? 0.69
01151337 Dinucleotide 279·293 0.60
01154178 Dinucleotide 238-260 0.68
FGn Dinucleotide 161 -177 0.82
01184139 Dinucleotide lSI -195 0.87
01181314 Dinucleotide 209·227 0.78
01181369 Teuanucleotide 180-?
1).\
AppndiI [ Mic:rosatdlite ••rbr i.form.lion for dlf'HtOSHIe IS. All d.h1 ..·er~
obCai.ed frHI The GeItOme Database aM Resc.~"GetldN:s, lac.
Mic:f'OSIItellite Repeal Type Size(bp) Heterozylosiry
Name
015S125 Dinucleotide 157- 169 0.80
015S216 Dinucleotide 225·2)] 0.64
0I5S131 Dinucleotide 235·274 0.84
DI5S204 Dinucleolide 116·1]4 0.79
015SI050 Dinucleotide 278-292 0.69
015SI026 Dinucleotide 201-215 0.74
015S114 Dinucleotide 177 -187 o.n
015$111 Dinucleotide 207·259 0.96
E-'
Appeadu. F Mic:roulellile marker i.formalioa for chromosome 16. All dahl we~
obtaiaed f~ Tile GeDO.e DlitabaH, Resn.1T1l Ge.etin, lac aDd P.
Baln (peno.al c:o.....alioe; i. red).
Mic:l'05aleUile Repea'Type Size (bp) Hderozygosily
Name
0165419 Dinucleotide 146-164 0.77
0165390 Dinucleotide 177 -195 0.80
01653039 Dinucleotide 255-265 0.73
016$408 Dinucleotide 241 -251 0.69
STRI>} 149-157
SlR!' I 308-337
SrRl'.:! 192-200
OI6S~():i7 Dinucleotide 188 -206 0.73
DI6S50.~ Dinucleotide 221-235 0.81
DI65526 Dinucleotide 205-? 0.83
DI653089 Dinucleotide 174 -200 0.88
D16$265 Dinucleotide 89·117 0.77
F·J
Appendix G Mic:ro!alrllile ...,ker iaCormalion Cor c:hrolllO!Omr 18. All dala were
oblaiHd Crnm The Grnome oalabue lIad Rneareb GeaelH:5,lnc.
Mitroulellile Repeat Type Size (bp) Heternzygo!ily
Name
0188481 Dinucleotide 183 -203 0.76
018863 Dinucleotide 255 -279 0.80
018852 Dinucleotide 116-130 0.77
DI88471 Dinucleotide 259-265 0.66
D18S452 Dinucleotide 123 -141 0.83
D18S458 Dinucleotide 208-218 0.59
018862 Dinucleotide 187- 195 0.67
018S464 Dinucleotide 283 -291 0.65
G-I
Appeadis H Mkroutdlice ••rker ia(o....lio. (or daromosolM 20. All dal. werr
obllliJIeod (ro.. Tille Gno_ o.lIIbue ••d Rnardl Ge.elks. lat.
MkntSllldlile RepnlType Sao(bp) HeterozylOlity
N••e
D20S192 Dinucleotide 287·299 0.75
020S900 Dinucleotide 135 ·145 0.63
0205115 Dinuc::leot.ide 232 - 238 0.67
020S85 I Dinucleotide 128·150 0.74
020S917 Dinucleotide 141 -167 0.81
D20S177 Dinucleotide 94· 102 0.59
020S175 Dinucleotide 166- 174 0.67
020S162 Tetranueleotide 246·? 0.80
020S189 Dinucleotide 295 -)09 0.75
020SI86 Dinucleotidt' 113·135 0.86
H-I
AppeDdis. I Primen uHd (or sequudD. no., 3 tllrou.h 6 or MXKS.
Pri.-erN.me Primt:r Seq.oCt: (5'-3')
MKKS.x3aF GATIlTATAGCCACAATGCT
MKKS.xJaR ATGACAGTGGTGGGTGTCAA
MKKShUbF TCTGGTGAGCATACAGGCAG
MKKS.ubR CGrITGGAAGCTAAGAAGCC
MKKS.xJcF GATCCTCCTITGTITGGTGC
MKKS.xkR GGTTAAGCAGCTGGTCCAAG
MKKS.xldF AATCAACTGCCCTCAAGGTG
MKKS.x3dR CCTTTGCTGCCAGAAATGAT
MKKS.x4F ATGCTIGTGGGGCTlTfATG
MKKS.x4R AATGGCAACACATGCCAAAT
MKKS.x5F GCACCACACAAGTIlTGlTC
MKKS.x5R CCTATACATGCACCCCTGAA
MIUCS~6aF GTGCCAGACCCCAAAITAAA
MKKS.x6aR CCAGITGAGlTCTTCCTGGC
MKKS.x6bF GGCAGAlTCTCCCTGTGTIG
MKKS.x6bR GCATITCCATTCACGAATCA
,.,




